NO145690B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF ALFA-METHYL-3,4-DIHYDROXYPHENYLALANINE. - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF ALFA-METHYL-3,4-DIHYDROXYPHENYLALANINE. Download PDFInfo
- Publication number
- NO145690B NO145690B NO743274A NO743274A NO145690B NO 145690 B NO145690 B NO 145690B NO 743274 A NO743274 A NO 743274A NO 743274 A NO743274 A NO 743274A NO 145690 B NO145690 B NO 145690B
- Authority
- NO
- Norway
- Prior art keywords
- solution
- methylalaninate
- dihydroxyphenyl
- reduced pressure
- mol
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 99
- 238000000034 method Methods 0.000 title claims description 26
- 230000001225 therapeutic effect Effects 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 61
- 150000001875 compounds Chemical class 0.000 claims description 39
- 229910052757 nitrogen Inorganic materials 0.000 claims description 31
- 229910052739 hydrogen Inorganic materials 0.000 claims description 26
- 239000001257 hydrogen Substances 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 23
- -1 monocyclic carboxylic acid Chemical class 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 230000000903 blocking effect Effects 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 238000001640 fractional crystallisation Methods 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000002950 monocyclic group Chemical group 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims 2
- 150000001340 alkali metals Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- HCXJFMDOHDNDCC-UHFFFAOYSA-N 5-$l^{1}-oxidanyl-3,4-dihydropyrrol-2-one Chemical group O=C1CCC(=O)[N]1 HCXJFMDOHDNDCC-UHFFFAOYSA-N 0.000 claims 1
- 125000002015 acyclic group Chemical group 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 313
- 239000000243 solution Substances 0.000 description 237
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 168
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 166
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 107
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 102
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 92
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 91
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 87
- 238000001914 filtration Methods 0.000 description 86
- 239000000203 mixture Substances 0.000 description 73
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 72
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 66
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 60
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 58
- 239000003054 catalyst Substances 0.000 description 57
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 56
- 239000000047 product Substances 0.000 description 55
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 54
- 239000002904 solvent Substances 0.000 description 54
- 239000000741 silica gel Substances 0.000 description 51
- 229910002027 silica gel Inorganic materials 0.000 description 51
- 239000007787 solid Substances 0.000 description 44
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 43
- 239000000706 filtrate Substances 0.000 description 41
- 238000004809 thin layer chromatography Methods 0.000 description 40
- 239000011541 reaction mixture Substances 0.000 description 33
- 229910000029 sodium carbonate Inorganic materials 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 26
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 24
- 235000019341 magnesium sulphate Nutrition 0.000 description 24
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 23
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 23
- 150000002148 esters Chemical class 0.000 description 22
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 238000001704 evaporation Methods 0.000 description 20
- 230000008020 evaporation Effects 0.000 description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 229960004132 diethyl ether Drugs 0.000 description 17
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 16
- 239000012453 solvate Substances 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 15
- 229960000583 acetic acid Drugs 0.000 description 15
- 238000001035 drying Methods 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 238000001953 recrystallisation Methods 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 12
- 239000000725 suspension Substances 0.000 description 11
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 239000005457 ice water Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 8
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 7
- 230000002378 acidificating effect Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 6
- 239000012346 acetyl chloride Substances 0.000 description 6
- 230000003276 anti-hypertensive effect Effects 0.000 description 6
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 6
- 239000012458 free base Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 5
- VXJJFIUCQHAHGD-UHFFFAOYSA-N 1-(1-chloroethyl)pyrrolidine-2,5-dione Chemical compound CC(Cl)N1C(=O)CCC1=O VXJJFIUCQHAHGD-UHFFFAOYSA-N 0.000 description 5
- 239000005909 Kieselgur Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000003957 anion exchange resin Substances 0.000 description 5
- 239000012223 aqueous fraction Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000003729 cation exchange resin Substances 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 239000002198 insoluble material Substances 0.000 description 5
- 235000006408 oxalic acid Nutrition 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000012259 ether extract Substances 0.000 description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- ZDYUUBIMAGBMPY-UHFFFAOYSA-N oxalic acid;hydrate Chemical compound O.OC(=O)C(O)=O ZDYUUBIMAGBMPY-UHFFFAOYSA-N 0.000 description 4
- 239000011592 zinc chloride Substances 0.000 description 4
- 235000005074 zinc chloride Nutrition 0.000 description 4
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 3
- LELWHPFBIHGMGF-UHFFFAOYSA-N 1-(1-chloroethyl)pyrrole-2,5-dione Chemical compound CC(Cl)N1C(=O)C=CC1=O LELWHPFBIHGMGF-UHFFFAOYSA-N 0.000 description 3
- DEAFKLPWKKXYPV-UHFFFAOYSA-N 1-(1-chloropropyl)pyrrolidine-2,5-dione Chemical compound CCC(Cl)N1C(=O)CCC1=O DEAFKLPWKKXYPV-UHFFFAOYSA-N 0.000 description 3
- BQMNOFMIPNDHEH-UHFFFAOYSA-N 1-(chloromethyl)piperidine-2,6-dione Chemical compound ClCN1C(=O)CCCC1=O BQMNOFMIPNDHEH-UHFFFAOYSA-N 0.000 description 3
- VWZUIIYOJGQRBR-UHFFFAOYSA-N 2-(3,4-dihydroxyanilino)-2-methylpropanoic acid Chemical compound OC(=O)C(C)(C)NC1=CC=C(O)C(O)=C1 VWZUIIYOJGQRBR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 3
- CTRMIYMAJSGICW-UHFFFAOYSA-N benzyl 4-(chloromethylamino)-4-oxobutanoate Chemical compound ClCNC(=O)CCC(=O)OCC1=CC=CC=C1 CTRMIYMAJSGICW-UHFFFAOYSA-N 0.000 description 3
- RNJVIZUFATYZGC-UHFFFAOYSA-N benzyl 4-(hydroxymethylamino)-4-oxobutanoate Chemical compound OCNC(=O)CCC(=O)OCC1=CC=CC=C1 RNJVIZUFATYZGC-UHFFFAOYSA-N 0.000 description 3
- ZLSTXEBTAJKDKH-UHFFFAOYSA-N benzyl 4-amino-4-oxobutanoate Chemical compound NC(=O)CCC(=O)OCC1=CC=CC=C1 ZLSTXEBTAJKDKH-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 description 3
- OPTDDWCXQQYKGU-UHFFFAOYSA-N diphenyldichloromethane Chemical compound C=1C=CC=CC=1C(Cl)(Cl)C1=CC=CC=C1 OPTDDWCXQQYKGU-UHFFFAOYSA-N 0.000 description 3
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 3
- 239000002024 ethyl acetate extract Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940091173 hydantoin Drugs 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 150000003891 oxalate salts Chemical class 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000001119 stannous chloride Substances 0.000 description 3
- 235000011150 stannous chloride Nutrition 0.000 description 3
- 150000003892 tartrate salts Chemical class 0.000 description 3
- LCPVUEPTKODYOL-SFHVURJKSA-N (2s)-3-(3,4-dihydroxyphenyl)-2-methyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@](C)(NC(=O)OCC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C(O)=C1 LCPVUEPTKODYOL-SFHVURJKSA-N 0.000 description 2
- KRODOTCDHSCOKN-UHFFFAOYSA-N 1-(bromomethyl)pyrrolidine-2,5-dione Chemical compound BrCN1C(=O)CCC1=O KRODOTCDHSCOKN-UHFFFAOYSA-N 0.000 description 2
- AZVYYSCOCHRFKW-UHFFFAOYSA-N 1-(hydroxymethyl)pyrrolidine-2,5-dione Chemical compound OCN1C(=O)CCC1=O AZVYYSCOCHRFKW-UHFFFAOYSA-N 0.000 description 2
- QWDRFWRNOIYJAW-UHFFFAOYSA-N 1-chloroethyl 3-chloro-2,2-dimethylpropanoate Chemical compound CC(Cl)OC(=O)C(C)(C)CCl QWDRFWRNOIYJAW-UHFFFAOYSA-N 0.000 description 2
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- IZEHTUOZCOJIIP-INIZCTEOSA-N [(2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoyl]oxymethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCOC(=O)[C@@](C)(N)CC1=CC=C(O)C(O)=C1 IZEHTUOZCOJIIP-INIZCTEOSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 2
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- QMEZUZOCLYUADC-UHFFFAOYSA-N hydrate;dihydrochloride Chemical compound O.Cl.Cl QMEZUZOCLYUADC-UHFFFAOYSA-N 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-M oxalate(1-) Chemical compound OC(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-M 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000012056 semi-solid material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 2
- 229960002317 succinimide Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ZFHLDFAQANWKNM-HNNXBMFYSA-N (2,5-dioxopyrrolidin-1-yl)methyl (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate Chemical compound C([C@@](N)(C)C(=O)OCN1C(CCC1=O)=O)C1=CC=C(O)C(O)=C1 ZFHLDFAQANWKNM-HNNXBMFYSA-N 0.000 description 1
- NLRUDGHSXOEXCE-PPHPATTJSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;hydrochloride Chemical compound Cl.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 NLRUDGHSXOEXCE-PPHPATTJSA-N 0.000 description 1
- CBDODEKCOJNURQ-BQAIUKQQSA-N (2s)-2-amino-3-(6,7-diphenyl-2,4-dioxabicyclo[3.2.2]nona-1(7),5,8-trien-9-yl)-2-methylpropanoic acid;hydrochloride Chemical compound Cl.OC(=O)[C@](N)(C)CC1=CC(=C2C=3C=CC=CC=3)OCOC1=C2C1=CC=CC=C1 CBDODEKCOJNURQ-BQAIUKQQSA-N 0.000 description 1
- PKZMQIOYOSAGPC-GPIXMLASSA-N (2s)-3-(6,7-diphenyl-2,4-dioxabicyclo[3.2.2]nona-1(7),5,8-trien-9-yl)-2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound N([C@@H](C(C)C=1C=2OCOC(=C(C=2C=2C=CC=CC=2)C=2C=CC=CC=2)C=1)C(O)=O)C(=O)OCC1=CC=CC=C1 PKZMQIOYOSAGPC-GPIXMLASSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- TYHWOUFVKPTEDK-UHFFFAOYSA-N 1-(bromomethyl)-2-[2-(bromomethyl)phenoxy]benzene Chemical compound BrCC1=CC=CC=C1OC1=CC=CC=C1CBr TYHWOUFVKPTEDK-UHFFFAOYSA-N 0.000 description 1
- QMKGDTFTYVGRIB-UHFFFAOYSA-N 1-(hydroxymethyl)piperidine-2,6-dione Chemical compound OCN1C(=O)CCCC1=O QMKGDTFTYVGRIB-UHFFFAOYSA-N 0.000 description 1
- VQEZDLXEVJCRMO-UHFFFAOYSA-N 1-chloroethyl 2,2-dimethylpropanoate Chemical compound CC(Cl)OC(=O)C(C)(C)C VQEZDLXEVJCRMO-UHFFFAOYSA-N 0.000 description 1
- KZCSJWFLPQFDNW-UHFFFAOYSA-N 1-ethenylpyrrole-2,5-dione Chemical compound C=CN1C(=O)C=CC1=O KZCSJWFLPQFDNW-UHFFFAOYSA-N 0.000 description 1
- VOCDJQSAMZARGX-UHFFFAOYSA-N 1-ethenylpyrrolidine-2,5-dione Chemical compound C=CN1C(=O)CCC1=O VOCDJQSAMZARGX-UHFFFAOYSA-N 0.000 description 1
- ILJLKOYRVKQUOJ-UHFFFAOYSA-N 1-prop-1-enylpyrrolidine-2,5-dione Chemical compound CC=CN1C(=O)CCC1=O ILJLKOYRVKQUOJ-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- CILPHQCEVYJUDN-UHFFFAOYSA-N 2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetic acid Chemical compound CC(C)C1CCC(C)CC1OCC(O)=O CILPHQCEVYJUDN-UHFFFAOYSA-N 0.000 description 1
- RFAHYFCQZDZXLP-UHFFFAOYSA-N 2-(chloromethyl)-1,1-dioxo-1,2-benzothiazol-3-one Chemical compound C1=CC=C2S(=O)(=O)N(CCl)C(=O)C2=C1 RFAHYFCQZDZXLP-UHFFFAOYSA-N 0.000 description 1
- VYEGAEUUQMJXTM-UHFFFAOYSA-N 2-(chloromethyl)-1-methylimidazole Chemical compound CN1C=CN=C1CCl VYEGAEUUQMJXTM-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- VIRWKAJWTKAIMA-UHFFFAOYSA-N 2-chloroethyl acetate Chemical compound CC(=O)OCCCl VIRWKAJWTKAIMA-UHFFFAOYSA-N 0.000 description 1
- WBBPRCNXBQTYLF-UHFFFAOYSA-N 2-methylthioethanol Chemical compound CSCCO WBBPRCNXBQTYLF-UHFFFAOYSA-N 0.000 description 1
- NSWICVLRGXOPTD-UHFFFAOYSA-N 3-(chloromethyl)-1-methylimidazolidine-2,4-dione Chemical compound CN1CC(=O)N(CCl)C1=O NSWICVLRGXOPTD-UHFFFAOYSA-N 0.000 description 1
- MQZNDDUMJVSIMH-UHFFFAOYSA-N 3-chloro-2,2-dimethylpropanoyl chloride Chemical compound ClCC(C)(C)C(Cl)=O MQZNDDUMJVSIMH-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- TWVDRFUUFFYSLR-NTISSMGPSA-N [(2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoyl]oxymethyl 2,2-dimethylpropanoate;hydrochloride Chemical compound Cl.CC(C)(C)C(=O)OCOC(=O)[C@@](C)(N)CC1=CC=C(O)C(O)=C1 TWVDRFUUFFYSLR-NTISSMGPSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- IYUKFAFDFHZKPI-DFWYDOINSA-N methyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@H](C)N IYUKFAFDFHZKPI-DFWYDOINSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- SYTINTXRJQFYAO-UHFFFAOYSA-N n-(2-chloroethyl)-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)NCCCl SYTINTXRJQFYAO-UHFFFAOYSA-N 0.000 description 1
- FYQJUYCGPLFWQR-UHFFFAOYSA-N n-(2-chloroethyl)benzamide Chemical compound ClCCNC(=O)C1=CC=CC=C1 FYQJUYCGPLFWQR-UHFFFAOYSA-N 0.000 description 1
- NIPIPZLKDRUXGB-UHFFFAOYSA-N n-(2-chloroethyl)pyridine-3-carboxamide Chemical compound ClCCNC(=O)C1=CC=CN=C1 NIPIPZLKDRUXGB-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- RLXDCJUIXHSXQD-UHFFFAOYSA-N oxalic acid;hydrate Chemical compound O.OC(=O)C(O)=O.OC(=O)C(O)=O RLXDCJUIXHSXQD-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
Foreliggende oppfinnelse angår en analogifremgangsmåte The present invention relates to an analog method
ved fremstilling av en ny og nyttig gruppe terapeutisk aktive forbindelser som er derivater av a-methyl-3,4-dihydroxyfenyl- in the preparation of a new and useful group of therapeutically active compounds which are derivatives of α-methyl-3,4-dihydroxyphenyl-
alanin. alanine.
Det har vært foreslått i faget at forskjellige alaninfor-bindelser kan være nyttige ved behandling av hypertensjon (se US patent 2.868-818). Det er videre kjent i faget at hypertensjon fortrinnsvis behandles med L-a-methyl-3,4-dihydroxyfenylalanin da D-formen av forbindelsen er terapeutisk inert og bare L-formen er terapeutisk aktiv. Fjernelsen av D-formen minsker derved toksi-siteten og øker effektiviteten (se US patent 3-344-023 og britisk patent 936.074)• L-isomeren av a-methyl-3,4-dihydroxyfenylalanin betegnes vanligvis som L-a-methyldopa eller methyldopa. Det er videre kjent i faget at alkylesterne av L- eller DL-a-methyl-3,4-dihydroxyfenylalanin er nyttige ved nødstilfellebehandling av hypertensjon ved parenteral administrasjon (se US patent 3.230.143). Det har nu vist seg at andre estere og derivater av DL- eller L-a-methyl-3,4-dihydroxyfenylalanin med spesifikke strukturer også er virksomme ved behandling av hypertensjon, hvorved man får alternative forbindelser for slik behandling. Det har også vist seg at noen av de nye forbindelser har en meget høyere aktivitet og således krever en lavere dosering enn de kjente forbindelser. It has been suggested in the art that various alanine compounds may be useful in the treatment of hypertension (see US patent 2,868-818). It is further known in the art that hypertension is preferably treated with L-α-methyl-3,4-dihydroxyphenylalanine as the D form of the compound is therapeutically inert and only the L form is therapeutically active. The removal of the D-form thereby reduces toxicity and increases effectiveness (see US patent 3-344-023 and British patent 936,074) • The L-isomer of α-methyl-3,4-dihydroxyphenylalanine is usually referred to as L-α-methyldopa or methyldopa. It is further known in the art that the alkyl esters of L- or DL-α-methyl-3,4-dihydroxyphenylalanine are useful in the emergency treatment of hypertension by parenteral administration (see US patent 3,230,143). It has now been shown that other esters and derivatives of DL- or L-α-methyl-3,4-dihydroxyphenylalanine with specific structures are also effective in the treatment of hypertension, whereby alternative compounds are obtained for such treatment. It has also been shown that some of the new compounds have a much higher activity and thus require a lower dosage than the known compounds.
Det er følgelig et mål ved foreliggende oppfinnelse å fremskaffe en ny og nyttig gruppe forbindelser som er mere aktive ved behandling av hypertensjon enn tidligere kjente forbind- It is therefore an aim of the present invention to provide a new and useful group of compounds which are more active in the treatment of hypertension than previously known compounds.
elser. others.
Foreliggende oppfinnelse angår således en analogifrem- The present invention thus relates to an analog
gangsmåte ved fremstilling av terapeutisk aktive forbindelser som angitt i overbegrepet til krav 1, procedure for the production of therapeutically active compounds as stated in the preamble to claim 1,
De alternative analogifremgangsmåter fremgår av karak-teristikken til krav 1. The alternative methods of analogy appear from the characteristics of claim 1.
I en foretrukken utførelsesform av foreliggende oppfinnelse er n og m O eller 1, A1 og A2 er hydrogen, R1 og R2 er hydrogen eller methyl, og R^ er den heterocycliske ring: In a preferred embodiment of the present invention, n and m are O or 1, A1 and A2 are hydrogen, R1 and R2 are hydrogen or methyl, and R^ is the heterocyclic ring:
som kan være substituert med lavere alkylgrupper med 1-3 carbonatomer, eller R^ er -X-R^ hvor X er -0- eller -NH-, og R^ er en acylgruppe av en alkansyre med 2-5 carbonatomer. which may be substituted with lower alkyl groups with 1-3 carbon atoms, or R^ is -X-R^ where X is -O- or -NH-, and R^ is an acyl group of an alkanoic acid with 2-5 carbon atoms.
Ved foreliggende fremgangsmåte fremskaffes videre estere av L-isomeren av en aminosyre, i det vesentlige fri for D-isomeren, med formelen: In the present method, further esters of the L-isomer of an amino acid, essentially free of the D-isomer, are obtained with the formula:
eller farmasøytisk godtagbare syreaddisjonssalter derav, hvor n, m, R^, R^ og Rg er som ovenfor angitt. Med hensyn til L-isomeren bør det merkes at det asymmetriske carbonatom er det som bærer amino- og methylgruppene i syredelen av molekylet. Det er denne del av molekylet som betegnes som værende i L-konfigurasjonen. Merk at L-konfigurasjonen refererer seg til romkonfigurasjonen og ikke til den optiske dreining, skjønt i dette tilfelle er L-romkonfigurasjonen 1- eller levo-formen av den optiske isomer. or pharmaceutically acceptable acid addition salts thereof, where n, m, R^, R^ and Rg are as above. With regard to the L-isomer, it should be noted that the asymmetric carbon atom is the one that carries the amino and methyl groups in the acid part of the molecule. It is this part of the molecule that is designated as being in the L configuration. Note that the L configuration refers to the space configuration and not to the optical rotation, although in this case the L space configuration is the 1 or levo form of the optical isomer.
Det bør imidlertid merkes at i noen tilfelle når R^ og R2 er forskjellige grupper, er det carbonatom til hvilket de er bundet, også et asymmetrisk carbonatom, og kan således foreligge i enten L- eller D-konfigurasjonen. Som det nedenfor vil bli påpekt, er begge isomerene av denne del av forbindelsen aktive. Som det videre påpekes, er disse stereoisomerer blitt adskilt, men deres stereokonfigurasjon er ikke blitt bestemt slik at de bare betegnes som a- og p-isomeren. i ethvert fall er både a- og (3-isomerene aktive uten hensyn til deres romkonfigurasjon. However, it should be noted that in some cases when R 1 and R 2 are different groups, the carbon atom to which they are attached is also an asymmetric carbon atom, and can thus be in either the L or D configuration. As will be pointed out below, both isomers of this part of the compound are active. As further pointed out, these stereoisomers have been separated, but their stereoconfiguration has not been determined so that they are only referred to as the α and β isomers. in any case, both the α- and β-isomers are active regardless of their spatial configuration.
Ved behandling av hypertensjon administreres fremgangsmåteforbindelsene i alminnelighet i mengder fra 0,005 til 300 mg/kg legemsvekt av dyret, og fortrinnsvis fra 0,05 til 100 mg/kg. Ved en enda mere foretrukken utførelsesform administreres forbindelsene i mengder fra 0,1 til 25 mg/kg legemsvekt av dyret. I denne forbindelse bør det merkes at dosen må avpasses avhengig av forbindelsens aktivitet, responsen som ønskes i reduksjon av blodtrykk, og også vekten av dyret. I de ovenfor angitte områder ville de mere aktive forbindelser bli gitt i de lavere doser, og de mindre aktive forbindelser i de høyere doser. In the treatment of hypertension, the process compounds are generally administered in amounts from 0.005 to 300 mg/kg body weight of the animal, and preferably from 0.05 to 100 mg/kg. In an even more preferred embodiment, the compounds are administered in amounts from 0.1 to 25 mg/kg body weight of the animal. In this connection, it should be noted that the dose must be adjusted depending on the activity of the compound, the desired response in reducing blood pressure, and also the weight of the animal. In the areas indicated above, the more active compounds would be given in the lower doses, and the less active compounds in the higher doses.
Når L-isomeren av en av fremgangsmåteforbindelsene gies i When the L-isomer of one of the process compounds is given in
i det vesentlige fravær av D-isomeren, er den nødvendige dose av L-isomeren ca. halvparten av den for racematet, da D-isomeren er terapeutisk inaktiv. Fremgangsmåteforbindelsene varierer imidlertid med hensyn til aktivitet i noen grad, og således kan racematet av en mindre aktiv fremgangsmåteforbindelse kreve flere ganger dosen av.en mere aktiv forbindelse. I alminnelighet vil imidlertid forbindelsene bli administrert innen de ovenfor angitte doser. in the substantial absence of the D-isomer, the required dose of the L-isomer is approx. half that of the racemate, as the D-isomer is therapeutically inactive. However, the process compounds vary with regard to activity to some extent, and thus the racemate of a less active process compound may require several times the dose of a more active compound. In general, however, the compounds will be administered within the dosages indicated above.
I en enkeltdoseform av preparater av fremgangsmåteforbindelsene er den aktive forbindelse i alminnelighet tilstede i preparatet i mengder fra 1 mg til 2000 mg, og mere foretrukket 5. mg til 1000 mg. I en enda mere foretrukken utførelsesform er den aktive forbindelse tilstede i mengder fra 10 mg til 500 mg. Enkeltdoseformen av forbindelsen kan administreres i en enkelt langsomtvirkende dose eller den kan administreres i flere små In a single dose form of preparations of the process compounds, the active compound is generally present in the preparation in amounts from 1 mg to 2000 mg, and more preferably 5 mg to 1000 mg. In an even more preferred embodiment, the active compound is present in amounts from 10 mg to 500 mg. The single dose form of the compound can be administered in a single slow-acting dose or it can be administered in several small doses
doser i løpet av døgnet, i alminnelighet 2 til 8 individuelle doser. doses during the day, generally 2 to 8 individual doses.
Reduserte doser av L-isomeren i det vesentlige fri for D-isomer kreves sammenlignet med racematet. Forskjellen i aktivitet hos forskjellige forbindelser nødvendiggjør imidlertid anvendelsen av forskjellige doser. I noen tilfelle er forbindelsene mange ganger mere aktive enn andre, og således kan racematet av en kreve en enda mindre dose enn den for L-isomeren av en annen. I alminnelighet vil imidlertid dosene ligge innenfor de ovenfor angitte områder. Reduced doses of the L-isomer substantially free of the D-isomer are required compared to the racemate. However, the difference in activity of different compounds necessitates the use of different doses. In some cases, the compounds are many times more active than others, and thus the racemate of one may require an even smaller dose than that of the L-isomer of another. In general, however, the doses will lie within the ranges indicated above.
Ved en foretrukken utførelsesform av oppfinnelsen utføres fremgangsmåten med en aminosyredel av molekylet som er i L-romkonfigurasjon. In a preferred embodiment of the invention, the method is carried out with an amino acid part of the molecule which is in the L space configuration.
Ved en foretrukken utførelsesform av oppfinnelsen utføres fremgangsmåten med en aminosyredel av molekylet som er i L-rom-konf igurasjon. In a preferred embodiment of the invention, the method is carried out with an amino acid part of the molecule which is in the L-space configuration.
Uttrykkene <M>(-CH2)n" og "(-CH2)m" omfatter også de forgrenede alkylengrupper som The terms <M>(-CH2)n" and "(-CH2)m" also include the branched alkylene groups which
Fortrinnsvis er n og m 0 eller 1. Preferably n and m are 0 or 1.
i in
Uttrykket "en monocyclisk eller bicyclisk ..... 5 til 6 ledd" betyr at forbindelsene inneholder ett eller to ring-nitrogenatomer med eventuelt et ring-svovelatom og fra 3 til 12 ring-carbonatomer. Forbindelsene inneholder videre 1 eller 2 ringer med 5 eller 6 ledd The expression "a monocyclic or bicyclic ..... 5 to 6 membered" means that the compounds contain one or two ring nitrogen atoms with optionally a ring sulfur atom and from 3 to 12 ring carbon atoms. The compounds also contain 1 or 2 rings with 5 or 6 members
i hver ring, og ringene kan være substituert med slike grupper som halogen, hydroxyl, amino eller andre slike grupper. in each ring, and the rings may be substituted with such groups as halogen, hydroxyl, amino or other such groups.
Uttrykket "L-isomeren av en aminosyre, i det vesentlige fri for D-isomeren" betyr at D-isomeren er tilstede i mengder som ikke overstiger 10%. Det er imidlertid ønskelig at D-isomeren er i det vesentlige fraværende fra preparatet. I eksemplene som følger, er, når L-isomeren angies , i det vesentlige 100% (dvs. godt over 99%) i L-konfigurasjonen. The phrase "the L-isomer of an amino acid, substantially free of the D-isomer" means that the D-isomer is present in amounts not exceeding 10%. However, it is desirable that the D-isomer is essentially absent from the preparation. In the examples that follow, when the L isomer is indicated, substantially 100% (ie, well over 99%) is in the L configuration.
Uttrykket "blokkerende gruppe" betegner en hvilken som helst gruppe som vil beskytte amino- eller hydroxylgruppene under reaksjonen. Blant passende blokkerende grupper for nitrogenatomet er carbobenzyloxy, p-methoxy-carbobenzyloxy, trifluoracety1, HCl og lignende. Passende blokkerende grupper for hydroxylgruppen er difenylketal for begge hydroxylgrupper og acetyl og carbobenzyloxy for de individuelle hydroxylgrupper såvel som andre slike grupper. Substituenten i den "substituerte -SO^-gruppe" kan stort sett være en hvilken som helst gruppe da disse grupper lett avspaltes under forestringsreaksjonen og naturen av gruppen er slett ikke kritisk. The term "blocking group" denotes any group that will protect the amino or hydroxyl groups during the reaction. Among suitable blocking groups for the nitrogen atom are carbobenzyloxy, p-methoxy-carbobenzyloxy, trifluoroacety1, HCl and the like. Suitable blocking groups for the hydroxyl group are diphenyl ketal for both hydroxyl groups and acetyl and carbobenzyloxy for the individual hydroxyl groups as well as other such groups. The substituent in the "substituted -SO^ group" can be basically any group as these groups are easily split off during the esterification reaction and the nature of the group is not at all critical.
Når racemiske blandinger dannes ved foreliggende fremgangsmåte, er det av og til ønskelig å skille blandingene i deres L- When racemic mixtures are formed by the present process, it is sometimes desirable to separate the mixtures into their L-
og D-isomerer. Isomerene kan skilles på et hvilket som helst punkt i syntesen,og i de fleste tilfelle er det ønskelig å skille dem før dannelsen av sluttproduktet. I andre tilfelle (som når R^ og er forskjellige grupper, og syredelen er i L-konfigurasjonen), dannes en blanding av diastereomerer som sluttprodukt, og disse kan skilles direkte ved krystallisasjon eller dannelsen av enkle derivater med krystallisasjon. Det er imidlertid langt foretrukket å gå ut fra den ønskede isomer (dvs. L-isomeren) når en enkelt isomer ønskes. Det er også mulig å danne en diastereomer av den racemiske blanding fremstilt ifølge oppfinnelsen for å bevirke adskillelse. and D isomers. The isomers can be separated at any point in the synthesis, and in most cases it is desirable to separate them before the formation of the final product. In the second case (when R^ and are different groups, and the acid part is in the L configuration), a mixture of diastereomers is formed as the final product, and these can be separated directly by crystallization or the formation of simple derivatives with crystallization. However, it is far preferred to proceed from the desired isomer (ie the L-isomer) when a single isomer is desired. It is also possible to form a diastereomer of the racemic mixture prepared according to the invention to effect separation.
I slike tilfelle kan en optisk aktiv syre som vinsyre, lO-kamfer-sulfonsyre, malinsyre, pyroglutamsyre, menthoxyeddiksyre og lignende anvendes. Valget av den spesielle syre kan skje efter ønske og vil være åpenbar for en fagmann. In such cases, an optically active acid such as tartaric acid, 10-camphor sulphonic acid, malic acid, pyroglutamic acid, menthoxyacetic acid and the like can be used. The choice of the particular acid can be as desired and will be obvious to a person skilled in the art.
Fremgangsmåteforbindelsene kan anvendes i form av preparater som fortrinnsvis administreres i enhetsdoseformer som tabletter, piller, kapsler, pulvere, granuler, sterile parenterale oppløs-ninger eller suspensjoner, orale oppløsninger eller suspensjoner og lignende. Slike preparater fremstilles på konvensjonelt vis. Tablettene eller pillene av fremgangsmåteforbindelsene kan være laminert eller på annen måte sammensatt for- å fremskaffe en dose som gir fordelen ved forlenget eller forsinket virkning eller forutbestemt suksessiv virkning av det inneholdte medikament. Eksempelvis kan tablettene eller pillen omfatte en indre dose og en ytre dosekomponent, idet sistnevnte er i form av et hylle over den førstnevnte. The process compounds can be used in the form of preparations which are preferably administered in unit dose forms such as tablets, pills, capsules, powders, granules, sterile parenteral solutions or suspensions, oral solutions or suspensions and the like. Such preparations are produced in a conventional manner. The tablets or pills of the method compounds may be laminated or otherwise composed to provide a dose which provides the benefit of prolonged or delayed action or predetermined successive action of the contained drug. For example, the tablets or pill may comprise an inner dose and an outer dose component, the latter being in the form of a shelf above the former.
De følgende eksempler er gitt for å belyse oppfinnelsen. The following examples are given to illustrate the invention.
Alle deler er angitt i vektdeler hvor annet ikke uttrykkelig er anført. Uttrykket "nedsatt trykk" anvendt i de følgende eksempler er 15 til 25 mm Hg ved 25 - 35°C (hvor annet ikke er anført). Når nedsatt trykk anvendes for å fjerne et oppløsningsmiddel, er det erholdte produkt ofte et solvat og således refererer eksemplene til dannelsen av et "konsentrert" produkt, skjønt alt oppløsnings-middel er fjernet med unntagelse av det som er bundet i produktet. All parts are stated in parts by weight unless otherwise expressly stated. The term "reduced pressure" used in the following examples is 15 to 25 mm Hg at 25 - 35°C (where not otherwise stated). When reduced pressure is used to remove a solvent, the product obtained is often a solvate and thus the examples refer to the formation of a "concentrated" product, although all solvent has been removed except that which is bound in the product.
Eks empel 1 Example 1
A. Fremstilling av L-3-(3>4-difenylmethylendioxyfenyl)-2-methyl-alanin- hydroklorid A. Preparation of L-3-(3>4-diphenylmethylenedioxyphenyl)-2-methyl-alanine hydrochloride
En blanding av 19,3 9 (O,0777 mol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-hydroklorid [L-a-methyldopa-hydroklorid] og 37 g. A mixture of 19.3 g (0.0777 mol) of L-3-(3,4-dihydroxyphenyl)-2-methylalanine hydrochloride [L-α-methyldopa hydrochloride] and 37 g.
(0,156 mol) diklordifenylmethan neddykkes under langsom omrøring (0.156 mol) of dichlorodiphenylmethane is immersed under slow stirring
i et foropphetet oljebad ved 190°C. Efter at reaksjonen har begynt, som det fremgår av kraftig gassutvikling, omrøres reaksjonsblandingen hurtig i 6 minutter ved 190°C, taes ut av det varme oljebad og får lov til å avkjøles til 25 - 30°C. Det rå produkt fra 12 for-søk forenes, oppslemmes med 3 1 diethylether, filtreres, vaskes med ytterligere 2 1 diethylether og tørres ved 30°C under 50 mm trykk. in a preheated oil bath at 190°C. After the reaction has begun, as evidenced by strong gas evolution, the reaction mixture is stirred rapidly for 6 minutes at 190°C, removed from the hot oil bath and allowed to cool to 25 - 30°C. The crude product from 12 experiments is combined, slurried with 3 1 diethyl ether, filtered, washed with a further 2 1 diethyl ether and dried at 30°C under 50 mm pressure.
Omkrystallisasjon utføres ved å oppløse produktet i ethanol og tilsette ethylacetat for å felle produktet. Fremgangsmåten gir 255 g (66,4%) L-3-(3,4-difenyImethylendioxyfenyl)-2-methylalanin-hydroklorid, smp. 267 - 268°C (spaltn.y Recrystallization is performed by dissolving the product in ethanol and adding ethyl acetate to precipitate the product. The process yields 255 g (66.4%) of L-3-(3,4-diphenylimethylenedioxyphenyl)-2-methylalanine hydrochloride, m.p. 267 - 268°C (splitn.y
Anal. beregn, for C^H^NO^HCL: C 67,07; H 5,39; N 3,40 Anal. calculate, for C^H^NO^HCL: C 67.07; H 5.39; N 3.40
Funnet: C 66,91; H 5,29; N 3,34 Found: C 66.91; H 5.29; N 3.34
B. Fremstilling av L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxy-f enyl1) - 2- methylalanin B. Preparation of L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxy-phenyl1)-2-methylalanine
En blanding av 175 g (0,425 mol) L-3-(3,4-difenylmethylen-dioxyf enyl)-2-methylalanin-hydroklorid, 1750 ml aceton og 1750 ml vann omrøres under nitrogen ved en temperatur under 10 C mens pH innstilles på 12,0 ved langsom tilsetning av en 10%-ig natrium-hydroxydoppløsning. 93 9 (0,545 mol) carbobenzyloxyklorid tilsettes dråpevis i løpet av 5 - 7 minutter til reaksjonsblandingen ved 20 - 30°C under samtidig tilsetning av en 10%-ig natriumhydroxyd-oppløsning for å opprettholde en pH på 12,0 - 12,2. Ef ter at tilsetningen av carbobenzyloxykloridet er avsluttet, omrøres reaksjonsblandingen ved 25 - 30°C i 3 timer. Det meste av acetonet fjernes så under nedsatt trykk ved 25 - 35°C for å felle natriumsaltet av det ønskede N-carbobenzyloxyderivat. Natriumsaltet ekstraheres i 1,5 1 ethylacetat, vaskes med 200 ml 5%-ig natriumhydroxydoppløs-ning og 200 ml av en mettet nat riumkloridoppløsning og tørres så over magnesiumsulfat. Efter tilsetning av 17,5 g avfarvende carbon og filtrering gjennom en magnesiumsulfatplate, fjernes opp-løsningsmidlene under nedsatt trykk ved 25 - 35°C. Residuet oppslemmes to ganger med 1 1 av en 20 volum% ethylether-80 volum% hexanoppløsning og filtreres, hvorved man får natriumsaltet av det ønskede N-carbobenzyloxyderivat. Dette natriumsalt oppløses i 1,5 1 ethylacetat, avkjøles til 10°C og syres til pH 2 med 6 N saltsyre. Ethylacetatekstraktet vaskes med 200 ml av en mettet natriumkloridoppløsning, tørres over magnesiumsulfat, filtreres og inndampes under nedsatt trykk ved 25 - 35°C. N-carbobenzyloxyderivatet tørres ytterligere ved 25 - 30°C og 0,2 - 0,3 mm Hg, hvorved man får 169 g (78,0%) L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyfenyl)-2-methylalanin. A mixture of 175 g (0.425 mol) L-3-(3,4-diphenylmethylene-dioxyphenyl)-2-methylalanine hydrochloride, 1750 ml of acetone and 1750 ml of water is stirred under nitrogen at a temperature below 10 C while the pH is adjusted to 12.0 by slow addition of a 10% sodium hydroxide solution. 93 9 (0.545 mol) carbobenzyloxychloride is added dropwise over 5 - 7 minutes to the reaction mixture at 20 - 30°C while simultaneously adding a 10% sodium hydroxide solution to maintain a pH of 12.0 - 12.2. After the addition of the carbobenzyloxychloride has been completed, the reaction mixture is stirred at 25 - 30°C for 3 hours. Most of the acetone is then removed under reduced pressure at 25-35°C to precipitate the sodium salt of the desired N-carbobenzyloxy derivative. The sodium salt is extracted in 1.5 1 ethyl acetate, washed with 200 ml of 5% sodium hydroxide solution and 200 ml of a saturated sodium chloride solution and then dried over magnesium sulphate. After adding 17.5 g of decolorizing carbon and filtering through a magnesium sulfate plate, the solvents are removed under reduced pressure at 25 - 35°C. The residue is slurried twice with 1 1 of a 20% by volume ethyl ether-80% by volume hexane solution and filtered, whereby the sodium salt of the desired N-carbobenzyloxy derivative is obtained. This sodium salt is dissolved in 1.5 1 ethyl acetate, cooled to 10°C and acidified to pH 2 with 6 N hydrochloric acid. The ethyl acetate extract is washed with 200 ml of a saturated sodium chloride solution, dried over magnesium sulphate, filtered and evaporated under reduced pressure at 25 - 35°C. The N-carbobenzyloxy derivative is further dried at 25 - 30°C and 0.2 - 0.3 mm Hg, whereby 169 g (78.0%) of L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2 are obtained -methylalanine.
C> Fremstilling av succinimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)- 2- methylalaninat C> Preparation of succinimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2- methylalaninate
En oppløsning av 13,5 g (0,0265 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,7 g (0,027 mol) triethylamin og 5,19 9 (0,029 mol) N-brommethylsuccinimid i 35 ml tørt dimethylformamid omrøres ved 25 - 30°C i 16 timer. Reaksjonsblandingen helles i 400 ml isvann, og produktet ekstraheres i 200 ml av en 50 volum% kloroform-50 volum% diethyletherblanding. A solution of 13.5 g (0.0265 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.7 g (0.027 mol) triethylamine and 5.19 9 (0.029 mol) N -bromomethylsuccinimide in 35 ml of dry dimethylformamide is stirred at 25 - 30°C for 16 hours. The reaction mixture is poured into 400 ml of ice water, and the product is extracted into 200 ml of a 50% by volume chloroform-50% by volume diethyl ether mixture.
Det organiske ekstrakt vaskes med 50 ml fortynnet (5%-ig) natrium-carbonatoppløsning og 50 ml mettet nat riumkloridoppløsning og tørres over vannfritt magnesiumsulfat for å fjerne vann. Efter filtrering og inndampning under nedsatt trykk omkrystalliseres residuet. Omkrystallisasjon utføres ved å oppløse produktet i ethanol og tilsette hexan for å felle produktet. Fremgangsmåten gir 12,1 g (73,6) succinimidomethyl-L-N-carbobenzyloxy-3-(3,4~di-fenylmethylendioxy—fenyl)-2-methylalaninat, smp. 143,0 - 145,0 C. The organic extract is washed with 50 ml of diluted (5% strength) sodium carbonate solution and 50 ml of saturated sodium chloride solution and dried over anhydrous magnesium sulfate to remove water. After filtration and evaporation under reduced pressure, the residue is recrystallized. Recrystallization is performed by dissolving the product in ethanol and adding hexane to precipitate the product. The process yields 12.1 g (73.6) of succinimidomethyl-L-N-carbobenzyloxy-3-(3,4~di-phenylmethylenedioxy-phenyl)-2-methylalaninate, m.p. 143.0 - 145.0 C.
Anal. beregn, for C^ H^ N^^ : C 69,66; H 5,20; N 4,51 Anal. calculate, for C^ H^ N^^ : C 69.66; H 5.20; N 4.51
Funnet: C 69,83; H 5,14» N 4,52 Found: C 69.83; H 5.14" N 4.52
D. Fremstilling av succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid- hydrat D. Preparation of succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate
En suspensjon av 6,6 g (0,0106 mol) succinimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 180 ml absolutt ethanol og 9 ml 9,6 N ethanolisk-vannfri hydrogen-kloridoppløsning hydrogeneres med 3,3 9 av en 10%-ig palladium-på-carbonkatalysator ved et begynnelsest rykk på o 2,1 kg/cm 2 inntil hydrogenopptageIsen er fullstendig. Efter fjernelse av katalysatoren ved filtrering inndampes filtratet under nedsatt trykk. Residuet ekstraheres med 50 ml benzen og derpå med 50 ml ethylacetat. Det uoppløselige faste stoff rystes så med 50 ml av en 10 volum% ethanol-90 volum% ethylacetatblanding og IO ml mettet natriumcarbonatoppløsning. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. Residuet oppløses i 25 ml absolutt ethanol, behandles med 5 ml 9,6 N ethanolisk-vannfri hydrogenkloridoppløsning og inndampes under nedsatt trykk, hvorved man får 2,5 9 (62,7%) succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 30 volum% methanol-70 volum% benzen-oppløsningsmiddel) med en iakttatt Rf = 0,5. A suspension of 6.6 g (0.0106 mol) of succinimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 180 ml of absolute ethanol and 9 ml of 9.6 N ethanolic-anhydrous hydrogen chloride solution is hydrogenated with 3.3 9 of a 10% palladium-on-carbon catalyst at an initial thrust of o 2.1 kg/cm 2 until hydrogen uptake is complete. After removal of the catalyst by filtration, the filtrate is evaporated under reduced pressure. The residue is extracted with 50 ml of benzene and then with 50 ml of ethyl acetate. The insoluble solid is then shaken with 50 ml of a 10% by volume ethanol-90% by volume ethyl acetate mixture and 10 ml of saturated sodium carbonate solution. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue is dissolved in 25 ml absolute ethanol, treated with 5 ml 9.6 N ethanolic-anhydrous hydrogen chloride solution and evaporated under reduced pressure, whereby 2.5 9 (62.7%) succinimidomethyl-L-3-(3,4- dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate, homogeneous by thin layer chromatography (fluorescent silica gel plate, 30 vol% methanol-70 vol% benzene solvent) with an observed Rf = 0.5.
Anal. beregn, for ^ 1^ 1^ 206'HC1-H20: C ^7'ol> H 5,62-, N 7,44 Funnet: C 48,09; H 5,74; N 7,42 Anal. calculate, for ^ 1^ 1^ 206'HC1-H20: C ^7'ol> H 5.62-, N 7.44 Found: C 48.09; H 5.74; N 7.42
Eksempel 2 Example 2
A. Fremstilling av N-( l- klorethyl)- succinimid A. Preparation of N-(1-chloroethyl)-succinimide
50,0 g (0,40 mol) N-vinylsuccinimid oppløses i 1000 ml carbontetraklorid, 5,20 g (0,020 mol) stanniklorid tilsettes, og blandingen omrøres mens den mettes med hydrogenklorid i 6 timer ved 20 - 30°C. Efter 24 timer mettes blandingen igjen med hydrogenklorid i 1,5 timer. Ved utløpet av 48 timer dekanteres oppløsningen, og det gummiaktige residuum vaskes med 10 x 100 ml carbontetraklorid. 50.0 g (0.40 mol) of N-vinylsuccinimide is dissolved in 1000 ml of carbon tetrachloride, 5.20 g (0.020 mol) of stannous chloride is added, and the mixture is stirred while being saturated with hydrogen chloride for 6 hours at 20 - 30°C. After 24 hours, the mixture is saturated again with hydrogen chloride for 1.5 hours. At the end of 48 hours, the solution is decanted, and the gummy residue is washed with 10 x 100 ml of carbon tetrachloride.
De forenede ekstrakter oppslemmes med 10 g diatoméjord, filtreres, og filtratet inndampes under nedsatt trykk til ca. 400 ml. N-(l-klorethyl)-succinimidet frafiltreres og tørres ved 20 - 30°C under nedsatt trykk, hvorved man får 38,4 g (59%) av hvitt, fast stoff som smelter ved 83,5 - 84,5°C. The combined extracts are slurried with 10 g of diatomaceous earth, filtered, and the filtrate is evaporated under reduced pressure to approx. 400 ml. The N-(1-chloroethyl)-succinimide is filtered off and dried at 20 - 30°C under reduced pressure, whereby 38.4 g (59%) of a white solid is obtained which melts at 83.5 - 84.5°C .
B. Fremstilling av a-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4~B. Preparation of α-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4~
difenylmethylendioxyfenyl)- 2- methylalaninat diphenylmethylenedioxyphenyl)- 2- methylalaninate
En blanding av 30,66 g (0,o6o mol) L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyf enyl ) -2-methylalanin , 9,70 g (0,o6o mol) N-(l-klorethyl)-succinimid, 6,07 g (0,060 mol) triethylamin og 75 ml tørt dimethylformamid omrøres ved 95°C i 19 timer. Reaksjonsblandingen helles i 750 ml vann, og produktet ekstraheres i 3 x 500 ml ethylacetat. De forenede organiske ekstrakter vaskes med 3 x 300 ml 5%-ig natriumhydroxydoppløsning, derpå med 3 x 300 ml mettet natriumkloridoppløsning, og tørres over vannfritt magnesiumsulfat. Efter filtrering behandles oppløsningen med 5 g trekull, filtreres, og oppløsningsmidlet fordampes under nedsatt trykk, hvorved man får 37,90 g (99%) a-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyfenyl)-2-methylalaninat som en blanding av diastereomere isomerer (a og (3) . A mixture of 30.66 g (0.060 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 9.70 g (0.060 mol) N-(1-chloroethyl) -succinimide, 6.07 g (0.060 mol) of triethylamine and 75 ml of dry dimethylformamide are stirred at 95°C for 19 hours. The reaction mixture is poured into 750 ml of water, and the product is extracted into 3 x 500 ml of ethyl acetate. The combined organic extracts are washed with 3 x 300 ml of 5% sodium hydroxide solution, then with 3 x 300 ml of saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. After filtration, the solution is treated with 5 g of charcoal, filtered, and the solvent is evaporated under reduced pressure, whereby 37.90 g (99%) of α-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2 is obtained -methylalaninate as a mixture of diastereomeric isomers (a and (3) .
C Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid C Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En suspensjon av 20,18 9 (0,032 mol) a-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 275 ml 25 volum% absolutt ethanol-75 volum% ethylacetat-oppløsning hydrogeneres med 8,5 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,8 kg/cm og værelsetemperatur i 23 timer. Katalysatoren frafiltreres, og filtratet inndampes under nedsatt trykk ved 30 - 40°C. Residuet oppløses i 250 ml lo volum% ethanol-90 volum% ethylacetat-oppløsning og omrøres med 20 ml mettet nat-riumcarbonatoppløsning og ca. 30 g. vannfritt natriumcarbonat i A suspension of 20.18 9 (0.032 mol) α-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 275 ml of 25% by volume absolute ethanol-75% by volume ethyl acetate solution is hydrogenated with 8 .5 g of 10% palladium-on-carbon catalyst at an initial pressure of 2.8 kg/cm and room temperature for 23 hours. The catalyst is filtered off, and the filtrate is evaporated under reduced pressure at 30 - 40°C. The residue is dissolved in 250 ml of 10% by volume ethanol-90% by volume ethyl acetate solution and stirred with 20 ml of saturated sodium carbonate solution and approx. 30 g. anhydrous sodium carbonate i
10 minutter. Efter filtrering tørres filtratet over vannfritt mag-nesiumsulf at, filtreres og inndampes til tørrhet under nedsatt trykk. Residuet oppløses i 130 ml tørr kloroform, oppløsningen av-kjøles på isbad og mettes med hydrogenklorid i 15 minutter. Det faste stoff oppsamles, vaskes ved å suspendere det i 100 ml vannfri ether tre ganger og derpå oppslemme det i 300 ml ethylacetat under nitrogen i en korket kolbe ved værelsetemperatur over natten. a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydrokloridet oppsamles, omrøres i 300 ml hexan i 2 timer og tørres i vakuumekssikator over calciumklorid, hvorved man får 8,32 g (62%) 10 minutes. After filtration, the filtrate is dried over anhydrous magnesium sulphate, filtered and evaporated to dryness under reduced pressure. The residue is dissolved in 130 ml of dry chloroform, the solution is cooled in an ice bath and saturated with hydrogen chloride for 15 minutes. The solid is collected, washed by suspending it in 100 ml of anhydrous ether three times and then slurried in 300 ml of ethyl acetate under nitrogen in a stoppered flask at room temperature overnight. The α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride is collected, stirred in 300 ml of hexane for 2 hours and dried in a vacuum desiccator over calcium chloride, thereby obtaining 8.32 g (62%)
av hydrokloridet av en blanding av a- og p-isomerer, iakttatt Rf =0,7 ved tynnskiktskromatografi (fluorescerende silicagelplate, 50 volum% methanol-50 volum% benzen-oppløsningsmiddel). of the hydrochloride of a mixture of α- and β-isomers, observed Rf =0.7 by thin-layer chromatography (fluorescent silica gel plate, 50 vol% methanol-50 vol% benzene solvent).
Anal. beregn, for <C>l<6H>20N206.HC1.1/2 CH3C02C2H^: C 51,86; H 6,05; Anal. calculate, for <C>1<6H>20N206.HC1.1/2 CH3C02C2H^: C 51.86; H 6.05;
N 6,7 Funnet: C 51,98; H 5,87; N 6.7 Found: C 51.98; H 5.87;
N 6,65 N 6.65
Eksempel 3 Example 3
A. Separasjon av a-succinimidoethyl-L-N-carbobenzyloxy-3-(3>4-dihydroxyfenylmethylendioxyfenyl)- 2- methylalaninat- isomerer A. Separation of α-succinimidoethyl-L-N-carbobenzyloxy-3-(3>4-dihydroxyphenylmethylenedioxyphenyl)-2- methylalaninate isomers
En blanding av 150,5 g av de diastereomere isomerer fra eksempel 2 oppløses i en kokende blanding av 1200 ml benzen og 100 ml absolutt methanol, filtreres, og filtratet inndampes til et volum på ca. 700 ml. 100 ml absolutt methanol tilsettes til oppløsningen som så fortynnes til blakning med lOOO ml hexan, podes og skrapes for å bevirke krystallisasjon. Blandingen avkjøles ved 5°C i ca. 16 timer, og den rå krystallinske a-isomer oppsamles så, vaskes ved suspendering i 200 ml av en 50:50 blanding (volum) av benzen og hexan og tørres ved 70°C. Produktet veier 68,1 g og smelter ved 185,5 - 191°C. En analyseprøve smelter ved 199,5 - 201,5°C efter ytterligere to omkrystallisasjoner. A mixture of 150.5 g of the diastereomeric isomers from example 2 is dissolved in a boiling mixture of 1200 ml of benzene and 100 ml of absolute methanol, filtered, and the filtrate is evaporated to a volume of approx. 700 ml. 100 ml of absolute methanol is added to the solution which is then diluted to pale with 1000 ml of hexane, seeded and scraped to effect crystallization. The mixture is cooled at 5°C for approx. 16 hours, and the crude crystalline α-isomer is then collected, washed by suspension in 200 ml of a 50:50 mixture (volume) of benzene and hexane and dried at 70°C. The product weighs 68.1 g and melts at 185.5 - 191°C. An analytical sample melts at 199.5 - 201.5°C after two further recrystallizations.
Anal. beregnet for C^H^I^Og: C 70,02; H 5,40; N 4,4l Anal. calculated for C^H^I^Og: C 70.02; H 5.40; N 4.4l
Funnet: C 70,22; H 5,52; N 4,29 Found: C 70.22; H 5.52; N 4.29
De forenede morluter og vaskinger fra a-isomeren inndampes til tørrhet under nedsatt trykk ved 6o°C, hvorved man får 79,3 g av (3-isomeren som en meget viskøs olje. The combined mother liquors and washings from the a-isomer are evaporated to dryness under reduced pressure at 6o°C, whereby 79.3 g of the (3-isomer) are obtained as a very viscous oil.
B. Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methy lalaninat - hydroklor id- dihydrat (( 3- isomer) B. Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methyl lananinate - hydrochloride id- dihydrate ((3-isomer)
En oppløsning av 10,0 g (0,016 mol) a-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat ((3-isomer) i 140 ml 25 volum% absolutt ethanol-75 volum% ethylacetat-oppløsning hydrogeneres med 4,2 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,8 kg/cm<2> og værelsetemperatur i 20 timer inntil hydrogenopptagelsen er fullstendig. Katalysatoren frafiltreres under nitrogen, filtratet syres med 2,0 ml 9,4 N ethanolisk hydrogenklorid og inndampes til tørrhet under nedsatt trykk ved 30 - 40°C. Det amorfe, faste residuum oppløses i 50 ml varm 95%-ig ethanol (5% vann), filtreres, og filtratet fortynnes til begynnende blakning med 68 ml vannfri ether, podes og skrapes for å bevirke krystallisasjon. Produktet oppsamles og omrøres i 300 ml vannfri ether for å fjerne eventuell difenylmethan. Efter 1 time oppsamles det faste stoff og tørres ved 70°C over natten, hvorved man får 3,7 g materiale som smelter ved 123 - 126°c (spaltn.). Omkrystallisasjon fra 20 ml 95%-ig ethanol gir 3,36 g (51%) a-succin-imidoethyl -L-3- (3 ,4-dihydroxyf enyl) -2-methylalaninat -hydroklorid-dihydrat (|3-isomer) som dihydrat som smelter ved 129 - 131 C (spaltn.) A solution of 10.0 g (0.016 mol) of α-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate ((3-isomer) in 140 ml of 25 vol% absolute ethanol-75 vol% ethyl acetate solution is hydrogenated with 4.2 g of 10% palladium-on-carbon catalyst at an initial pressure of 2.8 kg/cm<2> and room temperature for 20 hours until hydrogen absorption is complete. The catalyst is filtered off under nitrogen, the filtrate is acidified with 2 .0 ml of 9.4 N ethanolic hydrogen chloride and evaporated to dryness under reduced pressure at 30 - 40° C. The amorphous, solid residue is dissolved in 50 ml of hot 95% ethanol (5% water), filtered, and the filtrate is diluted to initial bleaching with 68 mL of anhydrous ether, seeded and scraped to effect crystallization. The product is collected and stirred in 300 mL of anhydrous ether to remove any diphenylmethane. After 1 hour, the solid is collected and dried at 70°C overnight to give 3.7 g of material melting at 123 - 126°c (dec.).Recrystallization n from 20 ml of 95% ethanol gives 3.36 g (51%) α-succin-imidoethyl -L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride dihydrate (|3-isomer) as dihydrate which melts at 129 - 131 C (dec.)
(tørret ved 70°C over natten), som er homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 50 volum% methanol-50 volum% benzen-oppløsningsmiddel), Rf = 0,7- (dried at 70°C overnight), which is homogeneous by thin-layer chromatography (fluorescent silica gel plate, 50 vol% methanol-50 vol% benzene solvent), Rf = 0.7-
Anal. beregn, for C^H^r^Og .HC1.2H20: C 47,00; H 6,l6; N 6,85 Funnet: C 46,85, 47,09; H 6,12, 6,l6; Anal. calculate, for C^H^r^Og .HCl.2H20: C 47.00; H 6,16; N 6.85 Found: C 46.85, 47.09; H 6.12, 6.16;
N 6,76, 6,61 N 6.76, 6.61
[a]2/* = + 33,46°(C = 1,5 CH30H) [a]2/* = + 33.46° (C = 1.5 CH 3 OH)
Eksempel 4 Example 4
A. Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat - hydroklorid fg- isomer) A. Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate - hydrochloride fg-isomer)
En oppløsning av 10,0 g (0,016 mol) a-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat (a-isomer) i 140 ml 25 volum% absolirtt ethanol-75 volum% ethylacetat-oppløsning hydrogeneres med 4,2 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsest rykk på o 2,8 kg/cm 2 og værelsetemperatur i 27,5 timer inntil hydrogenopptagelsen er fullstendig. 2 ml av en 9,4 N ethanolisk oppløsning av vannfritt hydrogenklorid tilsettes, A solution of 10.0 g (0.016 mol) α-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate (α-isomer) in 140 mL 25% absolute ethanol-75% ethyl acetate by volume solution is hydrogenated with 4.2 g of 10% palladium-on-carbon catalyst at an initial pressure of 2.8 kg/cm 2 and room temperature for 27.5 hours until hydrogen uptake is complete. 2 ml of a 9.4 N ethanolic solution of anhydrous hydrogen chloride is added,
og katalysatoren fjernes ved filtrering gjennom en plate diatoméjord. Efter inndampning under nedsatt trykk ekstraheres residuet ved rystning med 200 ml diethylether, to ganger med 200 ml benzen og til slutt med 200 ml diethylether. Materialet som er tilbake efter disse ekst raksjoner, er det ønskede a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-diethylether-solvat (a-isomer), Rf = 0,7 (tynnskiktskromatografi, fluorescerende silicagelplate, 5o volum% methanol-50 volum% benzen-oppløsnings-middel) forurenset med 12% difenylmethan. and the catalyst is removed by filtration through a pad of diatomaceous earth. After evaporation under reduced pressure, the residue is extracted by shaking with 200 ml of diethyl ether, twice with 200 ml of benzene and finally with 200 ml of diethyl ether. The material remaining after these extractions is the desired α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride diethylether solvate (α-isomer), Rf = 0.7 (thin layer chromatography , fluorescent silica gel plate, 50 vol% methanol-50 vol% benzene solvent) contaminated with 12% diphenylmethane.
[a]24 = -18,75 (C = 1,68, CHgOH) . [α] 24 = -18.75 (C = 1.68, CH 2 OH).
Eksempel 5 Example 5
A. Fremstilling av 2-trifluoracetamidoethyl-L-N-carbobenzyloxy-3-( 3, 4- difenylmethylendioxyfenyl)- 2- methylalaninat A. Preparation of 2-trifluoroacetamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 5,09 9 (0,010 mol) L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyf enyl) -2-methylalanin , 1,01 g (0,010 mol) triethylamin, og 1,7° g (0,010 mol) N-(2-klorethyl)-2,2,2-trifluoracet - amid i 20 ml tørt dimethylformamid omrøres ved 110°C i 20 timer under nitrogen. Den avkjølte reaksjonsblanding helles i 500 ml isvann, A solution of 5.09 g (0.010 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 1.01 g (0.010 mol) triethylamine, and 1.7 g (0.010 mol ) N-(2-chloroethyl)-2,2,2-trifluoroacetamide in 20 ml of dry dimethylformamide is stirred at 110°C for 20 hours under nitrogen. The cooled reaction mixture is poured into 500 ml of ice water,
og produktet ekstraheres i 3 x 500 ml ethylacetat. De forenede ekstrakter vaskes med 200 ml vann, tørres over magnesiumsulfat, filtreres og inndampes til en olje under nedsatt trykk. Den gjenværende olje oppløses i 100 ml ethylacetat, ekstraheres med 2 x 50 ml 5%-ig natriumhydroxydoppløsning, vaskes med 50 ml vann og tørres over magnesiumsulfat. Filtrering og inndampning under nedsatt trykk gir 4,92 g av en olje. Kromatografi av denne olje på 200 g silicagel og eluering med en 5%-ig oppløsning av methanol i kloroform gir 4,11 g (63,4%) 2-trifluoracetamidoethyl-L-N-carbobenzyloxy-3-(3,4-difeny1-.. methylendioxyf enyl) -2-methylalaninat som en olje, homogen ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 5 volum% methanol-95 volum% kloroform) Rf = 0,8- and the product is extracted in 3 x 500 ml of ethyl acetate. The combined extracts are washed with 200 ml of water, dried over magnesium sulphate, filtered and evaporated to an oil under reduced pressure. The remaining oil is dissolved in 100 ml of ethyl acetate, extracted with 2 x 50 ml of 5% sodium hydroxide solution, washed with 50 ml of water and dried over magnesium sulphate. Filtration and evaporation under reduced pressure gives 4.92 g of an oil. Chromatography of this oil on 200 g of silica gel and elution with a 5% solution of methanol in chloroform gives 4.11 g (63.4%) of 2-trifluoroacetamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenyl-1-). .methylenedioxyphenyl)-2-methylalaninate as an oil, homogeneous by thin-layer chromatography (fluorescent silica gel plate developed with 5 vol% methanol-95 vol% chloroform) Rf = 0.8-
B. Fremstilling av 2-trifluoracetamidoethyl-L-3-(3,4-dihydroxyfenyl)-2- methylalaninat- hydroklorid B. Preparation of 2-trifluoroacetamidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 2,0 g (0,0031 mol) 2-trifluoracetamidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 125 ml absolutt ethanol og 1,0 g 10%-ig palladium-på-carbonkatalysator hydrogeneres ved værelsetemperatur og et begynnelsestrykk på 2.5 kg/cm i 5 timer og 40 minutter inntil hydrogenopptagelsen er fullstendig. Katalysatoren fjernes ved filtrering under nitrogen gjennom en diatoméjord filterplate, og filtratet inndampes under nedsatt trykk ved en temperatur på 20 - 30°C. Residuet oppløses i 25 ml absolutt ethanol, overføres til hydrokloridet ved tilsetning av 2 ml 7.6 N ethanolisk vannfri hydrogenkloridoppløsning og inndampes så under nedsatt trykk. Residuet felles to ganger ved oppløsning i ethanol og tilsetning av tilstrekkelig ethylether til å felle produktet, hvorved man får 800 mg (66,6%) 2-trifluoracetamidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid som et ethanol-solvat , homogent ved tynnskiktskromatografi (fluorescerende silicagel-^1 «te utviklet med 50 v ;^um% methanol-50 volum% kloroform) Rf = 0,8- A solution of 2.0 g (0.0031 mol) of 2-trifluoroacetamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 125 ml of absolute ethanol and 1.0 g of 10% palladium- on-carbon catalyst is hydrogenated at room temperature and an initial pressure of 2.5 kg/cm for 5 hours and 40 minutes until hydrogen absorption is complete. The catalyst is removed by filtration under nitrogen through a diatomaceous earth filter plate, and the filtrate is evaporated under reduced pressure at a temperature of 20 - 30°C. The residue is dissolved in 25 ml of absolute ethanol, transferred to the hydrochloride by adding 2 ml of 7.6 N ethanolic anhydrous hydrogen chloride solution and then evaporated under reduced pressure. The residue is precipitated twice by dissolving in ethanol and adding sufficient ethyl ether to precipitate the product, whereby 800 mg (66.6%) of 2-trifluoroacetamidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride is obtained as an ethanol solvate, homogeneous by thin-layer chromatography (fluorescent silica gel developed with 50 vol% methanol-50 vol% chloroform) Rf = 0.8-
Anal. beregn, for C^H-^F^C^.HC1 .C^OH: C 44,40; H 5,59; N 6,47 Funnet: C 44,55; H 5,29; N 6,72 Anal. calculate, for C^H-^F^C^.HCl .C^OH: C 44.40; H 5.59; N 6.47 Found: C 44.55; H 5.29; N 6.72
Eksempel 6 Example 6
A. Fremstilling av 2-nicotinamidoethyl-L-N-carbobenzyloxy-3-(3 ,4-difenylmethylendioxyfenyl)- 2- methylalaninat A. Preparation of 2-nicotinamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 5,84 g (0,015 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 1,52 g (0,015 mol) triethylamin og 2,77 9 (0,015 mol) N-(2-klorethyl)-nicotinamid i 20 ml tørt dimethylformamid omrøres under nitrogen ved 95°C i 20 timer. A solution of 5.84 g (0.015 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 1.52 g (0.015 mol) triethylamine and 2.77 9 (0.015 mol) N-( 2-chloroethyl)-nicotinamide in 20 ml of dry dimethylformamide is stirred under nitrogen at 95°C for 20 hours.
Den avkjølte reaksjonsblanding helles i 200 ml isvann, og produktet ekstraheres i 3 x 175 ml ethylacetat. De forenede ekstrakter vaskes med 100 ml mettet natriumbicarbonatoppløsning, 100 ml vann og tørres over magnesiumsulfat. Efter filtrering fjernes oppløsningsmidlene under nedsatt trykk, hvorved man får 6,28 9 (85%) 2-nicotinamido-ethyl-L-N -carbobenzyloxy -3- (3 ,4-difenylmethylendioxyfenyl)-2-methylalaninat , homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med en 20 volum% methanol-80 volum% benzen-oppløs-ning) iakktatt Rf = 0,45. The cooled reaction mixture is poured into 200 ml of ice water, and the product is extracted into 3 x 175 ml of ethyl acetate. The combined extracts are washed with 100 ml saturated sodium bicarbonate solution, 100 ml water and dried over magnesium sulphate. After filtration, the solvents are removed under reduced pressure, whereby 6.28 9 (85%) of 2-nicotinamido-ethyl-L-N -carbobenzyloxy -3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate is obtained, homogeneous by thin-layer chromatography (fluorescent silica gel plate developed with a 20% by volume methanol-80% by volume benzene solution) observed Rf = 0.45.
B. Fremstilling av 2-nicotinamiiroethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- dihydrobromid B. Preparation of 2-nicotinamiiroethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate dihydrobromide
En blanding av 1,0 g (2,0 mmol) 2-nicotinamidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat og 10 ml 30 - 32%-ig oppløsning av vannfritt hydrogenbromid i eddiksyre hensettes ved 20 - 25°C i 30 minutter inntil gassutviklingen er avsluttet. Den homogene oppløsning inndampes under nedsatt trykk ved 20 - 25°C, A mixture of 1.0 g (2.0 mmol) 2-nicotinamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate and 10 ml of a 30 - 32% solution of anhydrous hydrogen bromide in acetic acid is prepared at 20 - 25°C for 30 minutes until gas evolution has ended. The homogeneous solution is evaporated under reduced pressure at 20 - 25°C,
og residuet omrøres med 50 ml diethylether i 3 dager. Det nesten hvite, faste stoff oppsamles, vaskes med 50 ml vannfri ethylether og tørres under høyvakuum (0,1 - 0,3 mm Hg) ved 20 - 25°C, hvorved man får 800 mg (77%) 2-nicotinamidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-dihydrobromid, iakttatt Rf = 0,5 ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med en oppløsning inneholdende like volumdeler n-butanol, eddiksyre, 1%-ig vandig nat riumbisulfit, benzen og aceton). and the residue is stirred with 50 ml of diethyl ether for 3 days. The almost white solid is collected, washed with 50 ml of anhydrous ethyl ether and dried under high vacuum (0.1 - 0.3 mm Hg) at 20 - 25°C, thereby obtaining 800 mg (77%) of 2-nicotinamidoethyl-L -3-(3,4-dihydroxyphenyl)-2-methylalaninate dihydrobromide, observed Rf = 0.5 by thin-layer chromatography (fluorescent silica gel plate developed with a solution containing equal parts by volume of n-butanol, acetic acid, 1% aqueous sodium bisulphite, benzene and acetone).
Anal. beregn, for C^H^N^. 2HBr. 2H20: C 38,79; H 4,88; N 7,54 Funnet: C 38,79; H 4,56; n 7,37 Eks empel 7 Anal. calculate, for C^H^N^. 2HBr. 2H 2 O: C 38.79; H 4.88; N 7.54 Found: C 38.79; H 4.56; n 7.37 Example 7
A. Fremstilling av g- klorethylpivalat A. Preparation of g-chloroethyl pivalate
400 mg zinkklorid smeltes ved 0,2 - 0,5 mm trykk og avkjøles 400 mg of zinc chloride is melted at 0.2 - 0.5 mm pressure and cooled
til 25 - 30°C under nitrogen. 48 g (0,40 mol) pivaloylklorid tilsettes til det smeltede zinkklorid fulgt av 19,2 g (0,44 mol) acetaldehyd. Under tilsetningen av acetaldehydet som skjer så hurtig som mulig, omrøres reaksjonsblandingen og avkjøles for å forhindre tap av acetaldehyd på grunn av reaksjonens eksoterme natur. Efter oppvarmning under tilbakeløp i 1 time gir destillasjon 3° 9 ( 55%) a-klorethylpivalat, kp. 32 - 34°C ved 4 mm. to 25 - 30°C under nitrogen. 48 g (0.40 mol) of pivaloyl chloride is added to the molten zinc chloride followed by 19.2 g (0.44 mol) of acetaldehyde. During the addition of the acetaldehyde which occurs as quickly as possible, the reaction mixture is stirred and cooled to prevent loss of acetaldehyde due to the exothermic nature of the reaction. After heating under reflux for 1 hour, distillation gives 3° 9 (55%) a-chloroethylpivalate, b.p. 32 - 34°C at 4 mm.
B. Fremstilling av a-pivaloyloxyethyl-L-N-carbobenzyloxy-3-(3,4~B. Preparation of α-pivaloyloxyethyl-L-N-carbobenzyloxy-3-(3,4~
difenylmethylendioxyfenyl)- 2- methylalaninat diphenylmethylenedioxyphenyl)- 2- methylalaninate
Til en omrørt oppløsning av 9,0 g (0,018 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin i 25 ml tørt dimethylformamid tilsettes 1,80 g (0,018 mol) triethylamin fulgt av 2,96 g (0,018 mol) a-klorethylpivalat. Efter omrøring ved 90 - 95°C To a stirred solution of 9.0 g (0.018 mol) of L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine in 25 ml of dry dimethylformamide is added 1.80 g (0.018 mol) of triethylamine followed by 2.96 g (0.018 mol) α-chloroethyl pivalate. After stirring at 90 - 95°C
i 20 timer helles reaksjonsblandingen i 350 ml vann, og produktet ekstraheres med 3 x lOO ml ethylether. Etherekstraktene forenes, for 20 hours, the reaction mixture is poured into 350 ml of water, and the product is extracted with 3 x 100 ml of ethyl ether. The ether extracts are combined,
vaskes med 50 ml 5%-ig natriumhydroxydoppløsning, 50 ml vann og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsningsmidlene under nedsatt trykk, hvorved man får 7,9 9washed with 50 ml of 5% sodium hydroxide solution, 50 ml of water and dried over anhydrous magnesium sulphate. After filtration, the solvents are removed under reduced pressure, whereby 7.9 9 is obtained
(68,9%) rått a-pivaloyloxyethyl-L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyf enyl)-2-methylalaninat. (68.9%) crude α-pivaloyloxyethyl-L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalaninate.
C. Fremstilling av a-pivaloyloxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid C. Preparation of α-pivaloyloxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 7,8 g a-pivaloyloxyethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 140 ml absolutt ethanol og 11 ml 8 N ethanolisk vannfri hydrogenkloridoppløsning hydrogeneres med 3,7 9 10%-ig palladium-på-carbonkatalysator ved 20 - 25°C og et begynnelsestrykk på 2,46 kg/cm<2> i 19 timer inntil hydrogenopptagelsen opphører. Efter fjernelse av katalysatoren ved filtrer- A solution of 7.8 g of α-pivaloyloxyethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 140 ml of absolute ethanol and 11 ml of 8 N ethanolic anhydrous hydrogen chloride solution is hydrogenated with 3.7 9 10%- ig palladium-on-carbon catalyst at 20 - 25°C and an initial pressure of 2.46 kg/cm<2> for 19 hours until hydrogen uptake ceases. After removal of the catalyst by filter-
ing fjernes ethanolen under nedsatt trykk. Residuet omrøres over natten med 80 ml benzen. Benzenet fjernes ved dekantering, erstattes med 80 ml hexan, omrøres og hexanet fradekanteres. Residuet opp- ing the ethanol is removed under reduced pressure. The residue is stirred overnight with 80 ml of benzene. The benzene is removed by decantation, replaced with 80 ml of hexane, stirred and the hexane decanted off. The residue up-
løses i 30O ml ethylacetat, omrøres kort med en blanding av 5 g fast natriumcarbonat og 5 ml mettet natriumcarbonatoppløsning, og tørres over vannfritt magnesiumsulfat. Efter filtrering tilsettes 3 ml 9,6 N ethanolisk vannfritt hydrogenklorid, og oppløsningen inndampes under nedsatt trykk til tørrhet. Videre tørring ved 65°C og 0,2 mm trykk gir 2,16 g (47,2%) av a-pivaloyloxyethylester-h'ydrokloridet. dissolve in 30O ml of ethyl acetate, stir briefly with a mixture of 5 g of solid sodium carbonate and 5 ml of saturated sodium carbonate solution, and dry over anhydrous magnesium sulfate. After filtration, 3 ml of 9.6 N ethanolic anhydrous hydrogen chloride are added, and the solution is evaporated under reduced pressure to dryness. Further drying at 65°C and 0.2 mm pressure gives 2.16 g (47.2%) of the α-pivaloyloxyethyl ester hydrochloride.
Anal. beregn, for C1?H25N06.HC1: C 54,32; H 6,97; N 3,73 Anal. calculate, for C1?H25N06.HC1: C 54.32; H 6.97; N 3.73
Funnet: C 54,47; H 7,36; n 3,39 Found: C 54.47; H 7.36; n 3.39
Eksempel 8 Example 8
A. Fremstilling av L-N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methylalanin A. Preparation of L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanine
Til en omrørt oppløsning av 3,0 g (0,0126 mol) L-3-(3,4-di-hydroxyf enyl ) -2 -methylalanin-seskvihydrat i 20 ml 2 N natriumhydroxyd-oppløsning holdt ved 0°C under en nitrogenatmosfære, tilsettes en oppløsning av 3 ml carbobenzyloxyklorid i 10 ml diethylether. Efter omrøring ved 0°C i 1 time, fulgt av 1 time ved 25°C, ekstraheres reaksjonsblandingen med 50 ml diethylether. Den vandige del syres til pH 3 - 4 med 6 N saltsyreoppløsning, og det urene produkt ekstraheres i 100 ml ethylacetat og vaskes tre ganger med 25 ml vann. To a stirred solution of 3.0 g (0.0126 mol) L-3-(3,4-di-hydroxyphenyl)-2-methylalanine sesquihydrate in 20 ml of 2 N sodium hydroxide solution kept at 0°C under a nitrogen atmosphere, a solution of 3 ml of carbobenzyloxychloride in 10 ml of diethyl ether is added. After stirring at 0°C for 1 hour, followed by 1 hour at 25°C, the reaction mixture is extracted with 50 ml of diethyl ether. The aqueous part is acidified to pH 3 - 4 with 6 N hydrochloric acid solution, and the impure product is extracted in 100 ml of ethyl acetate and washed three times with 25 ml of water.
Efter tørring over vannfritt magnesiumsulfat og filtrering fjernes oppløsningsmidlet under nedsatt trykk, hvorved man får 1,5 g (34,5%) L-N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methylalanin som en viskøs olje. After drying over anhydrous magnesium sulfate and filtration, the solvent is removed under reduced pressure, whereby 1.5 g (34.5%) of L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanine is obtained as a viscous oil.
B. Fremstilling av pivaloyloxymethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid B. Preparation of pivaloyloxymethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En blanding av 2,1 g (6,1 mmol) L-N-carbobenzyloxy-3~(3,4-dihydroxyf enyl ) -2-methylalanin , 0,93 g (6,2 mmol) klormethylpivalat, 0,63 g (6,3 mmol) kaliumbicarbonat og 0,15 g kaliumjodid i 60 ml aceton og 4 ml vann omrøres ved tilbakeløp under nitrogen i 18 timer. Efter inndampning under nedsatt trykk tilsettes 50 ml vann, og N-carbobenzyloxyderivatet av den ønskede ester ekstraheres med 3 x 50 ml diethylether. Etherekst raktet vaskes med 50 ml vann, tørres over vannfritt magnesiumsulfat og inndampes under nedsatt trykk. Det olje-aktige residuum oppløses i 100 ml absolutt ethanol og 4 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning og hydrogeneres med 1 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,74 kg/cm i 24 timer. Efter fjernelse av katalysatoren ved filtrering inndampes filtratet under nedsatt trykk. Residuet oppløses i 5 ml vann, gjøres basisk til pH 8 med en standard natriumcarbonat-oppløsning, og det uoppløselige produkt ekstraheres i 25 ml ethylacetat. Efter tørring over vannfritt magnesiumsulfat og filtrering tilsettes 1 ml 9,6 N éthanolisk vannfri hydrogenkloridoppløsning, og oppløsningen inndampes under nedsatt trykk, hvorved man får 0,50 g (22,6%) av hydrokloridet av pivaloyloxymethyl-L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-hydroklorid, Rf = 0,86 ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med en 5:2:3 i volum blanding av n-butanol:eddiksyre:vann). A mixture of 2.1 g (6.1 mmol) L-N-carbobenzyloxy-3~(3,4-dihydroxyphenyl)-2-methylalanine, 0.93 g (6.2 mmol) chloromethylpivalate, 0.63 g (6 .3 mmol) of potassium bicarbonate and 0.15 g of potassium iodide in 60 ml of acetone and 4 ml of water are stirred at reflux under nitrogen for 18 hours. After evaporation under reduced pressure, 50 ml of water is added, and the N-carbobenzyloxy derivative of the desired ester is extracted with 3 x 50 ml of diethyl ether. The ether extract is washed with 50 ml of water, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The oily residue is dissolved in 100 ml of absolute ethanol and 4 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution and hydrogenated with 1 g of 10% palladium-on-carbon catalyst at an initial pressure of 2.74 kg/cm for 24 hours. After removal of the catalyst by filtration, the filtrate is evaporated under reduced pressure. The residue is dissolved in 5 ml of water, made basic to pH 8 with a standard sodium carbonate solution, and the insoluble product is extracted into 25 ml of ethyl acetate. After drying over anhydrous magnesium sulfate and filtration, 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution is added, and the solution is evaporated under reduced pressure, whereby 0.50 g (22.6%) of the hydrochloride of pivaloyloxymethyl-L-3-(3, 4-dihydroxy-phenyl)-2-methylalaninate hydrochloride, Rf = 0.86 by thin layer chromatography (fluorescent silica gel plate developed with a 5:2:3 by volume mixture of n-butanol:acetic acid:water).
Anal. beregn, for C-^H^NOg.HC1: C 53,11; H 6,69; N 3,87 Anal. calculate, for C-^H^NOg.HCl: C 53.11; H 6.69; N 3.87
Funnet: C 53,76; H 6,64; N 3,69 Found: C 53.76; H 6.64; N 3.69
Eksempel 9 Example 9
A. Fremstilling av 1,2-ethylen-bis-L-N-carbobenzyloxy-3-(3,4-di-hydroxyf enyl) - 2- methylalaninat A. Preparation of 1,2-ethylene-bis-L-N-carbobenzyloxy-3-(3,4-di-hydroxyphenyl)-2-methylalaninate
En oppløsning av 7,8 g (0,023 mol) L-N-carbobenzyloxy-3-(3,4-dihydroxyf enyl ) -2-methylalanin , 1,88 9 (0,01 mol) 1,2-dibromethan og 2,1 g (0,021 mol) triethylamin i 20 ml dimethylformamid oppvarmes ved 85 - 90°C i 10 timer og helles så i 200 ml vann. Den blokkerte bis-ester ekstraheres med 3 x 100 ml ethylacetat og vaskes med 100 ml mettet natriumbicarbonatoppløsning og lOO ml mettet natriumklorid-oppløsning. Efter tørring over vannfritt magnesiumsulfat og inndampning under nedsatt trykk ved 30 - 40°C fåes 5,3 9 (74%) 1,2-ethylen-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methylalaninat . A solution of 7.8 g (0.023 mol) L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanine, 1.88 g (0.01 mol) 1,2-dibromoethane and 2.1 g (0.021 mol) of triethylamine in 20 ml of dimethylformamide is heated at 85 - 90°C for 10 hours and then poured into 200 ml of water. The blocked bis-ester is extracted with 3 x 100 ml of ethyl acetate and washed with 100 ml of saturated sodium bicarbonate solution and 100 ml of saturated sodium chloride solution. After drying over anhydrous magnesium sulfate and evaporation under reduced pressure at 30 - 40°C, 5.3 9 (74%) of 1,2-ethylene-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalaninate are obtained .
B. Fremstilling av 1,2-ethylen-bis-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- dihydroklorid B. Preparation of 1,2-ethylene-bis-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate dihydrochloride
En oppløsning av 5,0 g (6,98 mmol) 1,2-ethylen-bis-L-N-carbobenzyloxy -3- (3 ,4-dihydroxyfenyl)-2-methylalaninat i 120 ml av en 25 volum% methanol-75 volum% ethylacetat-blanding hydrogeneres ved et begynnelsest rykk på o 2,46 kg/cm 2 med 2 g 10%-ig palladium-påo-carbonkatalysator inntil hydrogenopptagelsen er fullstendig. Efter filtrering for å fjerne katalysator fjernes oppløsningsmidlene under nedsatt trykk. Residuet oppløses i en lo volum% ethanol-90 volum% ethylacetat-blanding, omrøres med 5 ml mettet natriumcarbonatoppløs-ning og 5 g fast natriumcarbonat. Vannfritt magnesiumsulfat tilsettes, blandingen filtreres, og filtratet syres med 1 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning. Oppløsningsmidlene fjernes under nedsatt trykk ved en temperatur på 20 - 30°C, hvorved man får 1,2-ethylen-bis-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-dihydroklorid som ethylacetatsolvatet. A solution of 5.0 g (6.98 mmol) of 1,2-ethylene-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalaninate in 120 ml of a 25% by volume methanol-75% by volume % ethyl acetate mixture is hydrogenated at an initial thrust of o 2.46 kg/cm 2 with 2 g of 10% palladium on o carbon catalyst until hydrogen absorption is complete. After filtration to remove the catalyst, the solvents are removed under reduced pressure. The residue is dissolved in a 1% by volume ethanol-90% by volume ethyl acetate mixture, stirred with 5 ml of saturated sodium carbonate solution and 5 g of solid sodium carbonate. Anhydrous magnesium sulfate is added, the mixture is filtered, and the filtrate is acidified with 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution. The solvents are removed under reduced pressure at a temperature of 20 - 30°C, whereby 1,2-ethylene-bis-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate dihydrochloride is obtained as the ethyl acetate solvate.
Anal. beregn, for C^H^N^g . 2HC1. 2C^Hg02 : C 51,65; H 6,65> N 4,07 Funnet: C 50,91; H 6,69; N 4,27 Anal. calculate, for C^H^N^g . 2HC1. 2C₂HgO₂ : C 51.65; H 6.65 > N 4.07 Found: C 50.91; H 6.69; N 4.27
Eksempel IO Example IO
A. Fremstilling av 1,3-propylen-bis-L-N-carbobenzyloxy-3-(3,4-di-hydroxyfenyl)- 2- methylalaninat A. Preparation of 1,3-propylene-bis-L-N-carbobenzyloxy-3-(3,4-di-hydroxyphenyl)-2-methylalaninate
En oppløsning av 7,8 g (0,023 mol) L-N-carbobenzyloxy-3-(3,4-dihydroxyf enyl)-2-methylalaninat, 2,1 g (0,020 mol) triethylamin og 2,02 g (0,010 mol) 1,3-dibrompropan i 20 ml dimethylformamid oppvarmes under nitrogen i 15 timer ved 95°C og helles så i 200 ml vann. Produktet ekstraheres med 3 x 100 ml ethylacetat og vaskes med 50 ml fortynnet (5%) natriumbicarbonatoppløsning, 50 ml vann og til slutt 50 ml mettet nat riumkloridoppløsning. Efter tørring over vannfritt magnesiumsulfat og inndampning under nedsatt trykk fåes 5,4 9 (73,8%) 1,3-propylen-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxy-fenyl)-2-methylalaninat. A solution of 7.8 g (0.023 mol) of L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalaninate, 2.1 g (0.020 mol) of triethylamine and 2.02 g (0.010 mol) of 1, 3-dibromopropane in 20 ml of dimethylformamide is heated under nitrogen for 15 hours at 95°C and then poured into 200 ml of water. The product is extracted with 3 x 100 ml of ethyl acetate and washed with 50 ml of diluted (5%) sodium bicarbonate solution, 50 ml of water and finally 50 ml of saturated sodium chloride solution. After drying over anhydrous magnesium sulfate and evaporation under reduced pressure, 5.4 9 (73.8%) of 1,3-propylene-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxy-phenyl)-2-methylalaninate are obtained.
B. Fremstilling av 1,3-propylen-bis-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- dihydroklorid B. Preparation of 1,3-propylene-bis-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate dihydrochloride
En oppløsning av 5,4 9 (7,39 mmol) 1,3-propylen-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methylalaninat i 100 ml 25 volum% ethanol-75 volum% ethylacetat hydrogeneres ved et begynnelsestrykk på 2,46 kg/cm med 255 g lO%-ig palladium-på-carbonkatalysator ved 25°C inntil hydrogenopptagelsen opphørte. Efter fjernelse av katalysatoren ved filtrering, fjernes oppløsningsmidlene under nedsatt trykk. Residuet oppløses i 10 volum% methanol-90 volum% ethylacetat, omrøres med 5 ml mettet natriumcarbonatoppløsning og 5 g fast natriumcarbonat. 5 9 vannfritt magnesiumsulfat tilsettes, blandingen filtreres, og filtratet gjøres surt med 1 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning. Oppløsningen inndampes under nedsatt trykk til ca. 50 - 6o ml volum og dekanteres fra en uoppløselig gummi. Gummien omrøres med 25 ml ethylacetat, filtreres og tørres, hvorved man får 1,74 9 (33%) 1,3-propylen-bis-L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-dihydroklorid som ethylacetatsolvatet , A solution of 5,4 9 (7.39 mmol) 1,3-propylene-bis-L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalaninate in 100 mL of 25% v/v ethanol-75% v/v ethyl acetate hydrogenated at an initial pressure of 2.46 kg/cm with 255 g of 10% palladium-on-carbon catalyst at 25°C until hydrogen absorption ceased. After removal of the catalyst by filtration, the solvents are removed under reduced pressure. The residue is dissolved in 10% by volume methanol-90% by volume ethyl acetate, stirred with 5 ml of saturated sodium carbonate solution and 5 g of solid sodium carbonate. 5 9 anhydrous magnesium sulfate is added, the mixture is filtered, and the filtrate is acidified with 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution. The solution is evaporated under reduced pressure to approx. 50 - 6o ml volume and decanted from an insoluble gum. The gum is stirred with 25 ml of ethyl acetate, filtered and dried, whereby 1.74 g (33%) of 1,3-propylene-bis-L-3-(3,4-dihydroxy-phenyl)-2-methylalaninate dihydrochloride is obtained as ethyl acetate solvate,
Rf = 0,56, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med en oppløsning inneholdende like volumdeler n-butanol, aceton, eddiksyre, vann og benzen). Rf = 0.56, thin layer chromatography (fluorescent silica gel plate developed with a solution containing equal parts by volume of n-butanol, acetone, acetic acid, water and benzene).
Eksempel 11 Example 11
A. Fremstilling av 1- klor- l- succinimidopropan A. Preparation of 1-chloro-1-succinimidopropane
Vannfritt hydrogenklorid bobles gjennom en blanding av lo g (0,072 mol) N-propenylsuccinimid og 1,04 9 stanniklorid i 6 timer. Oppløsningen hensettes ved værelsetemperatur i 10 dager, idet oppløs-ningen igjen mettes med hydrogenkloridgass efter 3 og 4 dager. Opp-løsningsmidlene fjernes under nedsatt trykk ved 30 - 40°C, hvorved man får 1-klor-l-succinimidopropan som en. gul olje. Anhydrous hydrogen chloride is bubbled through a mixture of 1 g (0.072 mol) N-propenyl succinimide and 1.04 g of stannous chloride for 6 hours. The solution is left at room temperature for 10 days, the solution being saturated again with hydrogen chloride gas after 3 and 4 days. The solvents are removed under reduced pressure at 30 - 40°C, whereby 1-chloro-1-succinimidopropane is obtained as a. yellow oil.
B. Fremstilling av a-succinimidopropyl-L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyf enyl )- 2- methylalaninat B. Preparation of α-succinimidopropyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 10,2 g (0,020 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-3-methylalanin, 2,1 g (0,021 mol) triethylamin og 3,51 g (0,020 mol) 1-klor-l-succinimidopropan i 20 ml dimethylformamid oppvarmes ved 90°C i 10 timer og helles så i 200 ml vann. Produktet ekstraheres med 3 x 100 ml ethylether og vaskes med 50 ml 5%-ig natriumhydroxyd, 50 ml vann og 50 ml av en mettet oppløs-ning av natriumklorid. Efter tørring over vannfritt magnesiumsulfat og filtrering fjernes oppløsningsmidlene under nedsatt trykk, hvorved man får 8,6 g (68%) a-succinimidopropyl-L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyfenyl)-2-methylalaninat, Rf =0,2, tynnskikt-kromatografi (fluorescerande silicagelplate utviklet med kloroform). • A solution of 10.2 g (0.020 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-3-methylalanine, 2.1 g (0.021 mol) triethylamine and 3.51 g (0.020 mol) 1-chloro -1-succinimidopropane in 20 ml of dimethylformamide is heated at 90°C for 10 hours and then poured into 200 ml of water. The product is extracted with 3 x 100 ml of ethyl ether and washed with 50 ml of 5% sodium hydroxide, 50 ml of water and 50 ml of a saturated solution of sodium chloride. After drying over anhydrous magnesium sulfate and filtration, the solvents are removed under reduced pressure, whereby 8.6 g (68%) of a-succinimidopropyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate are obtained, Rf =0 ,2, thin-layer chromatography (fluorescent silica gel plate developed with chloroform). •
C. Fremstilling av a-succinimidopropyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid C. Preparation of α-succinimidopropyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 8,6 g (0,014 mol) a-succinimidopropyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 120 ml 25 volum% ethanol-75 volum% ethylacetat-oppløsning hydrogeneres med 4 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på o 2,81 kg/cm 2 i 18 timer inntil hydrogenopptagelsen opphører. Efter fjernelse av katalysatoren ved filtrering, fjernes oppløsnings-midlene under nedsatt trykk ved 30 - 4o°C. Residuet oppløses i 10 volum% ethanol-90 volum% ethylacetat og omrøres med 5 ml mettet natriumcarbonatoppløsning og overskudd av fast natriumcarbonat i A solution of 8.6 g (0.014 mol) of α-succinimidopropyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 120 ml of 25% by volume ethanol-75% by volume ethyl acetate solution is hydrogenated with 4 g 10% palladium-on-carbon catalyst at an initial pressure of o 2.81 kg/cm 2 for 18 hours until hydrogen absorption ceases. After removal of the catalyst by filtration, the solvents are removed under reduced pressure at 30 - 4o°C. The residue is dissolved in 10 vol% ethanol-90 vol% ethyl acetate and stirred with 5 ml saturated sodium carbonate solution and excess solid sodium carbonate in
2 minutter. 10 g vannfritt magnesiumsulfat tilsettes, blandingen filtreres, og filtratet gjøres surt med 2 ml 9,6 N ethanolisk hydro-genkloridoppløsning. Oppløsningen inndampes til tørrhet under nedsatt trykk, lOO ml ethylacetat tilsettes, og blandingen inndampes igjen til tørrhet under nedsatt trykk. lOO ml ethylacetat tilsettes, og efter omrøring ved 25°C i 1 time fjernes produktet ved filtrering og tørres under nedsatt trykk, hvorved man får 3,0 g (51,0%) a-succin-imidopropyl-L-3- (3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid som ethanolsolvatet, Rf =0,63, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 30 volum% methanol-70 volum% benzen) Anal. beregn, for C-^H^N.^ .HC1 .C^OH: C 52,71; H 6,75-, N 6,47 Funnet: C 53,62; H 6,51* N 6,32 2 minutes. 10 g of anhydrous magnesium sulfate are added, the mixture is filtered, and the filtrate is made acidic with 2 ml of 9.6 N ethanolic hydrogen chloride solution. The solution is evaporated to dryness under reduced pressure, 100 ml ethyl acetate is added, and the mixture is evaporated again to dryness under reduced pressure. 100 ml of ethyl acetate are added, and after stirring at 25°C for 1 hour, the product is removed by filtration and dried under reduced pressure, whereby 3.0 g (51.0%) of a-succin-imidopropyl-L-3-(3 ,4-dihydroxyphenyl)-2-methylalaninate hydrochloride as the ethanol solvate, Rf =0.63, thin layer chromatography (fluorescent silica gel plate developed with 30 vol% methanol-70 vol% benzene) Anal. calculate, for C-^H^N.^ .HCl .C^OH: C 52.71; H 6.75-, N 6.47 Found: C 53.62; H 6.51* N 6.32
Eksempel 12 Example 12
A. Fremstilling av N- klormethylglutarimid A. Preparation of N-chloromethylglutarimide
8,35 9 (0,070 mol) thionylklorid tilsettes langsomt til en oppløsning av 9,0 g (0,063 mol) N-hydroxymethylglutarimid i 50 ml benzen ved 4o°C. Efter at tilsetningen er avsluttet, omrøres oppløs-ningen under tilbakeløp i 1,5 timer og så ved værelsetemperatur i ytterligere 1,5 timer. Benzenet fjernes under nedsatt trykk ved 30 - 40°C, og residuet destilleres, hvorved man får 5,4 9 (53%) N-klormethylglutarimid, kp. 97 - 100°C ved 0,1 mm. 8.35 9 (0.070 mol) of thionyl chloride is added slowly to a solution of 9.0 g (0.063 mol) of N-hydroxymethylglutarimide in 50 ml of benzene at 4o°C. After the addition is finished, the solution is stirred under reflux for 1.5 hours and then at room temperature for a further 1.5 hours. The benzene is removed under reduced pressure at 30 - 40°C, and the residue is distilled, whereby 5.4 9 (53%) N-chloromethylglutarimide is obtained, b.p. 97 - 100°C at 0.1 mm.
B. Fremstilling av glutarimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)- 2- methylalaninat B. Preparation of glutarimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 10,2 g (0,020 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,02 g (0,020 mol) triethylamin og 3,23 g (0,020 mol) N-klormethylglutarimid i 20 ml dimethylformamid omrøres ved 70°C i 5 timer, derpå.ved 20 - 30°C i 5 timer, og til slutt helles blandingen i 200 ml vann. Produktet ekstraheres med 3 x 100 ml ethylacetat, vaskes med 50 ml 5%-ig natriumhydroxydoppløsning, 50 ml vann og 50 ml mettet natriumklorid-oppløsning og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsningsmidlene under nedsatt trykk, hvorved man får 12,1 g (95%) glutarimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyfenyl)-2-methylalaninat, Rf = 0,14 ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med kloroform). A solution of 10.2 g (0.020 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.02 g (0.020 mol) triethylamine and 3.23 g (0.020 mol) N-chloromethylglutarimide in 20 ml of dimethylformamide is stirred at 70°C for 5 hours, then at 20 - 30°C for 5 hours, and finally the mixture is poured into 200 ml of water. The product is extracted with 3 x 100 ml ethyl acetate, washed with 50 ml 5% sodium hydroxide solution, 50 ml water and 50 ml saturated sodium chloride solution and dried over anhydrous magnesium sulfate. After filtration, the solvents are removed under reduced pressure, whereby 12.1 g (95%) of glutarimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalaninate is obtained, Rf = 0.14 by thin-layer chromatography (fluorescent silica gel plate developed with chloroform).
C. Fremstilling av glutarimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid C. Preparation of glutarimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 12 g (0,0189 mol) glutarimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 130 ml 25 volum% absolutt ethanol-75 volum% ethylacetat hydrogeneres med 5 g 10%-ig palladium-på-carbonkatalysator ved 20 - 25°C og et begynnelsestrykk på 2,81 kg/cm i 18 timer inntil hydrogenopptagelsen opp-hører. Efter fjernelse av katalysatoren ved filtrering og inndampning til tørrhet under nedsatt trykk oppløses residuet i 200 ml 10 volum% absolutt ethanol-90 volum% ethylacetat-oppløsning og om-røres med 5 ml av en mettet natriumcarbonatoppløsning og overskudd A solution of 12 g (0.0189 mol) glutarimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 130 ml of 25% by volume absolute ethanol-75% by volume ethyl acetate is hydrogenated with 5 g of 10%- ig palladium-on-carbon catalyst at 20 - 25°C and an initial pressure of 2.81 kg/cm for 18 hours until hydrogen uptake ceases. After removal of the catalyst by filtration and evaporation to dryness under reduced pressure, the residue is dissolved in 200 ml of 10 vol% absolute ethanol-90 vol% ethyl acetate solution and stirred with 5 ml of a saturated sodium carbonate solution and excess
av fast carbonat i 2 minutter. lo g vannfritt magnesiumsulfat tilsettes og fjernes efter noen få minutter ved filtrering. Oppløsnings-midlene fjernes under nedsatt trykk, residuet vaskes med 25 ml hexan og derpå med 25 ml ethylacetat og tørres under nedsatt trykk. Resi-duet behandles igjen med natriumcarbonat som ovenfor for å fjerne de of solid carbonate for 2 minutes. Add anhydrous magnesium sulfate and remove after a few minutes by filtration. The solvents are removed under reduced pressure, the residue is washed with 25 ml of hexane and then with 25 ml of ethyl acetate and dried under reduced pressure. The residue is again treated with sodium carbonate as above to remove them
siste spor av a-methyl-3,4-dihydroxyfenylalanin og overføres til hydrokloridsaltet med 3 ml 9,6 N ethanolisk vannfritt hydrogenklorid, hvorved man får 3,0 g (36%) glutarimidomethyl-L-3"(3,4-dihydroxy-fenyl)-2-methylalaninat-hydroklorid som ethylacetatsolvatet, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 30 volum% methanol-70 volum% benzen), Rf = 0,56. last trace of α-methyl-3,4-dihydroxyphenylalanine and transferred to the hydrochloride salt with 3 ml of 9.6 N ethanolic anhydrous hydrogen chloride, thereby obtaining 3.0 g (36%) glutarimidomethyl-L-3"(3,4-dihydroxy -phenyl)-2-methylalaninate hydrochloride as the ethyl acetate solvate, homogeneous by thin layer chromatography (fluorescent silica gel plate developed with 30 vol% methanol-70 vol% benzene), Rf = 0.56.
Anal. beregn, for Cl6H2oN206.HCl. 3/4 C^H^: C 51,99; H 6,20; N 6,38 Funnet: C 52,15; H 6,45; N 6,53 Anal. calculate, for Cl6H2oN206.HCl. 3/4 C₂H₂: C 51.99; H 6.20; N 6.38 Found: C 52.15; H 6.45; N 6.53
Eksempel 13 Example 13
A. Fremstilling av 2-[L-N-carbobenzyloxy-3-(3,4-difenylmethylen-dioxyf enyl)-2-methylalanyloxymethyl]-1,2-benzisothiazol-3(2H)-on- 1, 1- dioxyd A. Preparation of 2-[L-N-carbobenzyloxy-3-(3,4-diphenylmethylene-dioxyphenyl)-2-methylalanyloxymethyl]-1,2-benzisothiazol-3(2H)-one-1,1-dioxyd
En oppløsning av 7,65 g (0,015 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 1,5 g (0,015 mol) triethylamin og 3,0 g (0,015 mol) N-klormethylsaccharin i 15 ml dimethylformamid oppvarmes ved 75 - 80°C i 17 timer og helles derpå i 150 ml vann. Produktet ekstraheres med 3 x lOO ethylacetat, vaskes med 50 ml mettet natriumbicarbonatoppløsning, 50 ml vann og 50 ml mettet nat riumkloridoppløsning og tørres over vannfritt magnesiumsulfat. A solution of 7.65 g (0.015 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 1.5 g (0.015 mol) triethylamine and 3.0 g (0.015 mol) N-chloromethylsaccharin in 15 ml of dimethylformamide is heated at 75 - 80°C for 17 hours and then poured into 150 ml of water. The product is extracted with 3 x 100 ethyl acetate, washed with 50 ml saturated sodium bicarbonate solution, 50 ml water and 50 ml saturated sodium chloride solution and dried over anhydrous magnesium sulphate.
Efter filtrering fjernes oppløsningsmidlene under nedsatt trykk, After filtration, the solvents are removed under reduced pressure,
hvorved man får 9,3 g (100%) 2-[L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyfenyl)-2-methylalanyloxymethyl]-1,2-benzisothiazol-3(2H)-on-1,1-dioxyd, Rf = 0,32, tynnskiktskromatografi (fluorescer- thereby obtaining 9.3 g (100%) of 2-[L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalanyloxymethyl]-1,2-benzisothiazol-3(2H)-one-1, 1-dioxide, Rf = 0.32, thin-layer chromatography (fluorescence
ende silicagelplate utviklet med kloroform). end silica gel plate developed with chloroform).
B. Fremstilling av 2-[L-3-(3,4-dihydroxyfenyl)-2-methylalanyloxy-methyl]- l, 2- benzisothiazol- 3( 2H)- on- 1, 1- dioxyd- hydroklorid B. Preparation of 2-[L-3-(3,4-dihydroxyphenyl)-2-methylalanyloxy-methyl]-1,2-benzisothiazol-3(2H)-one-1,1-dioxyd-hydrochloride
En oppløsning av 3,0 g (0,0043 mol) 2-[L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanyloxymethyl]-1,2-benz-isothiazol-3(2H)-on-1,1-dioxyd i 100 ml absolutt ethanol og 5 ml 8 N ethanolisk vannfri hydrokloridoppløsning hydrogeneres med 1,5 g lO%-ig palladium-på-carbonkatalysator ved 20 - 25°C og et begynnelsestrykk på o 2,46 kg/cm 2 i 20 timer inntil hydrogenopptagelsen opphører. Efter fjernelse av katalysatoren ved filtrering og inndampning til tørrhet under nedsatt trykk omrøres residuet med 50 ml ethylacetat A solution of 3.0 g (0.0043 mol) of 2-[L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanyloxymethyl]-1,2-benz-isothiazol-3(2H)-one- 1,1-dioxide in 100 ml of absolute ethanol and 5 ml of 8 N ethanolic anhydrous hydrochloride solution is hydrogenated with 1.5 g of 10% palladium-on-carbon catalyst at 20 - 25°C and an initial pressure of o 2.46 kg/cm 2 for 20 hours until hydrogen absorption ceases. After removal of the catalyst by filtration and evaporation to dryness under reduced pressure, the residue is stirred with 50 ml of ethyl acetate
i 1 time, og ethylacetatet fradekanteres. Residuet oppløses i 200 ml 20 volum% ethanol-80 volum% ethylacetat og omrøres med 10 ml mettet natriumcarbonatoppløsning og overskudd av fast natriumcarbonat. for 1 hour, and the ethyl acetate is decanted off. The residue is dissolved in 200 ml of 20% by volume ethanol-80% by volume ethyl acetate and stirred with 10 ml of saturated sodium carbonate solution and excess solid sodium carbonate.
IO g vannfritt magnesiumsulfat tilsettes og fjernes efter noen få minutter ved filtrering, og filtratet gjøres surt med 1 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning. Oppløsningsmidlene fjernes under nedsatt trykk, hvorved man får 0,2 g (10,0%) 2-[L-3-(3,4-dihydroxyfenyl)-2-methylalanyloxymethyl]-1,2-benzisothiazol-3(2H) -on-1,1-dioxyd-hydroklorid som ethylacetatsolvatet, Rf = 0,74, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med et oppløsningsmiddel bestående av Like volumdeler benzen, vann, eddiksyre, n-butanol og aceton). 10 g of anhydrous magnesium sulphate is added and removed after a few minutes by filtration, and the filtrate is acidified with 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution. The solvents are removed under reduced pressure, whereby 0.2 g (10.0%) of 2-[L-3-(3,4-dihydroxyphenyl)-2-methylalanyloxymethyl]-1,2-benzisothiazol-3(2H)- one-1,1-dioxyd-hydrochloride as the ethyl acetate solvate, Rf = 0.74, thin-layer chromatography (fluorescent silica gel plate developed with a solvent consisting of equal parts benzene, water, acetic acid, n-butanol and acetone).
Anal. beregn, for C^H^N^yS .HC1. l/4c^Hg02: C 49,08; H 4,55; N 6,03 Funnet: C 49,27; H 4,76; N 5,65 Anal. calculate, for C^H^N^yS .HC1. 1/4c^HgO 2 : C 49.08; H 4.55; N 6.03 Found: C 49.27; H 4.76; N 5.65
Eksempel 14 Example 14
A. Fremstilling av 1-methyl-2-[L-N-carbobenzyloxy-3-(3,4-dihydroxy - A. Preparation of 1-methyl-2-[L-N-carbobenzyloxy-3-(3,4-dihydroxy -
fenyl)- 2- methylalanyloxymethyl]- imidazol phenyl)- 2- methylalanyloxymethyl]- imidazole
En oppløsning av 7,8 9 (0,0226 mol) L-N-carbobenzyloxy-3-(3,4-dihydroxyf enyl)-2-methylalanin, 4,2 g (0,042 mol) triethylamin og 3,34 g (0,0256 mol) l-methyl-2-klormethylimidazol i 20 .ml dimethylformamid oppvarmes ved 70 - 75°C i 10 timer og helles så i 200 ml vann. Produktet ekstraheres med 3 x 100 ml ethylacetat, vaskes med 50 ml mettet natriumbicarbonatoppløsning, 50 ml mettet natriumklorid-oppløsning og inndampes under nedsatt trykk, hvorved man får 2,2 g (22%) l-methyl-2-[L-N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methyl-alanyloxymethyl ] -imidazol , homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 15 volum% methanol- A solution of 7.8 9 (0.0226 mol) L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanine, 4.2 g (0.042 mol) triethylamine and 3.34 g (0.0256 mol) of 1-methyl-2-chloromethylimidazole in 20 ml of dimethylformamide is heated at 70 - 75°C for 10 hours and then poured into 200 ml of water. The product is extracted with 3 x 100 ml of ethyl acetate, washed with 50 ml of saturated sodium bicarbonate solution, 50 ml of saturated sodium chloride solution and evaporated under reduced pressure, whereby 2.2 g (22%) of l-methyl-2-[L-N-carbobenzyloxy- 3-(3,4-dihydroxyphenyl)-2-methyl-alanyloxymethyl]-imidazole, homogeneous by thin-layer chromatography (fluorescent silica gel plate developed with 15 vol% methanol-
85 volum% kloroform), Rf = 0,66. 85% by volume chloroform), Rf = 0.66.
B. Fremstilling av L-l-methyl-2-[2-(3,4-dihydroxybenzyl)-alanyloxy-methyl1- imidazol- dihydroklorid- dxhydrat B. Preparation of L-1-methyl-2-[2-(3,4-dihydroxybenzyl)-alanyloxy-methyl-1-imidazole-dihydrochloride-dxhydrate
En oppløsning av 2,1 g (4,78 mmol) l-methyl-2-[L-N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methylalanyloxymethyl]-imidazol i 100 ml absolutt ethanol hydrogeneres med 1 g 10%-ig"palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,46 kg/cm i 4 timer. Efter fjernelse av katalysatoren ved filtrering og inndampning til 50 ml under nedsatt trykk tilsettes 2 ml 9,6 N ethanolisk vannfritt hydrogenklorid, og de gjenværende oppløsningsmidler fjernes under nedsatt trykk. Residuet omrøres med 200 ml 20 volum% ethanol-80 volum% ethylacetat, 10 ml mettet natriumcarbonatoppløsning og overskudd av fast natriumcarbonat. 10 g vannfritt magnesiumsulfat tilsettes og fjernes efter noen få minutter ved filtrering. Filtratet gjøres surt med 1 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning. Oppløs-ningsmidlene fjernes under nedsatt trykk, hvorved man får 0,2 g (8,5%) L-l-methyl-2-[2-(3,4-dihydroxybenzy1)-alanyloxymethyl]-imidazol-dihydroklorid-dihydrat som ethylacetatsolvatet, Rf = 0,3 ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med en oppløsning bestående av like volumdeler n-butanol, eddiksyre, vann, benzen og aceton) A solution of 2.1 g (4.78 mmol) of 1-methyl-2-[L-N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanyloxymethyl]-imidazole in 100 ml of absolute ethanol is hydrogenated with 1 g of 10 % palladium-on-carbon catalyst at an initial pressure of 2.46 kg/cm for 4 hours. After removal of the catalyst by filtration and evaporation to 50 ml under reduced pressure, 2 ml of 9.6 N ethanolic anhydrous hydrogen chloride are added, and the remaining solvents are removed under reduced pressure. The residue is stirred with 200 ml of 20% by volume ethanol-80% by volume ethyl acetate, 10 ml of saturated sodium carbonate solution and excess solid sodium carbonate. 10 g of anhydrous magnesium sulfate is added and removed after a few minutes by filtration. The filtrate is acidified with 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution The solvents are removed under reduced pressure to give 0.2 g (8.5%) of L-1-methyl-2-[2-(3,4-dihydroxybenzy1)-alanyloxymethyl] -imidazole dihydrochloride dihydrate as the ethyl acetate solvate, Rf = 0.3 at thins liquid chromatography (fluorescent silica gel plate developed with a solution consisting of equal parts by volume of n-butanol, acetic acid, water, benzene and acetone)
Anal. beregn, for C^H-^N.^. 2HC1. 2H20. l/2C^Hg02 : C 44,55; H 6,34; Anal. calculate, for C^H-^N.^. 2HC1. 2H20. 1/2C₂HgO 2 : C 44.55; H 6.34;
N 9,17 Funnet: C 44,62; H 6,84; N 9.17 Found: C 44.62; H 6.84;
N 8,95 N 8.95
Eksempel 15 Example 15
A. Fremstilling av l- methyl- 3- klormethylhydantoin A. Preparation of l-methyl-3-chloromethylhydantoin
30 ml thionylklorid tilsettes langsomt i løpet av 20 minutter til en godt omrørt blanding av 25 g (0,173 mol) l-methyl-3-hydroxy-methylhydantoin og l6o ml benzen under tilbakeløp. Efter omrøring under tilbakeløp i 2 timer inndampes reaksjonsblandingen til tørrhet under nedsatt trykk, 70 ml benzen tilsettes, og oppløsningen inndampes igjen til tørrhet. Efter gjentagelse av denne fremgangsmåte nok en gang med 70 ml benzen ekstraheres residuet med 3 x 100 ml carbontetraklorid. Fjernelse av oppløsningsmidler under nedsatt trykk gir 15,7 9 (55,7%) l-methyl-3-klormethylhydantoin. 30 ml of thionyl chloride are added slowly over 20 minutes to a well-stirred mixture of 25 g (0.173 mol) of 1-methyl-3-hydroxy-methylhydantoin and 160 ml of benzene under reflux. After stirring under reflux for 2 hours, the reaction mixture is evaporated to dryness under reduced pressure, 70 ml of benzene is added, and the solution is evaporated again to dryness. After repeating this procedure once more with 70 ml of benzene, the residue is extracted with 3 x 100 ml of carbon tetrachloride. Removal of solvents under reduced pressure gives 15.7% (55.7%) 1-methyl-3-chloromethylhydantoin.
B. Fremstilling av l-methyl-3-[L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyfenyl)- 2- methylalanyloxymethyl]- hydantoin B. Preparation of l-methyl-3-[L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalanyloxymethyl]- hydantoin
En oppløsning av 10,2 g (0,020 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,1 g (0,021 mol) triethylamin og 3,25 g (0,020 mol) l-methyl-3-klormethylhydantoin i 23 ml dimethylformamid oppvarmes ved 70°C i 18 timer og helles så i 230 ml vann. Produktet ekstraheres med 3 x 100 ml ethylacetat, vaskes med 50 ml fortynnet (5%) natriumhydroxydoppløsning, 50 ml vann og 50 ml mettet natriumkloridoppløsning, og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsningsmidlene under nedsatt trykk, hvorved man får 11,7 9 (92%) l-methyl-3-[L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanyloxymethyl]-hydantoin. A solution of 10.2 g (0.020 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.1 g (0.021 mol) triethylamine and 3.25 g (0.020 mol) l-methyl -3-Chloromethylhydantoin in 23 ml of dimethylformamide is heated at 70°C for 18 hours and then poured into 230 ml of water. The product is extracted with 3 x 100 ml of ethyl acetate, washed with 50 ml of dilute (5%) sodium hydroxide solution, 50 ml of water and 50 ml of saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. After filtration, the solvents are removed under reduced pressure, whereby 11.7 9 (92%) of 1-methyl-3-[L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanyloxymethyl]-hydantoin is obtained.
C Fremstilling av L-l-methyl-3-[2-(3,4-dihydroxybenzyl)-alanyloxy- methyl ]- hydantoin - hydroklorid - hyarat C Preparation of L-1-methyl-3-[2-(3,4-dihydroxybenzyl)-alanyloxy-methyl]- hydantoin - hydrochloride - hyarate
En oppløsning av 4,0 g (6,3 mmol) 1-methyl-3-[L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanyloxymethyl]-hydantoin i 140 ml absolutt ethanol og 2 g 10%-ig palladium-på-carbonkatalysator hydrogeneres ved et begynnelsestrykk på 2,53 kg/cm<2> i A solution of 4.0 g (6.3 mmol) of 1-methyl-3-[L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanyloxymethyl]-hydantoin in 140 ml of absolute ethanol and 2 g of 10% -ig palladium-on-carbon catalyst is hydrogenated at an initial pressure of 2.53 kg/cm<2> in
20 timer. Efter fjernelse av katalysatoren ved filtrering og inh-dampning til tørrhet under nedsatt trykk vaskes residuet med lOO ml hexan. Det hexan-uoppløselige materiale oppløses i 150 ml IO volum% methanol-90 volum% ethylacetat, omrøres med 5 ml mettet natrium-carbonatoppløsning og overskudd av natriumcarbonat og tørres over vannfritt magnesiumsulfat. Efter filtrering gjøres filtratet surt med 2 ml 9,6 N ethanolisk vannfritt hydrogenklorid og inndampes til tørrhet under nedsatt trykk. Residuet omrøres med 80 ml ethylacetat i 3 timer, filtreres og tørres under nedsatt trykk, hvorved man får 0,50 g (18%) L-l-methyl-3-[2-(3,4-dihydroxybenzyl)-alanyl-oxymethyl]-hydantoin-hydroklorid-hydrat som ethylacetatsolvatet. Anal. beregn, for C^H^N^Og .HCl .H20.1/2C^Hg02: c 46,84; h 6,oi; n 9,64 20 hours. After removal of the catalyst by filtration and evaporation to dryness under reduced pressure, the residue is washed with 100 ml of hexane. The hexane-insoluble material is dissolved in 150 ml of 10 vol.% methanol-90 vol.% ethyl acetate, stirred with 5 ml of saturated sodium carbonate solution and excess sodium carbonate and dried over anhydrous magnesium sulfate. After filtration, the filtrate is acidified with 2 ml of 9.6 N ethanolic anhydrous hydrogen chloride and evaporated to dryness under reduced pressure. The residue is stirred with 80 ml of ethyl acetate for 3 hours, filtered and dried under reduced pressure, whereby 0.50 g (18%) of L-1-methyl-3-[2-(3,4-dihydroxybenzyl)-alanyl-oxymethyl]- hydantoin hydrochloride hydrate as the ethyl acetate solvate. Anal. calculate, for C^H^N^Og .HCl .H 2 O.1/2C^HgO 2 : c 46.84; h 6,00; n 9.64
Funnet: C 46,28; H 6,09; N 9,06 Found: C 46.28; H 6.09; N 9.06
Eksempel 16 Example 16
A. Fremstilling av 2-fenoxyethyl-L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyf enyl) - 2- methylalaninat A. Preparation of 2-phenoxyethyl-L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalaninate
En oppløsning av 4,5 g (0,0088 mol) L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyf enyl) -2-methylalanin, 0,90 g (0,009 mol) triethylamin og 1,81 9 (0,009 mol) 2-bromethylfenylether i 15 ml dimethylformamid oppvarmes ved JO - 75°C i 24 timer, avkjøles så og helles i 150 ml vann. Produktet ekstraheres med 3 x lOO ml por-sjoner ethylether, vaskes med 50 ml 5%-ig natriumhydroxydoppløsning, 50 ml vann og 50 ml mettet nat riumkloridoppløsning og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsnings-midlene under nedsatt trykk, hvorved man får 4,8 g (86,5) 2-fenoxy-ethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat , homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med kloroform) Rf = o,91. A solution of 4.5 g (0.0088 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 0.90 g (0.009 mol) triethylamine and 1.81 g (0.009 mol ) 2-bromomethylphenyl ether in 15 ml of dimethylformamide is heated at JO - 75°C for 24 hours, then cooled and poured into 150 ml of water. The product is extracted with 3 x 100 ml portions of ethyl ether, washed with 50 ml of 5% sodium hydroxide solution, 50 ml of water and 50 ml of saturated sodium chloride solution and dried over anhydrous magnesium sulfate. After filtration, the solvents are removed under reduced pressure, whereby 4.8 g (86.5) of 2-phenoxy-ethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate are obtained, homogeneous by thin-layer chromatography ( fluorescent silica gel plate developed with chloroform) Rf = o.91.
B. Fremstilling av 2-fenoxyethyl-L-3-(3,4-dihydroxybenzyl)-alaninat-hydroklorid- hemihydrat B. Preparation of 2-phenoxyethyl-L-3-(3,4-dihydroxybenzyl)-alaninate hydrochloride hemihydrate
En oppløsning av 4,7 g (7,5 mmol) 2-fenoxyethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i A solution of 4.7 g (7.5 mmol) of 2-phenoxyethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in
120 ml absolutt ethanol hydrogeneres ved 1,7 Q 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på l,4l kg/cm<2> i 20 timer. Efter frafiltrering av katalysatoren fjernes oppløsningsmidlene under nedsatt trykk, og residuet kromatograferes på en kolonne av 75 g silicagel. Eluering med 400 ml av en 5 volum% methanol-95 volum% benzen-blanding gir 1,42 g (58%) av esterbase, smp. 35 - 42°C homo- 120 ml of absolute ethanol is hydrogenated at 1.7 Q of 10% palladium-on-carbon catalyst at an initial pressure of 1.4 l kg/cm<2> for 20 hours. After filtering off the catalyst, the solvents are removed under reduced pressure, and the residue is chromatographed on a column of 75 g silica gel. Elution with 400 ml of a 5 vol% methanol-95 vol% benzene mixture gives 1.42 g (58%) of ester base, m.p. 35 - 42°C homo-
gent ved tynnskiktskromatografi(fluorescerende silicagelplate utviklet med 30 volum% methanol-70 volum% benzen) Rf = 0,52. Basen overføres til hydrokloridsaltet ved oppløsning i 25 ml av en 50 volum% kloroform-50 volum% methanol-blanding og syring med 2 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning. Oppløsningsmidler fjernes under nedsatt trykk, hvorved man får 2-fenoxyethyl-L-3-(3,4-dihydroxybenzyl ) -alaninat-hydroklorid-hemihydrat. gent by thin-layer chromatography (fluorescent silica gel plate developed with 30% by volume methanol-70% by volume benzene) Rf = 0.52. The base is transferred to the hydrochloride salt by dissolving in 25 ml of a 50% by volume chloroform-50% by volume methanol mixture and acidifying with 2 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution. Solvents are removed under reduced pressure, whereby 2-phenoxyethyl-L-3-(3,4-dihydroxybenzyl)-alaninate hydrochloride hemihydrate is obtained.
Anal. beregn, for C^H^NO^ .HC1.1/2H20: C 57,37; H 6,15; N 3,72 Funnet: C 57,17; H 6,16; N 3,41 Anal. calculate, for C^H^NO^ .HCl.1/2H2O: C 57.37; H 6.15; N 3.72 Found: C 57.17; H 6.16; N 3.41
Eksempel 17 Example 17
A. Fremstilling av 2-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyf enyl) - 2- methylalaninat" A. Preparation of 2-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate"
En oppløsning av 4,5 g (8,8 mmol) L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyf enyl) -2-methylalanin , 0,90 g (9 mmol) triethylamin og 1,85 g (9,3 mmol) N-(2-bromethyl)-succinimid i 15 ml dimethylformamid oppvarmes ved 95°C i 19 timer, avkjøles så og helles i 150 ml vann. Produktet ekstraheres med 3 * 100 ml ethylether, vaskes med 50 ml 5%-ig natriumhydroxydoppløsning, 50 ml vann og 50 ml mettet natriumkloridoppløsning, og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsningsmidlene under nedsatt trykk, hvorved man får 3,8 9 (86%) 2-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med kloroform) Rf = 0,27. A solution of 4.5 g (8.8 mmol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 0.90 g (9 mmol) triethylamine and 1.85 g (9, 3 mmol) of N-(2-bromomethyl)-succinimide in 15 ml of dimethylformamide is heated at 95° C. for 19 hours, then cooled and poured into 150 ml of water. The product is extracted with 3 x 100 ml ethyl ether, washed with 50 ml 5% sodium hydroxide solution, 50 ml water and 50 ml saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. After filtration, the solvents are removed under reduced pressure, thereby obtaining 3.8 9 (86%) 2-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate, homogeneous by thin-layer chromatography (fluorescent silica gel plate developed with chloroform ) Rf = 0.27.
B. Fremstilling av 2-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid- hemihydrat B. Preparation of 2-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hemihydrate
En suspensjon av 2,5 g (3,94 mmol) 2-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 75 ml methanol, 75 ml ethanol og 3 ml 7,6 N ethanolisk vannfri hydrogen-kloridoppløsning hydrogeneres med 1,2 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på l,4l kg/cm i 20 timer. Efter fjernelse av katalysatoren ved filtrering fjernes oppløsningsmidlene under nedsatt trykk, og residuet omrøres med 25 ml benzen og derpå 25 ml ethylacetat. Det uoppløselige materiale behandles med 100 ml IO volum% ethanol-90 volum% ethylacetat, 5 ml mettet natriumcarbonat-oppløsning og 5 g fast natriumcarbonat . Det organiske ekstrakt tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. 1 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløs-ning tilsettes. Fjernelse av. alle oppløsningsmidler under nedsatt trykk gir 0,5 g (33%) 2-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hemihydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 30 volum% methanol-70 volum% benzen), Rf = 0,4- A suspension of 2.5 g (3.94 mmol) of 2-succinimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 75 ml of methanol, 75 ml of ethanol and 3 ml of 7.6 N ethanolic anhydrous hydrogen chloride solution is hydrogenated with 1.2 g of 10% palladium-on-carbon catalyst at an initial pressure of 1.4 l kg/cm for 20 hours. After removal of the catalyst by filtration, the solvents are removed under reduced pressure, and the residue is stirred with 25 ml of benzene and then 25 ml of ethyl acetate. The insoluble material is treated with 100 ml of 10 vol% ethanol-90 vol% ethyl acetate, 5 ml of saturated sodium carbonate solution and 5 g of solid sodium carbonate. The organic extract is dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution is added. Removal of. all solvents under reduced pressure yield 0.5 g (33%) 2-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hemihydrate, homogeneous by thin-layer chromatography (fluorescent silica gel plate developed with 30 vol% methanol -70 vol% benzene), Rf = 0.4-
Anal. beregn, for Cl6H2Q<N>2<0>6.HC1.1/2H20: C 50,33; H 5,54; N 7,34 Funnet: C 50,89; H 5,65; N 7,22 Anal. calculate, for Cl6H2Q<N>2<0>6.HC1.1/2H2O: C 50.33; H 5.54; N 7.34 Found: C 50.89; H 5.65; N 7.22
Eksempel 18 Example 18
A. Fremstilling av 1,2-ethylen-bis-[L-N-carbobenzyloxy-3-(3,4~di-fenylmethylendioxyfenyl)- 2- methylalaninat] A. Preparation of 1,2-ethylene-bis-[L-N-carbobenzyloxy-3-(3,4~di-phenylmethylenedioxyphenyl)-2-methylalaninate]
En oppløsning av 10,18 9 (0,020 mol) L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyfenyl)-2-methylalanin, 2,12 g (0,021 mol) triethylamin og 0,99 g (0,010 mol) 1,2-diklorethan i 35 ml dimethylformamid omrøres under nitrogen ved 105 - HO°C i 28 timer og helles så i 400 ml isvann. Produktet ekstraheres i 800 ml ethylether, vaskes med 100 ml 5%-ig natriumhydroxydoppløsning, 100 ml vann, tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. Residuet kromatograferes på 800 g silicagel, 2,25 9 (21,5%) 1,2-ethylen-bis-[L-N-carbobenzyloxy-3-(3,4-difenylmethylen-dioxyf enyl ) -2-methylalaninat elueres med kloroform. A solution of 10.18 9 (0.020 mol) of L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.12 g (0.021 mol) of triethylamine and 0.99 g (0.010 mol) of 1, 2-dichloroethane in 35 ml of dimethylformamide is stirred under nitrogen at 105 - HO°C for 28 hours and then poured into 400 ml of ice water. The product is extracted in 800 ml ethyl ether, washed with 100 ml 5% sodium hydroxide solution, 100 ml water, dried over anhydrous magnesium sulphate, filtered and evaporated under reduced pressure. The residue is chromatographed on 800 g of silica gel, 2.25 9 (21.5%) of 1,2-ethylene-bis-[L-N-carbobenzyloxy-3-(3,4-diphenylmethylene-dioxyphenyl)-2-methylalaninate is eluted with chloroform.
Fremstilling av L,L-2-[2-(3,4-difenylmethylendioxybenzyl)-alanyloxy]-ethyl-2-(3,4-dihydroxybenzyl)-alaninat-bishydrogen-oxalat Preparation of L,L-2-[2-(3,4-diphenylmethylenedioxybenzyl)-alanyloxy]-ethyl-2-(3,4-dihydroxybenzyl)-alaninate-bishydrogen-oxalate
En oppløsning av 2,25 g (2,2 mmol) 1,2-ethylen-bis-[L-N-carbo~ benzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat] i 100 ml absolutt ethanol hydrogeneres med 1,2 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,11 kg/cm i 28 timer inntil hydrogenopptagelsen er avsluttet. Efter fjernelse av katalysatoren ved filtrering fjernes oppløsningsmidlene under nedsatt trykk. Residuet omrøres med lOO ml 10 volum% ethanol-90 volum% ethylacetat, 2 ml mettet natriumcarbonatoppløs.ning og 3 g fast nattiumcarbonat i 15 minutter og filtreres så. Filtratet tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. Residuet kromatograferes over silicagel og elueres med 30 volum% methanol-70 volum% benzen, hvilket gir 220 mg produkt. Dette produkt overføres til oxalatsaltet med 500 mg oxalsyre i 10 ml ethanol ved feining med tilstrekkelig ethylether. Efter nok en feining fra 10 ml ethanol ved tilsetning av tilstrekkelig ethylether, fåes 246 mg (14%) L,L-2-[2-(3,4-difenyImethylendioxybenzyl)-alanyloxy]-ethyl-2 - A solution of 2.25 g (2.2 mmol) of 1,2-ethylene-bis-[L-N-carbo~ benzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate] in 100 ml of absolute ethanol is hydrogenated with 1 .2 g of 10% palladium-on-carbon catalyst at an initial pressure of 2.11 kg/cm for 28 hours until the hydrogen uptake has ended. After removing the catalyst by filtration, the solvents are removed under reduced pressure. The residue is stirred with 100 ml of 10% by volume ethanol-90% by volume ethyl acetate, 2 ml of saturated sodium carbonate solution and 3 g of solid sodium carbonate for 15 minutes and then filtered. The filtrate is dried over anhydrous magnesium sulphate, filtered and evaporated under reduced pressure. The residue is chromatographed over silica gel and eluted with 30% by volume methanol-70% by volume benzene, which gives 220 mg of product. This product is transferred to the oxalate salt with 500 mg of oxalic acid in 10 ml of ethanol by filtering with sufficient ethyl ether. After another filtration from 10 ml of ethanol with the addition of sufficient ethyl ether, 246 mg (14%) of L,L-2-[2-(3,4-diphenyImethylenedioxybenzyl)-alanyloxy]-ethyl-2 are obtained -
(3,4-dihydroxybenzyl)-alaninat-bishydrogenoxalat. (3,4-dihydroxybenzyl)-alanine bishydrogen oxalate.
Anal. beregn, for C^H^N^g.20^0^: C 59,08; H 5,08; N 3,53 Funnet: c 59,15; H 5,18; N 3,55 Anal. calculate, for C^H^N^g.20^O^: C 59.08; H 5.08; N 3.53 Found: c 59.15; H 5.18; N 3.55
Eksempel 19 Example 19
A. Fremstilling av 2-fthalimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)- 2- methylalaninat A. Preparation of 2-phthalimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 10,18 9 (0,020 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat, 2,12 g (0,021 mol) triethylamin og 5,08 9 (0,020 mol) N-(2-bromethyl)-fthalimid i 30 ml dimethylformamid omrøres under nitrogen ved 105 - 110 C over natten og helles så i 6oo ml isvann. Produktet ekstraheres med 3 x 100 ml ethylether og vaskes med 50 ml vann. Etherekstraktet tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk, hvorved man får et gummiaktig fast stoff. Kromatografi over silicagel og eluering med kloroform gir 10,88 9 (80%) 2-fthalimido-ethyl-L-N-carbobenzyloxy ~3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat, Rf = 0,53, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med kloroform). A solution of 10.18 9 (0.020 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate, 2.12 g (0.021 mol) triethylamine and 5.08 9 (0.020 mol) N-( 2-bromomethyl)-phthalimide in 30 ml of dimethylformamide is stirred under nitrogen at 105 - 110 C overnight and then poured into 600 ml of ice water. The product is extracted with 3 x 100 ml of ethyl ether and washed with 50 ml of water. The ether extract is dried over anhydrous magnesium sulphate, filtered and evaporated under reduced pressure, whereby a gummy solid is obtained. Chromatography over silica gel and elution with chloroform gives 10.88 9 (80%) 2-phthalimido-ethyl-L-N-carbobenzyloxy ~3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate, Rf = 0.53, thin-layer chromatography (fluorescent silica gel plate developed with chloroform).
B. Fremstilling av 2-fthaiimidoethyl-L-3-(3,4-dihydroxyfenyl)-2- ' B. Preparation of 2-hydroxyimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-
methylalaninat- hydroklorid methylalaninate hydrochloride
En oppløsning av 10,88 9 (0,0159 mol) 2-fthalimidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 125 ml ethylacetat hydrogeneres med 6 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,18 kg/cm i 5 timer inntil hydrogenopptagelsen opphører. Efter fjernelse av katalysatoren ved filtrering og fjernelse av oppløsningsmidler under nedsatt trykk, oppløses residuet i 150 ml absolutt ethanol inneholdende 4 ml 5,15 N ethanolisk vannfri hydrogenkloridoppløsning og hydrogeneres med 4,3 9 palladium-på-carbonkatalysator ved 1,90 - 2,67 kg/cm <2>i 5 dager. Ytterligere 4,3 9 mengder av 10%-ig palladium-på-carbonkatalysator tilsettes i løpet av denne tid. Efter fjernelse av katalysatoren ved filtrering og inndampning under nedsatt trykk, vaskes residuet med 100 ml petrolether og oppløses i ethanol. Det felles tre ganger fra ethanol ved tilsetning av tilstrekkelig ethylether til å felle produktet. Produktet tørres under nedsatt trykk, hvorved man får 2,80 g (4l,8%) 2-fthalimidoethyl-L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-hydroklorid, smp. 138,0 - l4o,0°C under spaltning, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 50 volum% methanol-50 volum% benzen), Rf = 0,6l. A solution of 10.88 g (0.0159 mol) of 2-phthalimidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 125 ml of ethyl acetate is hydrogenated with 6 g of 10% palladium-on- carbon catalyst at an initial pressure of 2.18 kg/cm for 5 hours until hydrogen absorption ceases. After removal of the catalyst by filtration and removal of solvents under reduced pressure, the residue is dissolved in 150 ml absolute ethanol containing 4 ml 5.15 N ethanolic anhydrous hydrogen chloride solution and hydrogenated with 4.3 9 palladium-on-carbon catalyst at 1.90 - 2, 67 kg/cm <2> for 5 days. A further 4.3 9 amounts of 10% palladium-on-carbon catalyst are added during this time. After removal of the catalyst by filtration and evaporation under reduced pressure, the residue is washed with 100 ml of petroleum ether and dissolved in ethanol. It is precipitated three times from ethanol by adding sufficient ethyl ether to precipitate the product. The product is dried under reduced pressure, whereby 2.80 g (41.8%) of 2-phthalimidoethyl-L-3-(3,4-dihydroxy-phenyl)-2-methylalaninate hydrochloride is obtained, m.p. 138.0 - 140.0°C during decomposition, homogeneous by thin layer chromatography (fluorescent silica gel plate developed with 50% by volume methanol-50% by volume benzene), Rf = 0.6l.
Anal. beregn, for C20H20<N>2<0>6.<H>Cl: C 57,07; H 5,03; N 6,65; Cl 8,<42 >Funnet: c 56,31; H 5,62; N 6,48; Cl 8,75 Anal. calculate, for C20H20<N>2<0>6.<H>Cl: C 57.07; H 5.03; N 6.65; Cl 8,<42 >Found: c 56.31; H 5.62; N 6.48; Cl 8.75
Eksempel 20 Example 20
A. Fremstilling av 2-acetoxyethyl -L-N-carbobenzyloxy-3-(3,4-dif enyl - A. Preparation of 2-acetoxyethyl -L-N-carbobenzyloxy-3-(3,4-diphenyl-
methylendioxyf enyl) - 2- methylalaninat methylenedioxyphenyl) - 2- methylalaninate
En oppløsning av 10,0 g (0,Ol96 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,39 g (0,0235 mol), triethylamin og 2,40 g (0,0196 mol) 2-klorethylacetat i 30 ml dimethylformamid omrøres under nitrogen ved 110°C i 20 timer og helles så i 500 ml isvann. Produktet ekstraheres i 4 x 20O ml ethylether som forenes og vaskes med 200 ml vann, 200 ml 5%-ig natrium-hydroxydoppløsning og så med 200 ml vann. Efter tørring over vannfritt magnesiumsulfat og filtrering fjernes oppløsningsmidlene under nedsatt trykk. Residuet kromatograferes på 700 g silicagel. Eluering med 5 volum% methanol-95 volum% kloroform gir 5,6o g (48%) 2-acetoxyethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat. A solution of 10.0 g (0.0196 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.39 g (0.0235 mol), triethylamine and 2.40 g (0 .0196 mol) of 2-chloroethyl acetate in 30 ml of dimethylformamide is stirred under nitrogen at 110°C for 20 hours and then poured into 500 ml of ice water. The product is extracted in 4 x 200 ml ethyl ether which is combined and washed with 200 ml water, 200 ml 5% sodium hydroxide solution and then with 200 ml water. After drying over anhydrous magnesium sulfate and filtration, the solvents are removed under reduced pressure. The residue is chromatographed on 700 g of silica gel. Elution with 5% by volume methanol-95% by volume chloroform gives 5.60 g (48%) of 2-acetoxyethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate.
B. Fremstilling av 2-acetoxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat ' B. Preparation of 2-acetoxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate
En oppløsning av 5,60 g (0,0094 mol) 2-acetoxyethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 100 ml absolutt ethanol hydrogeneres med 2,8 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,6o kg/cm p i 24 timer inntil hydrogenopptagelsen er avsluttet. Efter fjernelse av katalysatoren ved filtrering og fjernelse av oppløsningsmidler under nedsatt trykk, vaskes residuet med lOO ml petrolether og oppløses i 124 ml lo volum% ethanol-90 volum% ethylacetat. 6,2 g natriumcarbonat og 4 ml mettet natriumcarbonatoppløsning tilsettes og omrøres i 20 minutter. Blandingen filtreres, tørres over vannfritt magnesiumsulfat, filtreres igjen og inndampes under nedsatt trykk. Residuet kromatograferes på silicagel og elueres med 20 volum% methanol-80 volum% benzen. Omkrystallisasjon utføres ved å oppløse det i ethylacetat og tilsette tilstrekkelig cyclohexan til å felle det, hvorved man får 1,01 g (36%) 2-acetoxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat, A solution of 5.60 g (0.0094 mol) of 2-acetoxyethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 100 ml of absolute ethanol is hydrogenated with 2.8 g of 10% palladium -on-carbon catalyst at an initial pressure of 2.6o kg/cm p for 24 hours until the hydrogen uptake has ended. After removal of the catalyst by filtration and removal of solvents under reduced pressure, the residue is washed with 100 ml of petroleum ether and dissolved in 124 ml of 10% by volume ethanol-90% by volume ethyl acetate. 6.2 g of sodium carbonate and 4 ml of saturated sodium carbonate solution are added and stirred for 20 minutes. The mixture is filtered, dried over anhydrous magnesium sulfate, filtered again and evaporated under reduced pressure. The residue is chromatographed on silica gel and eluted with 20 vol% methanol-80 vol% benzene. Recrystallization is carried out by dissolving it in ethyl acetate and adding sufficient cyclohexane to precipitate it, yielding 1.01 g (36%) of 2-acetoxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate,
smp. 114 - 118°C, spaltn. m.p. 114 - 118°C, split.
Anal. beregn, for C^H^NOg.- C 56,55; H 6,44; N 4,71 Anal. calculate, for C^H^NOg.- C 56.55; H 6.44; N 4.71
Funnet; C 56,64; H 6,63; N 4,33 Found; C 56.64; H 6.63; N 4.33
kkseropel 21 kkseropel 21
A. Fremstilling av 2-benzamidoethyl-L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyfeny1)- 2- methylalaninat A. Preparation of 2-benzamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 10,0 g (0,0196 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,11 g (0,021 mol) triethylamin og 3,64 9 (0,Ol96 mol) N-(2-klorethyl)-benzamid i 20 ml dimethylformamid omrøres under nitrogen ved 110°C i 20 timer og helles så i 400 ml isvann. Bunnfallet fjernes ved filtrering, vaskes med lOO ml vann og oppløses i 200 ml ethylether. Etheroppløsningen vaskes med 50 ml 5%-ig natriumhydroxydoppløsning, 50 ml vann og tørres over vannfritt magnesiumsulfat. Tørremidlet frafiltreres, og filtratet inndampes under nedsatt trykk, hvorved man får 11,21 g (87%) 2-benzamidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylen-dioxyf enyl)-2-methylalaninat, Rf = 0,7, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 5 volum% methanol-95 volum% kloroform). A solution of 10.0 g (0.0196 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.11 g (0.021 mol) triethylamine and 3.64 9 (0.0196 mol ) N-(2-chloroethyl)-benzamide in 20 ml of dimethylformamide is stirred under nitrogen at 110°C for 20 hours and then poured into 400 ml of ice water. The precipitate is removed by filtration, washed with 100 ml of water and dissolved in 200 ml of ethyl ether. The ether solution is washed with 50 ml of 5% sodium hydroxide solution, 50 ml of water and dried over anhydrous magnesium sulphate. The drying agent is filtered off, and the filtrate is evaporated under reduced pressure, thereby obtaining 11.21 g (87%) of 2-benzamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylene-dioxyphenyl)-2-methylalaninate, Rf = 0, 7, thin layer chromatography (fluorescent silica gel plate developed with 5 vol% methanol-95 vol% chloroform).
B. Fremstilling av 2-benzamidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- oxalat- hemihydrat B. Preparation of 2-benzamidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate oxalate hemihydrate
En oppløsning av 11,21 g (0,017 mol) 2-benzamidoethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 100 absolutt ethanol hydrogeneres med 5,5 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,11 kg/cm i 7 timer. Efter fjernelse av katalysatoren ved filtrering og fjernelse av opp-løsningsmidler under nedsatt trykk, omrøres residuet med lOO ml petroléther over natten. Det uoppløselige materiale oppløses i 250 ml 10 volum% ethanol-90 volum% ethylacetat, rystes i lo minutter med 12 ml mettet natriumcarbonatoppløsning og 12 g natriumcarbonat og filtreres. Filtratet tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. Residuet behandles med 1,3 g oxalsyre oppløst i 25 ml absolutt ethanol, og oxalatsaltet felles ved tilsetning av tilstrekkelig ethylether. To ytterligere felninger ut-føres ved å oppløse produktet i ethanol og tilsette tilstrekkelig ethylether til å felle produktet, hvorved man får 1,6o g (23%) 2-benz-amidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-oxalat-hemihydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 50 volum% methanol-5o volum% kloroform) Rf = 0,44. A solution of 11.21 g (0.017 mol) of 2-benzamidoethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 100 absolute ethanol is hydrogenated with 5.5 g of 10% palladium-on- carbon catalyst at an initial pressure of 2.11 kg/cm for 7 hours. After removal of the catalyst by filtration and removal of solvents under reduced pressure, the residue is stirred with 100 ml of petroleum ether overnight. The insoluble material is dissolved in 250 ml of 10% by volume ethanol-90% by volume ethyl acetate, shaken for 10 minutes with 12 ml of saturated sodium carbonate solution and 12 g of sodium carbonate and filtered. The filtrate is dried over anhydrous magnesium sulphate, filtered and evaporated under reduced pressure. The residue is treated with 1.3 g of oxalic acid dissolved in 25 ml of absolute ethanol, and the oxalate salt is precipitated by adding sufficient ethyl ether. Two further precipitations are carried out by dissolving the product in ethanol and adding sufficient ethyl ether to precipitate the product, whereby 1.60 g (23%) of 2-benz-amidoethyl-L-3-(3,4-dihydroxyphenyl)- 2-methylalaninate oxalate hemihydrate, homogeneous by thin layer chromatography (fluorescent silica gel plate developed with 50 vol% methanol-50 vol% chloroform) Rf = 0.44.
Anal. beregn, for ClgH22N205.1/20^0^. 1/2H20: C 58,24; H 5,86; n"6,79 Funnet: c 58,39; h 5,73; n 6,37 Anal. calculate, for ClgH22N205.1/20^0^. 1/2H 2 O: C 58.24; H 5.86; n"6.79 Found: c 58.39; h 5.73; n 6.37
Eksempel 22 Example 22
A. Fremstilling av nafthalimidomethyl-L-N-carbobenzyloxy-3-(3,4-dif enylmethylendioxyfeny1)- 2- met hy1alaninat A. Preparation of naphthalimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 10,2 g (0,020 mol) L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,02 g (0,020 mol) triethylamin og 4,9 9 (0,020 mol) N-klormethylnafthalimid i 50 ml dimethylformamid omrøres ved 90°C i 20 timer og helles så i 500 ml isvann. Produktet ekstraheres med 200 ml ethylacetat, vaskes med 50 ml 5%-ig natriumhydroxydoppløsning, 50 ml vann og 50 ml mettet natriumkloridoppløsning og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsningsmidler under nedsatt trykk, hvorved man får 13,1 g (91%) nafthalimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat. A solution of 10.2 g (0.020 mol) L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.02 g (0.020 mol) triethylamine and 4.9 9 (0.020 mol) N-chloromethylnaphthalimide in 50 ml of dimethylformamide is stirred at 90°C for 20 hours and then poured into 500 ml of ice water. The product is extracted with 200 ml ethyl acetate, washed with 50 ml 5% sodium hydroxide solution, 50 ml water and 50 ml saturated sodium chloride solution and dried over anhydrous magnesium sulphate. After filtration, solvents are removed under reduced pressure, whereby 13.1 g (91%) of naphthalimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate are obtained.
B. Fremstilling av nafthalimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid B. Preparation of naphthalimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 13 g (0,0181 mol) nafthalimidomethyl-L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 150 ml 25 volum% absolutt ethanol-75 volum% ethylacetat hydrogeneres med 5 g 10%-ig palladium-på-carbonkatalysator ved 25°C og et begynnelsestrykk på o 2,81 kg/cm 2 i 24 timer inntil hydrogenopptagelsen er avsluttet. Efter fjernelse av katalysatoren ved filtrering og inndampning av filtratet under nedsatt trykk, oppløses residuet i 200 ml 10 volum% absolutt ethanol-90 volum% ethylacetat og omrøres med 5 ml mettet natriumcarbonatoppløsning og 5 g fast natriumcarbonat i 10 minutter. Blandingen filtreres, filtratet tørres over vannfritt mag-nesiumsulf at , filtreres igjen og inndampes under nedsatt trykk. Residuet vaskes med 100 ml hexan for å fjerne difenylmethan, oppløses i 25 ml absolutt ethanol og gjøres suit med 5 ml 8 N ethanolisk vannfri hydrogenkloridoppløsning. Tilsetning av ethylether feller hydrokloridsaltet av nafthaiimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat . A solution of 13 g (0.0181 mol) of naphthalimidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 150 ml of 25 vol% absolute ethanol-75 vol% ethyl acetate is hydrogenated with 5 g of 10%- ig palladium-on-carbon catalyst at 25°C and an initial pressure of o 2.81 kg/cm 2 for 24 hours until the hydrogen uptake has ended. After removal of the catalyst by filtration and evaporation of the filtrate under reduced pressure, the residue is dissolved in 200 ml of 10 vol% absolute ethanol-90 vol% ethyl acetate and stirred with 5 ml of saturated sodium carbonate solution and 5 g of solid sodium carbonate for 10 minutes. The mixture is filtered, the filtrate is dried over anhydrous magnesium sulphate, filtered again and evaporated under reduced pressure. The residue is washed with 100 ml of hexane to remove diphenylmethane, dissolved in 25 ml of absolute ethanol and made sut with 5 ml of 8 N ethanolic anhydrous hydrogen chloride solution. Addition of ethyl ether precipitates the hydrochloride salt of naphthaiimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate.
Eksempel 23 Example 23
A. Fremstilling av racemisk N-carbobenzyloxy-3-(3,4-dihydroxyfenyl) - A. Preparation of racemic N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-
2- methylalanin 2- methylalanine
Til en omrørt oppløsning av 8,0 g (0,0378 mol) racemisk DL-3-(3,4-dihydroxyfenyl)-2-methylalanin i 6o ml 2 N natriumhydroxydopp-løsning under nitrogen tilsettes en oppløsning av 9 ml carbobenzyloxyklorid i 25 ml diethylether. Efter omrøring ved 0°C i 1 time fulgt av 1 time ved 25°C, ekstraheres reaksjonsblandingen med 50 ml diethylether. Den vandige del gjøres sur til pH 3 med 6 N saltsyre, og råproduktet ekstraheres i 100 ml ethylacetat og vaskes tre ganger med 35 ml vann. Efter tørring over vannfritt magnesiumsulfat og filtrering fjernes oppløsningsmidlet under nedsatt trykk,- hvorved man får 4,5 g (34%) racemisk N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2 - methylalanin som en viskøs olje. A solution of 9 ml of carbobenzyloxychloride in 25 ml of diethyl ether. After stirring at 0°C for 1 hour followed by 1 hour at 25°C, the reaction mixture is extracted with 50 ml of diethyl ether. The aqueous part is acidified to pH 3 with 6 N hydrochloric acid, and the crude product is extracted in 100 ml of ethyl acetate and washed three times with 35 ml of water. After drying over anhydrous magnesium sulfate and filtration, the solvent is removed under reduced pressure, whereby 4.5 g (34%) of racemic N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanine are obtained as a viscous oil.
B. Fremstilling av racemisk pivaloyloxymethyl-3-(3,4-dihydroxy-fenyl)- 2- methylalaninat- hydroklorid B. Preparation of racemic pivaloyloxymethyl-3-(3,4-dihydroxy-phenyl)-2-methylalaninate hydrochloride
En oppløsning av 4,2 g (0,012 mol) racemisk N-carbobenzyloxy-3-(3,4-dihydroxyfenyl)-2-methylalanin, 1,3 g (0,013 mol) triethylamin og 1,26 g (0,013 mol) klormethylpivalat i 20 ml dimethylformamid omrøres ved 90°C i 20 timer og helles så i 200 ml vann. Produktet ekstraheres i 100 ml ethylacetat og vaskes med 25 ml mettet natrium-bicarbonatoppløsning og 25 ml vann. Efter tørring over vannfritt magnesiumsulfat og filtrering, inndampes filtratet under nedsatt trykk, hvorved man får N-carbobenzyloxyderivatet av den ønskede ester. Dette materiale oppløses i 100 ml absolutt ethanol inneholdende 10 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning og hydrogeneres med 3 g 10%-ig palladium-på-carbpnkatalysator ved et begynnelsestrykk på o 2,46 kg/cm 2 i 24 timer. Efter fjernelse av katalysatoren ved filtrering, inndampes filtratet under nedsatt trykk. Residuet oppløses i 25 ml vann, gjøres alkalisk med en mettet natriumcarbonatoppløsning til pH 8, og det uoppløselige produkt ekstraheres med 100 ml ethylacetat. Efter tørring over vannfritt magnesiumsulfat og filtrering, tilsettes 5 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning, og oppløsningen inndampes under nedsatt trykk, hvorved man får 1,5 g (22,6%) av hydrokloridet av det racemiske pivaloyloxymethyl-3-(3,4-dihydroxyfenyl)-2-methylalaninat , homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med en 5 volum:2 volum:3 volum blanding av n-butanol:eddiksyre:vann) Rf = 0,86. A solution of 4.2 g (0.012 mol) of racemic N-carbobenzyloxy-3-(3,4-dihydroxyphenyl)-2-methylalanine, 1.3 g (0.013 mol) of triethylamine and 1.26 g (0.013 mol) of chloromethylpivalate in 20 ml of dimethylformamide is stirred at 90°C for 20 hours and then poured into 200 ml of water. The product is extracted in 100 ml of ethyl acetate and washed with 25 ml of saturated sodium bicarbonate solution and 25 ml of water. After drying over anhydrous magnesium sulfate and filtering, the filtrate is evaporated under reduced pressure, whereby the N-carbobenzyloxy derivative of the desired ester is obtained. This material is dissolved in 100 ml of absolute ethanol containing 10 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution and hydrogenated with 3 g of 10% palladium-on-carbon catalyst at an initial pressure of o 2.46 kg/cm 2 for 24 hours. After removing the catalyst by filtration, the filtrate is evaporated under reduced pressure. The residue is dissolved in 25 ml of water, made alkaline with a saturated sodium carbonate solution to pH 8, and the insoluble product is extracted with 100 ml of ethyl acetate. After drying over anhydrous magnesium sulfate and filtering, 5 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution is added, and the solution is evaporated under reduced pressure, whereby 1.5 g (22.6%) of the hydrochloride of the racemic pivaloyloxymethyl-3-(3 ,4-dihydroxyphenyl)-2-methylalaninate, homogeneous by thin layer chromatography (fluorescent silica gel plate developed with a 5 volume:2 volume:3 volume mixture of n-butanol:acetic acid:water) Rf = 0.86.
Eksempel 24 Example 24
Fremstilling av 2-acetamidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat - hydroklorid Preparation of 2-acetamidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate - hydrochloride
En suspensjon av 88,3 g (0,30 mol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-hydroklorid-ethanolsolvat (ved inndampning av en ethanolisk oppløsning av hydrokloridet under nedsatt trykk) og 146,4 g (1,42 mol) N-acetylethanolamin, under nitrogen, oppvarmes til 104 - 108 C. 84,8 g (0,713 mol) thionylklorid tilsettes i løpet av 15 minutter under omrøring. Reaksjonsblandingen skummer kraftig under tilsetningen. Efter at tilsetningen er avsluttet, omrøres reaksjonsblandingen ved 104 - 108°C i 18 timer. Ytterligere 42,4 g (0,357 mol) thionylklorid tilsettes i løpet av 7 minutter. Reaksjonsblandingen omrøres ved 104 - 108°C i ytterligere 3,5 timer, avkjøles så til 30°C og inndampes under nedsatt trykk, hvorved man får en viskøs olje. Denne olje oppslemmes med 100 ml kloroform, og kloroformen fjernes under nedsatt trykk. Dette gjentaes ytterligere tre ganger, og derpå vaskes oljen med lOO ml benzen som fradekanteres. Residuet oppløses i 7O0 ml isopropanol og tilsettes til 6 1 ethylether. Bunnfallet som dannes, vaskes med 500 ml ethylether og rystes med 6 1 10 volum% ethanol-90 volum% ethylacetat, 150 ml mettet natriumcarbonatoppløsning og 100 g natriumcarbonat. Det organiske ekstrakt tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk, hvorved man får den frie base av acetamidoethylesteren. Denne base behandles med 15 g fumarsyre i 300 ml isopropanol, og fumaratsaltet felles ved tilsetning av tilstrekkelig ethylether. Fumaratsaltet felles nok en gang fra isopropanol ved tilsetning av tilstrekkelig ethylether og overføres så til den frie base som før ved rystning med 200 ml 10 volum% ethanol-90 volum% ethylacetat, 20 ml mettet natriumcarbonatoppløsning og 20 g fast natriumcarbonat. Den frie base overføres til hydrokloridsaltet ved oppløsning i 100 ml absolutt ethanol, tilsetning av 10 ml 9,6 N saltsyre og feining ved tilsetning av 1 1 ethylether. Efter tre felninger fra ethanol-ethylether utført som ovenfor, fåes 15,1 g (15%) av hydrokloridsaltet av 2-acetamidoethyl-L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-hydroklorid, Rf =0,57, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 50 volum% methanol-50 volum% benzen). A suspension of 88.3 g (0.30 mol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine hydrochloride ethanol solvate (by evaporation of an ethanolic solution of the hydrochloride under reduced pressure) and 146.4 g (1.42 mol) of N-acetylethanolamine, under nitrogen, is heated to 104 - 108 C. 84.8 g (0.713 mol) of thionyl chloride are added during 15 minutes with stirring. The reaction mixture foams vigorously during the addition. After the addition has ended, the reaction mixture is stirred at 104 - 108°C for 18 hours. A further 42.4 g (0.357 mol) of thionyl chloride is added over 7 minutes. The reaction mixture is stirred at 104 - 108°C for a further 3.5 hours, then cooled to 30°C and evaporated under reduced pressure, whereby a viscous oil is obtained. This oil is slurried with 100 ml of chloroform, and the chloroform is removed under reduced pressure. This is repeated a further three times, and then the oil is washed with 100 ml of benzene which is decanted. The residue is dissolved in 700 ml isopropanol and added to 6 1 ethyl ether. The precipitate that forms is washed with 500 ml of ethyl ether and shaken with 6 1 10% by volume ethanol-90% by volume ethyl acetate, 150 ml of saturated sodium carbonate solution and 100 g of sodium carbonate. The organic extract is dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure, whereby the free base of the acetamidoethyl ester is obtained. This base is treated with 15 g of fumaric acid in 300 ml of isopropanol, and the fumarate salt is precipitated by adding sufficient ethyl ether. The fumarate salt is separated once again from isopropanol by adding sufficient ethyl ether and then transferred to the free base as before by shaking with 200 ml of 10% by volume ethanol-90% by volume ethyl acetate, 20 ml of saturated sodium carbonate solution and 20 g of solid sodium carbonate. The free base is transferred to the hydrochloride salt by dissolving in 100 ml of absolute ethanol, adding 10 ml of 9.6 N hydrochloric acid and refining by adding 1 1 of ethyl ether. After three precipitations from ethanol-ethyl ether carried out as above, 15.1 g (15%) of the hydrochloride salt of 2-acetamidoethyl-L-3-(3,4-dihydroxy-phenyl)-2-methylalaninate hydrochloride are obtained, Rf =0 ,57, thin layer chromatography (fluorescent silica gel plate developed with 50 vol% methanol-50 vol% benzene).
Anal. be<r>e<g>n, for C^H^N^ .HC1: C 50,52; H 6,36; N 8,4l Anal. be<r>e<g>n, for C^H^N^ .HCl: C 50.52; H 6.36; N 8.4l
Funnet: C 50 , 49; H 6,69; N 8,49 Found: C 50 , 49; H 6.69; N 8.49
Eksempel 25 Example 25
Fremstilling av 3-acetamidopropyl-L-3-(3,4-dihydroxyfenyl)-2-methy1-alaninat- hydrogenoxalat- hydrat Preparation of 3-acetamidopropyl-L-3-(3,4-dihydroxyphenyl)-2-methyl-alaninate hydrogen oxalate hydrate
275 ml thionylklorid tilsettes til 250 g L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-seskvihydrat ved 25°C, og blandingen oppvarmes på dampbad. Efter oppvarmning i 2 timer fortynnes den tykke reaksjonsblanding med 7,5 ml dimethylformamid oppløst i 25 ml benzen 275 ml of thionyl chloride are added to 250 g of L-3-(3,4-dihydroxy-phenyl)-2-methylalaninate sesquihydrate at 25°C, and the mixture is heated on a steam bath. After heating for 2 hours, the thick reaction mixture is diluted with 7.5 ml of dimethylformamide dissolved in 25 ml of benzene
og omrøres på dampbad inntil gassutviklingen opphører. lOO ml benzen tilsettes, og den rå svovelsyrlingester fjernes ved filtrering, vaskes med 100 ml benzen, lOO ml kloroform og 100 ml ether, and stirred on a steam bath until gas evolution ceases. 100 ml of benzene is added, and the crude sulfuric acid ester is removed by filtration, washed with 100 ml of benzene, 100 ml of chloroform and 100 ml of ether,
og tørres under nedsatt trykk, hvorved man får 280 g av svovelsyrlingester-mellomproduktet, smp. 199°C under spaltning. and dried under reduced pressure, whereby 280 g of the sulfuric acid ester intermediate is obtained, m.p. 199°C during decomposition.
En blanding av 13,7 g av det rå svovelsyrlingester-mellom-produkt, 24,98 9 (0,212 mol) N-acetylpropanolamin og 2 g vannfritt dimethylformamid omrøres på dampbad i 20 timer og avkjøles. Reaksjonsblandingen vaskes med 6 x 200 ml ethylether, 4 x 200 ml methylenklorid og tørres under nedsatt trykk. Det halvfaste materiale som er tilbake, omrøres med 200 ml 20 volum% ethanol-80 volum% ethylacetat, 20 ml mettet natriumcarbonatoppløsning og 20 g fast natriumcarbonat. Det organiske ekstrakt tørres over vannfritt mag-nesiumsulf at , filtreres og filtratet tilsettes til en oppløsning av 3,2 g oxalsyre i 50 ml ethanol. Oppløsningsmidler fjernes under nedsatt trykk, og produktet felles ved å oppløse det i 50 ml ethanol og tilsette 500 ml ethylether. Produktet felles igjen ved oppløs-ning i 50 ml ethanol og tilsetning av 500 ml ethylacetat, hvorved man får 3-acetamidopropyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydrogenoxalat-hydrat, Rf = 0,45, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 25 volum% methanol-75 volum% kloroform) . A mixture of 13.7 g of the crude sulfuric ester intermediate, 24.98 g (0.212 mol) of N-acetylpropanolamine and 2 g of anhydrous dimethylformamide is stirred on a steam bath for 20 hours and cooled. The reaction mixture is washed with 6 x 200 ml ethyl ether, 4 x 200 ml methylene chloride and dried under reduced pressure. The semi-solid material that remains is stirred with 200 ml of 20 vol% ethanol-80 vol% ethyl acetate, 20 ml of saturated sodium carbonate solution and 20 g of solid sodium carbonate. The organic extract is dried over anhydrous magnesium sulphate, filtered and the filtrate is added to a solution of 3.2 g of oxalic acid in 50 ml of ethanol. Solvents are removed under reduced pressure, and the product is precipitated by dissolving it in 50 ml of ethanol and adding 500 ml of ethyl ether. The product is separated again by dissolving in 50 ml of ethanol and adding 500 ml of ethyl acetate, whereby 3-acetamidopropyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrogen oxalate hydrate is obtained, Rf = 0.45 , thin-layer chromatography (fluorescent silica gel plate developed with 25 vol% methanol-75 vol% chloroform) .
Anal. beregn for C-^H^I^O^ .C2H20^ -H20: C 48,80; H 6,26; N 6,69 Funnet: C 48,73; H 6,85; N 6,68 Anal. calculate for C-^H^I^O^ .C 2 H 2 O^ -H 2 O : C 48.80; H 6.26; N 6.69 Found: C 48.73; H 6.85; N 6.68
Eksempel 26 Example 26
Fremstilling av 2-methylthioethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydrogenoxalat Preparation of 2-methylthioethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrogen oxalate
275 ml thionylklorid tilsettes til 250 g L-3-(3-,4~dihydroxy-fenyl)-2-methylalaninat-seskvihydrat ved 25°C, og blandingen oppvarmes på dampbad. Efter oppvarmning i 2 timer fortynnes den tykke reaksjonsblanding med 7,5 ml dimethylformamid i 25"ml benzen og om-røres på dampbad inntil gassutviklingen opphører. lOO ml benzen tilsettes, og den rå svovelsyrlingester fjernes ved filtrering, vaskes med lOO ml benzen, 100 ml kloroform og lOO ml ether, og tørres under nedsatt trykk, hvorved man får 280 g av svovelsyrlingester-mellom-produktet, smp. 199°C under spaltning. 275 ml of thionyl chloride are added to 250 g of L-3-(3-,4~dihydroxy-phenyl)-2-methylalaninate sesquihydrate at 25°C, and the mixture is heated on a steam bath. After heating for 2 hours, the thick reaction mixture is diluted with 7.5 ml of dimethylformamide in 25 ml of benzene and stirred on a steam bath until gas evolution ceases. 100 ml of benzene is added, and the crude sulfuric acid ester is removed by filtration, washed with 100 ml of benzene, 100 ml of chloroform and 100 ml of ether, and dried under reduced pressure, whereby 280 g of the intermediate sulfur acid ester product, mp 199°C with decomposition, is obtained.
En blanding av 30 g av den rå svovelsyrlingester, 34,6 g A mixture of 30 g of the crude sulfuric acid ester, 34.6 g
(0,375 mol) 2-hydroxyethylmethylsulfid og 6 g vannfritt dimethylformamid omrøres på dampbad i 28 timer og avkjøles. Reåcsjons- (0.375 mol) of 2-hydroxyethylmethylsulphide and 6 g of anhydrous dimethylformamide are stirred on a steam bath for 28 hours and cooled. reaction
blandingen vaskes med 4 x 100 ml ethylether og 3 x 100 methylenklorid. Det gjenværende materiale omrøres med 250 ml 20 volum% ethanol-80 volum% ethylacetat, 30 ml mettet nat riumcarbonatoppløs - ning og 60 fast natriumcarbonat og filtreres så. Det uoppløselige materiale vaskes med 3 x 250 ml 20 volum% ethanol-80 volum% ethylacetat, forenes med det første ethanol-ethylacetatekstrakt og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløs-ningsmidler under nedsatt trykk, og residuet kromatograferes over silicagel. Tilsammen 2,3 g produkt elueres med en 25 volum% methanol-75 volum% kloroformblanding. Dette produkt overføres til oxalatsaltet ved å tilsette det til en oppløsning av 1,3 9 oxalsyre 1 25 ml ethanol fulgt av feining med tilstrekkelig ethylether. the mixture is washed with 4 x 100 ml ethyl ether and 3 x 100 methylene chloride. The remaining material is stirred with 250 ml of 20 vol% ethanol-80 vol% ethyl acetate, 30 ml of saturated sodium carbonate solution and 60 ml of solid sodium carbonate and then filtered. The insoluble material is washed with 3 x 250 ml 20% by volume ethanol-80% by volume ethyl acetate, combined with the first ethanol-ethyl acetate extract and dried over anhydrous magnesium sulfate. After filtration, solvents are removed under reduced pressure, and the residue is chromatographed over silica gel. A total of 2.3 g of product is eluted with a 25% by volume methanol-75% by volume chloroform mixture. This product is transferred to the oxalate salt by adding it to a solution of 1.39 oxalic acid in 125 ml of ethanol followed by filtration with sufficient ethyl ether.
Efter ytterligere tre felninger under anvendelse av ethanol for å oppløse produktet og ethylether for å felle det, fåes 300 mg 2-methylthioethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydrogen-oxalat , homogent ved tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 25 volum% methanol-75 volum% kloroform) After three additional precipitations using ethanol to dissolve the product and ethyl ether to precipitate it, 300 mg of 2-methylthioethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrogen oxalate is obtained, homogeneous by thin-layer chromatography ( fluorescent silica gel plate developed with 25 vol% methanol-75 vol% chloroform)
Rf =0,83, smp. 85 - 90°C under spaltning. Rf =0.83, m.p. 85 - 90°C during decomposition.
Anal. beregn, for C-^H^NO^S .C^O^: C 47,99; H 5,64; N 3,73 Anal. calculate, for C-^H^NO^S .C^O^: C 47.99; H 5.64; N 3.73
Funnet: C 48,00; H 6,IO; N 4,07 Found: C 48.00; H 6.10; N 4.07
Eksempel 27 Example 27
A. Fremstilling av D,L-3-(3,4-difenylmethylendioxyfenyl)-2-methyl-alanin- hydroklorid A. Preparation of D,L-3-(3,4-diphenylmethylenedioxyphenyl)-2-methyl-alanine hydrochloride
En blanding av 38,6 g (0,155 mol) racemisk-3-(3,4-dihydroxy-fenyl)-2-methylalanin-hydroklorid og 74 g (0,312 mol) diklordifenylmethan neddykkes under langsom omrøring i et foropphetet oljebad ved 190°C. Efter at reaksjonen er begynt, omrøres reaksjonsblandingen hurtig i 6 minutter ved 190°C, taes ut av det varmeooljebad og får avkjøle til 25 - 30°C. Råproduktet fra 6 slike forsøk forenes, oppslemmes med 2 1 diethylether, filtreres, vaskes med ytterligere 2 1 diethylether og tørres ved 30°C under 50 mm trykk. ' Det faste stoff omkrystalliseres ved å oppløse produktet i ethanol og tilsette ethylacetat for å felle D,L-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin-hydroklorid. A mixture of 38.6 g (0.155 mol) of racemic 3-(3,4-dihydroxy-phenyl)-2-methylalanine hydrochloride and 74 g (0.312 mol) of dichlorodiphenylmethane is immersed with slow stirring in a preheated oil bath at 190°C . After the reaction has started, the reaction mixture is stirred rapidly for 6 minutes at 190°C, removed from the hot oil bath and allowed to cool to 25 - 30°C. The crude product from 6 such experiments is combined, slurried with 2 1 diethyl ether, filtered, washed with a further 2 1 diethyl ether and dried at 30°C under 50 mm pressure. The solid is recrystallized by dissolving the product in ethanol and adding ethyl acetate to precipitate D,L-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine hydrochloride.
B. Fremstilling av D,L-N-carbobenzyloxy-3-(3,4-difenyImethylendioxy-f enyl) - 2- methylalanin B. Preparation of D,L-N-carbobenzyloxy-3-(3,4-diphenylimethylenedioxy-phenyl)-2-methylalanine
En blanding av 175 g (0,425 mol) racemisk-3-(3,4-difenyl-methylendioxyf enyl)-2-methylalanin-hydroklorid, 1750 ml aceton og 1750 ml vann omrøres under nitrogen ved en temperatur under 10°C, mens pH innstilles på 12,0 ved langsom tilsetning av en 10%-ig natriumhydroxydoppløsning. 93 g (0,545 mol) carbobenzyloxyklorid tilsettes dråpevis i løpet av 5 - 7 minutter til reaksjonsblandingen ved 20 - 30°C under samtidig tilsetning av en 10%-ig natrium-hydroxydoppløsning for å holde pH på 12,0 - 12,2. Efter at tilsetningen av carbobenzyloxykloridet er avsluttet, omrøres reaksjonsblandingen ved 25 - 30°C i 3 timer. Det meste av acetonet fjernes så under nedsatt trykk ved 25 - 35°C for å felle natriumsaltet av det ønskede N-carbobenzyloxyderivat. Natriumsaltet ekstraheres i 1,5 1 ethylacetat, vaskes med 200 ml 5%-ig natriumhydroxydoppløs-ning og 200 ml mettet natriumkloridoppløsning, og tørres så over magnesiumsulfat. Efter tilsetning av 17,5 g avfarvende kull og filtrering gjennom en magnesiumsulfatplate, fjernes oppløsnings-midler under nedsatt trykk ved 25 - 35°C Residuet oppslemmes to ganger med 1 1 20 volum% ethylether-80 volum% hexanoppløsning og filtreres, hvorved man får natriumsaltet av det ønskede N-carbobenzyloxyderivat. Dette natriumsalt oppløses i 1,5 1 ethylacetat, avkjøles til 10°C og gjøres surt til pH 2 med 6 N saltsyre. Ethylacetatekstraktet vaskes med 200 ml mettet natriumkloridoppløsning, tørres over magnesiumsulfat, filtreres og inndampes under nedsatt trykk ved 25 - 35°C. N-carbobenzyloxyderivatet tørres ytterligere ved 25 - 30°C og 0,2 - 0,3 mm Hg, hvorved man får D,L-N-carbobenzyloxy -3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin. A mixture of 175 g (0.425 mol) of racemic 3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalanine hydrochloride, 1750 ml of acetone and 1750 ml of water is stirred under nitrogen at a temperature below 10°C, while the pH is set to 12.0 by slow addition of a 10% sodium hydroxide solution. 93 g (0.545 mol) carbobenzyloxychloride is added dropwise over 5 - 7 minutes to the reaction mixture at 20 - 30°C while simultaneously adding a 10% sodium hydroxide solution to keep the pH at 12.0 - 12.2. After the addition of the carbobenzyloxychloride is finished, the reaction mixture is stirred at 25 - 30°C for 3 hours. Most of the acetone is then removed under reduced pressure at 25-35°C to precipitate the sodium salt of the desired N-carbobenzyloxy derivative. The sodium salt is extracted in 1.5 1 ethyl acetate, washed with 200 ml of 5% sodium hydroxide solution and 200 ml of saturated sodium chloride solution, and then dried over magnesium sulphate. After adding 17.5 g of decolorizing charcoal and filtering through a magnesium sulfate plate, solvents are removed under reduced pressure at 25 - 35°C. The residue is slurried twice with 1 1 20% by volume ethyl ether-80% by volume hexane solution and filtered, which gives the sodium salt of the desired N-carbobenzyloxy derivative. This sodium salt is dissolved in 1.5 1 ethyl acetate, cooled to 10°C and acidified to pH 2 with 6 N hydrochloric acid. The ethyl acetate extract is washed with 200 ml saturated sodium chloride solution, dried over magnesium sulphate, filtered and evaporated under reduced pressure at 25 - 35°C. The N-carbobenzyloxy derivative is further dried at 25 - 30°C and 0.2 - 0.3 mm Hg, whereby D,L-N-carbobenzyloxy -3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine is obtained.
C. Fremstilling av D,L-succinimidomethyl-N-carbobenzyloxy~3-(3,4-difenylmethylendioxyfenyl)- 2- methylalaninat C. Preparation of D,L-succinimidomethyl-N-carbobenzyloxy~3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate
En oppløsning av 13,5 g (0,0265 mol) D,L-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,7 g (0,027 mol) triethylamin og 5,19 9 (0,029 mol) N-brommethylsuccinimid i 35 ml tørt dimethylformamid omrøres ved 25 - 30°C i 16 timer. Reaksjonsblandingen helles i 400 ml isvann, og produktet ekstraheres i 200 ml av en 50 volum% kloroform-50 volum% diethyletherblanding. Det organiske ekstrakt vaskes med 50 ml 5%-ig natriumcarbonatoppløsning og 50 ml mettet natriumkloridoppløsning og tørres så over vannfritt magnesiumsulfat. Efter filtrering og inndampning under nedsatt trykk, omkrystalliseres residuet. Omkrystallisasjon ble utført ved å oppløse produktet i ethanol og tilsette hexan for å felle D,L-succinimidomethyl-N-carbobenzyloxy-3-(3,4-difen<y>lmeth<y>fe ndioxyfenyl)-2-methylalaninat. A solution of 13.5 g (0.0265 mol) D,L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.7 g (0.027 mol) triethylamine and 5.19 g (0.029 mol ) N-bromomethylsuccinimide in 35 ml of dry dimethylformamide is stirred at 25 - 30°C for 16 hours. The reaction mixture is poured into 400 ml of ice water, and the product is extracted into 200 ml of a 50% by volume chloroform-50% by volume diethyl ether mixture. The organic extract is washed with 50 ml of 5% sodium carbonate solution and 50 ml of saturated sodium chloride solution and then dried over anhydrous magnesium sulphate. After filtration and evaporation under reduced pressure, the residue is recrystallized. Recrystallization was performed by dissolving the product in ethanol and adding hexane to precipitate D,L-succinimidomethyl-N-carbobenzyloxy-3-(3,4-diphen<y>lmeth<y>phen ndioxyphenyl)-2-methylalaninate.
D. Fremstilling av D,L-succinimidomethyl-3-(3,4-dihydroxyfenyl)-2- methylalaninat - hydroklorid- hydrat D. Preparation of D,L-succinimidomethyl-3-(3,4-dihydroxyphenyl)-2- methylalaninate - hydrochloride - hydrate
En suspensjon av 6,6 g (0,0106 mol) racemisk succinimido-methyl-N-carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat i 180 ml absolutt ethanol og 9 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning hydrogeneres med 3,3 9 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,11 kg/cm <2> inntil hydrogenopptagelsen var fullstendig. Efter fjernelse av katalysatoren ved filtrering, konsentreres filtratet under nedsatt trykk. Residuet ekstraheres med 50 ml benzen og derpå 50 ml ethylacetat. Det uoppløselige faste stoff ble så rystet med 50 ml 10 volum% ethanol-90 volum% ethylacetatblanding og IO ml mettet natriumcarbonat oppløsning . Efter filtrering ble filtratet tørret over vannfritt magnesiumsulfat, filtrert og inndampet under nedsatt trykk, hvorved man fikk D,L-succinimidomethyl-3-(3,4-dihydroxyf.enyl)-2-methylalaninat som basen. A suspension of 6.6 g (0.0106 mol) of racemic succinimido-methyl-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 180 ml of absolute ethanol and 9 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution hydrogenated with 3.3 9 10% palladium-on-carbon catalyst at an initial pressure of 2.11 kg/cm <2> until hydrogen absorption was complete. After removing the catalyst by filtration, the filtrate is concentrated under reduced pressure. The residue is extracted with 50 ml of benzene and then 50 ml of ethyl acetate. The insoluble solid was then shaken with 50 ml of 10% by volume ethanol-90% by volume ethyl acetate mixture and 10 ml of saturated sodium carbonate solution. After filtration, the filtrate was dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure, whereby D,L-succinimidomethyl-3-(3,4-dihydroxyphenyl)-2-methylalaninate was obtained as the base.
E. Fremstilling av succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat via omkrystallisasjon av diastereomere salter E. Preparation of succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate via recrystallization of diastereomeric salts
En oppløsning av O,47 9 (3,1 mmol) (-)-vinsyre i IO ml 50 A solution of 0.47 9 (3.1 mmol) (-)-tartaric acid in 10 ml 50
50 volum% absolutt ethanol-50 volum% ethylacetatoppløsning ble under nitrogen ved 20 - 25°C tilsatt til en oppløsning av 1,0 g (3,1 mmol) D,L-succinimidomethyl-3-(3,4-dihydroxyfenyl)-2-methylalaninat i IO ml absolutt ethanol. Efter oppvarmning av oppløs-ningen til 40 - 60°C ble ethylacetat tilsatt til begynnende blakning og derpå avkjølt langsomt til 25°C og til slutt lagret ved 5 - 10°C i 12 timer. Det uoppløselige rå vinsyresalt ble fjernet ved filtrering og tørret ved 20 - 25°C og 0,2 - 0,5 mm trykk. 50 vol% absolute ethanol-50 vol% ethyl acetate solution was added under nitrogen at 20 - 25°C to a solution of 1.0 g (3.1 mmol) D,L-succinimidomethyl-3-(3,4-dihydroxyphenyl)- 2-methylalaninate in 10 ml absolute ethanol. After heating the solution to 40 - 60°C, ethyl acetate was added to start bleaching and then cooled slowly to 25°C and finally stored at 5 - 10°C for 12 hours. The insoluble crude tartaric salt was removed by filtration and dried at 20-25°C and 0.2-0.5 mm pressure.
Denne omkrystallisasjonsbehandling ble gjentatt inntil smeltepunktet og optisk dreining av vinsyresaltet var i det vesentlige konstant. This recrystallization treatment was repeated until the melting point and optical rotation of the tartaric salt were substantially constant.
Morluten fra den første krystallisasjon ble inndampet ved The mother liquor from the first crystallization was evaporated with wood
15 - 20 mm og 4o - 50°C. Residuet ble rystet med 25 ml 10 volum% ethanol-90 volum% ethylacetatblanding og 10 ml mettet natriumcar-bonatoppløsning. Efter filtrering ble filtratet tørret over vannfritt magnesiumsulfat, filtrert og inndampet ved 15 - 20 mm og 40°C til en gummi. Residuet ble oppløst i 5 ml absolutt ethanol og under nitrogen tilsatt til en oppløsning av o,3 av (+)-vinsyre i 10 ml 50 volum% absolutt ethanol-50 volum% ethylacetatoppløsning. Efter oppvarmning av oppløsningen til 40 - 6o°C ble ethylacetat tilsatt til begynnende blakning og derpå avkjølt langsomt til 25°C og så 15 - 20 mm and 4o - 50°C. The residue was shaken with 25 ml of 10% by volume ethanol-90% by volume ethyl acetate mixture and 10 ml of saturated sodium carbonate solution. After filtration, the filtrate was dried over anhydrous magnesium sulfate, filtered and evaporated at 15-20 mm and 40°C to a gum. The residue was dissolved in 5 ml of absolute ethanol and under nitrogen added to a solution of 0.3 of (+)-tartaric acid in 10 ml of 50% by volume absolute ethanol-50% by volume ethyl acetate solution. After heating the solution to 40 - 6o°C, ethyl acetate was added to begin to pale and then cooled slowly to 25°C and then
lagret ved 5 - 10°C i 14 timer. Det uoppløselige rå vinsyresalt ble fjernet ved filtrering. Gjentagelse av denne omkrystallisasjons - behandling gir den annen optiske antipode av succinimidomethyl-3-(3,4-dihydroxyfenyl)-2-methylalaninat som vinsyresaltet. De optisk aktive vinsyresalter ble overført til de optisk aktive hydrokloridsalter ved følgende metode. Vinsyresaltet av succinimido-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat rystes med 50 ml 10 volum% ethanol-90 volum% ethylacetatblanding og 10 ml mettet natriumcarbonatoppløsning. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. Residuet oppløses i 25 ml absolutt ethanol, behandles med 5 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning og inndampes under nedsatt trykk, hvorved man får succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 30 volum% methanol-70 volum% benzenoppløsningsmiddel) med en iakttatt Rf = 0,5. stored at 5 - 10°C for 14 hours. The insoluble crude tartaric salt was removed by filtration. Repetition of this recrystallization treatment gives the second optical antipode of succinimidomethyl-3-(3,4-dihydroxyphenyl)-2-methylalaninate as the tartaric acid salt. The optically active tartaric acid salts were converted to the optically active hydrochloride salts by the following method. The tartaric acid salt of succinimido-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate is shaken with 50 ml of 10% by volume ethanol-90% by volume ethyl acetate mixture and 10 ml of saturated sodium carbonate solution. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue is dissolved in 25 ml of absolute ethanol, treated with 5 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution and evaporated under reduced pressure, whereby succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate is obtained, homogeneous by thin layer chromatography (fluorescent silica gel plate, 30 vol% methanol-70 vol% benzene solvent) with an observed Rf = 0.5.
Eksempel 28 Example 28
Spaltning av racemisk pivaloyloxymethyl-3-(3,4-dihydroxyfenyl)-2-methylalaninat ved direkte omkrystallisasjon Cleavage of racemic pivaloyloxymethyl-3-(3,4-dihydroxyphenyl)-2-methylalaninate by direct recrystallization
Racemisk pivaloyloxymethy1-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid ble fremstilt som i eksempel 23. 30 g racemisk pivaloyloxymethy1-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid ble oppslemmet ved 35°C i lOO ml 1,0 N saltsyre. Overskudd av faste stoffer ble frafiltrert. Den mettede oppløsning ble så podet ved 35°C med pivaloyloxymethyl-D-3-(3,4-dihydroxyf enyl)-2-methylalaninat-hydroklorid-hydrat. Blandingen ble avkjølt til 20°C i 30 minutter og hensatt ved 20°C i 0,5 timer. Det utskilte materiale ble isolert ved filtrering, vasket to ganger med 5 ml koldt vann og tørret ved 0,1 - 0,5 mm og 20 - 25°C i 20 timer, hvorved man fikk pivaloyloxymethyl-D-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat. Racemic pivaloyloxymethy1-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride was prepared as in Example 23. 30 g of racemic pivaloyloxymethy1-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride were slurried at 35° C in lOO ml of 1.0 N hydrochloric acid. Excess solids were filtered off. The saturated solution was then seeded at 35°C with pivaloyloxymethyl-D-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate. The mixture was cooled to 20°C over 30 minutes and left at 20°C for 0.5 hours. The precipitated material was isolated by filtration, washed twice with 5 ml of cold water and dried at 0.1 - 0.5 mm and 20 - 25°C for 20 hours to give pivaloyloxymethyl-D-3-(3,4 -dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate.
Morluten fra ovenstående trinn ble oppvarmet til 35°c og podet ved 35°C med pivaloyloxymethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid. Blandingen ble så avkjølt til 20°C i løpet av 30 minutter og hensatt ved 20°C i 0,5 timer. Det utfelte materiale ble isolert ved filtrering, vasket to ganger med .5 ml koldt vann og tørret ved 0,1 - 0,5 mm og 20 - 25°C i 20 timer, hvorved man fikk pivaloyloxymethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat . The mother liquor from the above step was heated to 35°C and seeded at 35°C with pivaloyloxymethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride. The mixture was then cooled to 20°C over 30 minutes and left at 20°C for 0.5 hours. The precipitated material was isolated by filtration, washed twice with .5 ml of cold water and dried at 0.1 - 0.5 mm and 20 - 25°C for 20 hours to give pivaloyloxymethyl-L-3-(3, 4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate.
Eksempel 29 Example 29
A. Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat -hydroklorid-dihydrat ((3-isomer) ved fraksjonert krystallisasjon A. Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride dihydrate ((3-isomer) by fractional crystallization
10 g a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat -hydroklorid (a- og (3-isomerblanding) fra eksempel 2 ble oppløst i 50 ml varm 95%-ig ethanol (5% vann), fortynnet til begynnende blakning med vannfri ether, podet og skrapet for å bevirke krystallisasjon. Efter avkjøling ved 5 - 10°C i 12 timer, ble det utfelte faste stoff oppsamlet og tørret ved 70°C. Ytterligere lignende omkrystallisasjoner fra 95 volum% ethanol-5 volum% vann-ethylether ga materiale som smeltet ved 123 - 126°C (spaltning). En endelig omkrystallisasjon fra 95%-ig ethanol ga a-succinimidoethyl-L-3- (3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-dihydrat (P-isomer) som dihydratet som smeltet ved 129 - 131°C (spaltning) 10 g of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride (α- and (3-isomer mixture) from example 2 was dissolved in 50 ml of hot 95% ethanol (5% water ), diluted to incipient paleness with anhydrous ether, seeded and scraped to effect crystallization. After cooling at 5 - 10°C for 12 hours, the precipitated solid was collected and dried at 70°C. Additional similar recrystallizations from 95 vol% ethanol-5 vol% water-ethyl ether gave material melting at 123 - 126°C (dec.) A final recrystallization from 95% ethanol gave α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2- methylalaninate hydrochloride dihydrate (P-isomer) as the dihydrate which melted at 129 - 131°C (decomposition)
(tørret ved 70°C over natten, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 50 volum% methanol-50 volum% benzen-oppløsningsmiddel), Rf =0,7- (dried at 70°C overnight, homogeneous by thin-layer chromatography (fluorescent silica gel plate, 50 vol% methanol-50 vol% benzene solvent), Rf =0.7-
B. Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid- hydrat ( a- isomer) B. Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate (α-isomer)
Morluten fra den første krystallisasjon av p-isomeren av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat som er rik på den tilsvarende a-isomer, ble inndampet ved 15 - 20 mm og 40 - 45°C. Residuet ble oppløst i 20 ml varm 95%-ig ethanol (5% vann), fortynnet til begynnende blakning med ethylacetat, podet og skrapet for å felle den anrikede a-isomer av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat. Ytterligere felninger fra,95%-ig ethanol (5% vann) og ethylacetat gir a-isomeren som ethylacetatsolvatet, Rf = o,7 The mother liquor from the first crystallization of the β-isomer of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate rich in the corresponding α-isomer was evaporated at 15-20 mm and 40 - 45°C. The residue was dissolved in 20 mL of hot 95% ethanol (5% water), diluted to incipient paleness with ethyl acetate, seeded and scraped to precipitate the enriched α-isomer of α-succinimidoethyl-L-3-(3,4- dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate. Further precipitation from 95% ethanol (5% water) and ethyl acetate gives the α-isomer as the ethyl acetate solvate, Rf = o.7
(tynnskiktskromatografi, fluorescerende silicagelplate, 5o volum% methanol-50 volum% benzenoppløsningsmiddel). (thin layer chromatography, fluorescent silica gel plate, 50 vol% methanol-50 vol% benzene solvent).
Eksempel 30 Example 30
Fremst illing av pivaloyloxymethyl-L-3-(3,4-dihydroxyfenyl)-2-methyl - alaninat- hydroklorid Preparation of pivaloyloxymethyl-L-3-(3,4-dihydroxyphenyl)-2-methyl-alanine hydrochloride
En oppløsning av 0,95 g (4,0 mmol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat og 0,6l g (4,06 mmol) pivaloyloxymethyl-klorid i 5 ml dimethylsulfoxyd omrøres ved 20 - 25°C i 23 timer. A solution of 0.95 g (4.0 mmol) of L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate and 0.6 l g (4.06 mmol) of pivaloyloxymethyl chloride in 5 ml of dimethylsulfoxide is stirred at 20 - 25°C for 23 hours.
Oppløsningen fortynnes med 10 ml destillert vann og føres gjennom The solution is diluted with 10 ml of distilled water and passed through
en kolonne inneholdende 5 g svakt basisk anionbytteharpiks i baseformen. Efter eluering med vannfraksjoner forenes fraksjonene som gir en positiv ferrikloridtest og tilsettes til en kolonne av 3 g svakt sur kationbytteharpiks i syreformen. Uomsatt L-3-(3,4-dihydroxyfenyl)-2-methylalanin elueres med destillert vann inntil en negativ ferrikloridtest fåes, esteren elueres så med 1 N eddiksyre. Esterf raks jonen, 50 ml (pH 3,2), syres til pH 2,0 med 1 N saltsyre og lyofiliseres ved 0,1 - 0,3 mm i 20 timer, hvorved man får pivaloyl-oxymethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid som eddiksyresolvatet. a column containing 5 g of weakly basic anion exchange resin in the base form. After elution with water fractions, the fractions which give a positive ferric chloride test are combined and added to a column of 3 g of weakly acidic cation exchange resin in the acid form. Unreacted L-3-(3,4-dihydroxyphenyl)-2-methylalanine is eluted with distilled water until a negative ferric chloride test is obtained, the ester is then eluted with 1 N acetic acid. The ester fraction, 50 ml (pH 3.2), is acidified to pH 2.0 with 1 N hydrochloric acid and lyophilized at 0.1 - 0.3 mm for 20 hours, whereby pivaloyl-oxymethyl-L-3-( 3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride as the acetic acid solvate.
Anal. beregn, for C^H^NOg .HC1.1/3HC2H^02: C 52,11; H 6,69; N 3,58 Funnet: C 52,11; H 6,49; N 3,73 Anal. calculate, for C^H^NOg.HCl.1/3HC2H^O2: C 52.11; H 6.69; N 3.58 Found: C 52.11; H 6.49; N 3.73
Eksempel 31 Example 31
Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 0,95 g (4,0 mmol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat og 0,65 g (4,0 mmol) N-(a-klorethyl)-succinimid i 5 ml dimethylsulfoxyd omrøres ved 20 - 25°C i 23 timer. Oppløsningen fortynnes med 10 ml destillert vann og føres gjennom en kolonne inneholdende 5 g svakt basisk anionbytteharpiks i den basiske form. Efter eluering med vannfraksjoner forenes fraksjonene som gir en positiv ferrikloridtest og tilsettes til en kolonne av 3 g svakt sur kationbytteharpiks i den sure form. Uomsatt L-3-(3,4-dihydroxyfenyl)-2-methylalanin elueres med destillert vann inntil en negativ ferrikloridtest fåes, og esteren elueres så med 1 N eddiksyre. Esterfraksjonen, 55 ml (pH 3,2), behandles med 1 N saltsyre til pH 2,0 og lyofiliseres ved 0,1 - 0,3 mm i 20 timer, hvorved man får a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-eddiksyresolvat. A solution of 0.95 g (4.0 mmol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate and 0.65 g (4.0 mmol) N-(α-chloroethyl)-succinimide in 5 ml of dimethylsulfoxide is stirred at 20 - 25°C for 23 hours. The solution is diluted with 10 ml of distilled water and passed through a column containing 5 g of weakly basic anion exchange resin in the basic form. After elution with water fractions, the fractions which give a positive ferric chloride test are combined and added to a column of 3 g of weakly acidic cation exchange resin in the acidic form. Unreacted L-3-(3,4-dihydroxyphenyl)-2-methylalanine is eluted with distilled water until a negative ferric chloride test is obtained, and the ester is then eluted with 1 N acetic acid. The ester fraction, 55 ml (pH 3.2), is treated with 1 N hydrochloric acid to pH 2.0 and lyophilized at 0.1 - 0.3 mm for 20 hours, whereby α-succinimidoethyl-L-3-(3, 4-dihydroxyphenyl)-2-methylalaninate hydrochloride-acetic acid solvate.
Anal. beregn, for C^H^gOg .HC1.1/3C2H^02: C 50,96; H 5,73; N 7,13 Funnet: c 50,48; H 6,13; H 6,77 Eksempel 32 Anal. calculate, for C^H^gOg .HCl.1/3C2H^O2: C 50.96; H 5.73; N 7.13 Found: c 50.48; H 6.13; H 6.77 Example 32
Fremstilling av 3-acetamidopropyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydrogenoxalat- hydrat Preparation of 3-acetamidopropyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrogen oxalate hydrate
275 ml thionylklorid tilsettes til 250 g L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-seskvihydrat ved 25°C, og blandingen oppvarmes på dampbad. Efter oppvarmning i 2 timer fortynnes den tykke 275 ml of thionyl chloride are added to 250 g of L-3-(3,4-dihydroxy-phenyl)-2-methylalaninate sesquihydrate at 25°C, and the mixture is heated on a steam bath. After heating for 2 hours, the thick mixture is diluted
reaksjonsblanding med 7,5 ml dimethylformamid oppløst i 25 ml benzen og omrøres på dampbad inntil gassutviklingen opphører. 100 ml benzen tilsettes, og den rå svovelsyrlingester fjernes ved filtrering, vaskes med 100 ml benzen, lOO ml kloroform og 100 ml ether og tørres under nedsatt trykk, hvorved man får 280 g av svovelsyrlingester-mellomproduktet, smp. 199°C under spaltning. reaction mixture with 7.5 ml of dimethylformamide dissolved in 25 ml of benzene and stirred on a steam bath until gas evolution ceases. 100 ml of benzene is added, and the crude sulfuric acid ester is removed by filtration, washed with 100 ml of benzene, 100 ml of chloroform and 100 ml of ether and dried under reduced pressure, thereby obtaining 280 g of the intermediate sulfuric acid ester, m.p. 199°C during decomposition.
En blanding av 13,7 g av det rå svovelsyrlingester-mellom-produkt, 24,98 g (0,212 mol) N-acetylpropanolamin og 2 g vannfritt dimethylformamid omrøres på dampbad i 20 timer og avkjøles. Reaksjonsblandingen vaskes med 6 x 200 ml ethylether, 4 x 200 ml methylenklorid og tørres under nedsatt trykk. Det halvfaste materiale som er igjen, omrøres med 200 ml 20 volum% ethanol-80 volum% ethylacetat, 20 ml mettet natriumcarbonatoppløsning og 20 g fast natriumcarbonat. Det organiske ekstrakt tørres over vannfritt magnesiumsulfat, filtreres, og filtratet tilsettes til en oppløs-ning av 3,2 g oxalsyre i 50 ml ethanol. Oppløsningsmidler fjernes under nedsatt trykk, og produktet felles ved å oppløse det i 50 ml ethanol og tilsette 500 ml ethylether. Produktet felles igjen ved oppløsning i 50 ml ethanol og tilsetning av 500 ml ethylacetat, hvorved man får 3-acetamidopropyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydrogenoxalat-hydrat, Rf = 0,45, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 25 volum% methanol- A mixture of 13.7 g of the crude sulfuric ester intermediate, 24.98 g (0.212 mol) of N-acetylpropanolamine and 2 g of anhydrous dimethylformamide is stirred on a steam bath for 20 hours and cooled. The reaction mixture is washed with 6 x 200 ml ethyl ether, 4 x 200 ml methylene chloride and dried under reduced pressure. The semi-solid material that remains is stirred with 200 ml of 20 vol% ethanol-80 vol% ethyl acetate, 20 ml of saturated sodium carbonate solution and 20 g of solid sodium carbonate. The organic extract is dried over anhydrous magnesium sulfate, filtered, and the filtrate is added to a solution of 3.2 g of oxalic acid in 50 ml of ethanol. Solvents are removed under reduced pressure, and the product is precipitated by dissolving it in 50 ml of ethanol and adding 500 ml of ethyl ether. The product is separated again by dissolving in 50 ml of ethanol and adding 500 ml of ethyl acetate, which gives 3-acetamidopropyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrogen oxalate hydrate, Rf = 0.45, thin layer chromatography (fluorescent silica gel plate developed with 25 vol% methanol-
75 volum% kloroform). 75 vol% chloroform).
Anal. beregn, for ^- L^ 22^ 2°5' C2H2°4' H2°: C Zf8'80; H 6'26' N °>69 Funnet: C 48,73; H 6,85; N 6,68 Anal. calculate, for ^- L^ 22^ 2°5' C2H2°4' H2°: C Zf8'80; H 6'26' N °>69 Found: C 48.73; H 6.85; N 6.68
Eksempel 33 Example 33
Fremstilling av 2-acetamidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid Preparation of 2-acetamidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppslemning av 88,3 9 (0,30 mol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-hydroklorid-ethanolsolvat (ved konsentrasjon av en ethanolisk oppløsning av hydrokloridet under nedsatt trykk) og 146,5 g (1,42 mol) N-acetylethanolamin, under nitrogen, oppvarmes til 104 - 108°C. 84,8 g (0,713 mol) thionylklorid tilsettes i løpet av 15 minutter under omrøring. Reaksjonsblandingen skummer kraftig under tilsetningen. Efter at tilsetningen er avsluttet, omrøres reaksjonsblandingen ved 104 - 108°C i 18 timer. Ytterligere 42,4 9 (0,357 mol) thionylklorid tilsettes i løpet av 7 minutter. Reaksjonsblandingen omrøres ved 104 - 108°C i ytterligere 3,5 timer, avkjøles så til 30°C og inndampes under nedsatt trykk, hvorved man får en viskøs olje. Denne olje oppslemmes med lOO ml kloroform, og kloroformen fjernes under nedsatt trykk. Dette gjentaes ytterligere tre ganger, og derpå vaskes oljen med lOO ml benzen som fradekanteres. Residuet oppløses i 700 ml isopropanol og tilsettes til 6 1 ethylether. Bunnfallet som dannes, vaskes med 500 ml ethylether og rystes med 6 1 IO volum% ethanol-90 volum% ethylacetat, 150 ml mettet natrium-carbonatoppløsning og 100 g natriumcarbonat. Det organiske ekstrakt tørres over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk, hvorved man får den frie base av acetamidoethylesteren. Denne base behandles med 15 g fumarsyre i 300 ml isopropanol, og fumaratsaltet felles ved tilsetning av tilstrekkelig ethylether. Fumaratsaltet felles nok en gang fra isopropanol ved tilsetning av tilstrekkelig ethylether og overføres så igjen til den frie base som før ved rystning med 200 ml 10% ethanol-90 volum% ethylacetat, 20 ml mettet natriumcarbonatoppløsning og 20 g fast natriumcarbonat. Den frie base overføres til hydrokloridsaltet ved oppløsning i lOO ml absolutt ethanol, tilsetning av lo ml 9,6 N saltsyre og feining ved tilsetning til 1 1 ethylether. Efter tre felninger fra ethanol-ethylether som utført ovenfor, fåes 2-acet-amidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydroklorid, Rf = 0,57, tynnskiktskromatografi (fluorescerende silicagelplate utviklet med 50 volum% methanol-50 volum% benzen). A slurry of 88.3 g (0.30 mol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine hydrochloride ethanol solvate (by concentration of an ethanolic solution of the hydrochloride under reduced pressure) and 146.5 g (1.42 mol) of N-acetylethanolamine, under nitrogen, is heated to 104 - 108°C. 84.8 g (0.713 mol) of thionyl chloride are added during 15 minutes with stirring. The reaction mixture foams vigorously during the addition. After the addition has ended, the reaction mixture is stirred at 104 - 108°C for 18 hours. A further 42.4 g (0.357 mol) of thionyl chloride is added over 7 minutes. The reaction mixture is stirred at 104 - 108°C for a further 3.5 hours, then cooled to 30°C and evaporated under reduced pressure, whereby a viscous oil is obtained. This oil is slurried with 100 ml of chloroform, and the chloroform is removed under reduced pressure. This is repeated a further three times, and then the oil is washed with 100 ml of benzene which is decanted. The residue is dissolved in 700 ml isopropanol and added to 6 1 ethyl ether. The precipitate that forms is washed with 500 ml of ethyl ether and shaken with 6 1 10 volume% ethanol-90 volume% ethyl acetate, 150 ml of saturated sodium carbonate solution and 100 g of sodium carbonate. The organic extract is dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure, whereby the free base of the acetamidoethyl ester is obtained. This base is treated with 15 g of fumaric acid in 300 ml of isopropanol, and the fumarate salt is precipitated by adding sufficient ethyl ether. The fumarate salt is separated once again from isopropanol by adding sufficient ethyl ether and then transferred back to the free base as before by shaking with 200 ml of 10% ethanol-90% by volume ethyl acetate, 20 ml of saturated sodium carbonate solution and 20 g of solid sodium carbonate. The free base is transferred to the hydrochloride salt by dissolving in 100 ml of absolute ethanol, adding 10 ml of 9.6 N hydrochloric acid and refining by adding 1 1 of ethyl ether. After three precipitations from ethanol-ethyl ether as carried out above, 2-acet-amidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrochloride, Rf = 0.57, thin-layer chromatography (fluorescent silica gel plate developed with 50 vol% methanol-50 vol% benzene).
Anal. beregn, for C^H^NgO^ .HC1: C 50,52; H 6,36; N 8,4l Anal. calculate, for C^H^NgO^ .HCl: C 50.52; H 6.36; N 8.4l
Funnet: C 50,49; H 6,69; N 8,49 Found: C 50.49; H 6.69; N 8.49
Eksempel 34 Example 34
A. Fremstilling av L-3-(3,4-diacetoxyfenyl)-2-methylalanin-hydroklorid A. Preparation of L-3-(3,4-diacetoxyphenyl)-2-methylalanine hydrochloride
Til en blanding av 320 ml iseddik og 24 mi acetylklorid tilsettes i en porsjon 69,4 g (0,291 mol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat. Temperaturen av reaksjonsblandingen stiger til ca. 50°C, og en klar oppløsning dannes. Ved denne temperatur tilsettes ytterligere 85 ml acetylklorid i løpet av 10 minutter. Den erholdte klare, blekt gule oppløsning hensettes ved 20 - 25°C i 14 timer. 400 ml vannfri ethylether tilsettes i løpet av 15 minutter. Når tilsetningen er nesten avsluttet, begynner et hvitt, fast stoff å utfelles. Blandingen omrøres ved 20 - 25°C i 30 minutter, ved 5 - 10°C i 1 time og avkjøles så til -10°C i 2 timer. To a mixture of 320 ml of glacial acetic acid and 24 ml of acetyl chloride, 69.4 g (0.291 mol) of L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate is added in one portion. The temperature of the reaction mixture rises to approx. 50°C, and a clear solution is formed. At this temperature, a further 85 ml of acetyl chloride are added over the course of 10 minutes. The clear, pale yellow solution obtained is allowed to stand at 20 - 25°C for 14 hours. 400 ml of anhydrous ethyl ether are added over 15 minutes. When the addition is nearly complete, a white solid begins to precipitate. The mixture is stirred at 20 - 25°C for 30 minutes, at 5 - 10°C for 1 hour and then cooled to -10°C for 2 hours.
Det faste stoff fjernes ved filtrering, suspenderes i 150 ml 30 volum% eddiksyre-70 volum% ethylether, filtreres og vaskes med 500 ml ethylether. Efter tørring ved 70 C i 2 timer fåes 83,7 g (88%) L-3-(3,4-diacetoxyfenyl)-2-methylalanin-hydroklorid, smp. 196,0 - 197,0°C. The solid is removed by filtration, suspended in 150 ml of 30% by volume acetic acid-70% by volume ethyl ether, filtered and washed with 500 ml of ethyl ether. After drying at 70 C for 2 hours, 83.7 g (88%) of L-3-(3,4-diacetoxyphenyl)-2-methylalanine hydrochloride are obtained, m.p. 196.0 - 197.0°C.
B. Fremstilling av.L-3-(3,4-diacetoxyfenyl)-2-methylalanylklorid-hydroklorid B. Preparation of L-3-(3,4-diacetoxyphenyl)-2-methylalanyl chloride hydrochloride
En blanding av 6,6o g (0,020 mol) L-3~(3,4-diacetoxyfenyl)-2-methylalanin-hydroklorid og 40 ml thionylklorid omrøres ved 6o°C i 2 timer inntil oppløsning er fullstendig. Overskudd av thionylklorid fjernes ved 15 - 20 mm og 40 - 50°C. 50 ml methylenklorid tilsettes, og blandingen konsentreres igjen ved 15 - 20 mm og 40 - 50°C. Dette gjentaes enda en gang med nok 50 ml methylenklorid. Efter tørring ved 0,2 - 0,5 mm og 40°C i 30 minutter, fåes L-3-(3,4-diacetoxyfenyl)-2-methylalanylklorid. A mixture of 6.60 g (0.020 mol) L-3~(3,4-diacetoxyphenyl)-2-methylalanine hydrochloride and 40 ml of thionyl chloride is stirred at 60°C for 2 hours until dissolution is complete. Excess thionyl chloride is removed at 15 - 20 mm and 40 - 50°C. 50 ml of methylene chloride are added, and the mixture is concentrated again at 15 - 20 mm and 40 - 50°C. This is repeated once more with another 50 ml of methylene chloride. After drying at 0.2 - 0.5 mm and 40°C for 30 minutes, L-3-(3,4-diacetoxyphenyl)-2-methylalanyl chloride is obtained.
C. Fremstilling av succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid- hydrat C. Preparation of succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate
En oppløsning av 3,50 g (10 mmol) L-3-(3,4-diacetoxyfenyl)-2-methylalanylklorid-hydroklorid i 20 ml kloroform tilsettes til en oppløsning av 3,87 g (30 mmol) N-hydroxymethylsuccinimid i 20 ml kloroform ved 25°C. Efter omrøring under tilbakeløp i 20 timer fjernes kloroformen ved 15 - 20 mm og 30 - 40°C. Residuet fortynnes med 10 ml 1 N saltsyre og ekstraheres med 2 x 20 ml ethylether. A solution of 3.50 g (10 mmol) of L-3-(3,4-diacetoxyphenyl)-2-methylalanyl chloride hydrochloride in 20 ml of chloroform is added to a solution of 3.87 g (30 mmol) of N-hydroxymethylsuccinimide in 20 ml of chloroform at 25°C. After stirring under reflux for 20 hours, the chloroform is removed at 15 - 20 mm and 30 - 40°C. The residue is diluted with 10 ml of 1 N hydrochloric acid and extracted with 2 x 20 ml of ethyl ether.
Det vandige ekstrakt omrøres under nitrogen ved 20 - 25°C i 5 timer. Efter lyofilisering ved 0,1 - 0,3 mm i 20 timer behandles residuet med 50 ml 10 volum% ethanol-90 volum% ethylacetatoppløsning, 5 ml The aqueous extract is stirred under nitrogen at 20 - 25°C for 5 hours. After lyophilization at 0.1 - 0.3 mm for 20 hours, the residue is treated with 50 ml of 10% by volume ethanol-90% by volume ethyl acetate solution, 5 ml
mettet nat riumcarbonatoppløsning og 5 g fast natriumcarbonat. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes ved 15 - 20 mm og 30 - 40°C. Residuet oppløses i 25 ml absolutt ethanol, behandles med 5 ml 9,6 N ethanolisk vannfri hydro-genkloridoppløsning og inndampes under nedsatt trykk, hvorved man får succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 30 volum% methanol-7o volum% benzenoppløs-ningsmiddel) med en iakttatt Rf =0,5. saturated sodium carbonate solution and 5 g of solid sodium carbonate. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated at 15 - 20 mm and 30 - 40°C. The residue is dissolved in 25 ml of absolute ethanol, treated with 5 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution and evaporated under reduced pressure, whereby succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride is obtained hydrate, homogeneous by thin-layer chromatography (fluorescent silica gel plate, 30% by volume methanol-70% by volume benzene solvent) with an observed Rf = 0.5.
Eksempel 35 ' Example 35'
A. Fremstilling av N-carboxyanhydridet av L-3-(3,4-dihydroxyfenyl) - A. Preparation of the N-carboxyanhydride of L-3-(3,4-dihydroxyphenyl)-
2- methylalanin 2- methylalanine
Fosgengass bobles gjennom en blanding av 9,0 g (0,038 mol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat i 500 ml tetra-hydrofuran i 25 minutter inntil oppløsningen er mettet. Under tilsetningen stiger temperaturen av reaksjonsblandingen til 45°C. Oppløsningen omrøres under nitrogengass-innbobling i ytterligere 50 minutter. Uoppløselig materiale fjernes ved filtrering gjennom en diatoméjordplate, og filtratet inndampes til en olje ved 15 - Phosgene gas is bubbled through a mixture of 9.0 g (0.038 mol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate in 500 ml tetrahydrofuran for 25 minutes until the solution is saturated. During the addition, the temperature of the reaction mixture rises to 45°C. The solution is stirred under nitrogen gas bubbling for a further 50 minutes. Insoluble material is removed by filtration through a diatomaceous earth plate, and the filtrate is evaporated to an oil at 15 -
20 mm trykk og 30 - 35°C. Residuet oppløses i 75 ml ethylacetat, 20 mm pressure and 30 - 35°C. The residue is dissolved in 75 ml of ethyl acetate,
og hexan tilsettes til blakningspunktet. Efter avkjøling i flere dager ved 0 - 5°C fjernes det utfelte, faste stoff ved filtrering og tørres ved 0,1 - 0,3 mm trykk og 25°C, hvorved man får N-carboxyanhydridet av L-3-(3,4-dihydroxyfenyl)-2-methylalanin. and hexane is added to the boiling point. After cooling for several days at 0 - 5°C, the precipitated solid substance is removed by filtration and dried at 0.1 - 0.3 mm pressure and 25°C, whereby the N-carboxyanhydride of L-3-(3, 4-dihydroxyphenyl)-2-methylalanine.
B. Fremstilling av succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid- hydrat B. Preparation of succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate
En oppløsning av 2,37 g (10 mmol) av N-carboxyanhydridet av L-3-(3,4-dihydroxyfenyl)-2-methylalanin og 1,29 g (10 mmol) N-hydroxymethylsuccinimid oppvarmes under tilbakeløp inntil alt N-carboxy-anhydrid har reagert. Efter inndampning ved 15 - 20 mm trykk og 30 - 40°C ekstraheres residuet med 50 ml benzen og derpå med 50 ml ethylacetat. Det uoppløselige faste stoff rystes så med 50 ml 10 volum% ethanol-90 volum% ethylacetatblanding og 10 ml mettet natriumcarbonatoppløsning. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes under nedsatt trykk. Residuet oppløses i 25 ml absolutt ethanol, behandles med 5 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning og inndampes under nedsatt trykk, hvorved man får succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid-hydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 30 volum% methanol-70 volum% benzenoppløsning) med en iakttatt Rf =0,5. A solution of 2.37 g (10 mmol) of the N-carboxyanhydride of L-3-(3,4-dihydroxyphenyl)-2-methylalanine and 1.29 g (10 mmol) of N-hydroxymethylsuccinimide is heated under reflux until all the N- carboxy anhydride has reacted. After evaporation at 15 - 20 mm pressure and 30 - 40°C, the residue is extracted with 50 ml of benzene and then with 50 ml of ethyl acetate. The insoluble solid is then shaken with 50 ml of 10% by volume ethanol-90% by volume ethyl acetate mixture and 10 ml of saturated sodium carbonate solution. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue is dissolved in 25 ml of absolute ethanol, treated with 5 ml of 9.6 N ethanolic anhydrous hydrogen chloride solution and evaporated under reduced pressure, whereby succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate is obtained, homogeneous by thin-layer chromatography (fluorescent silica gel plate, 30 vol% methanol-70 vol% benzene solution) with an observed Rf =0.5.
Eksempel 36 Example 36
A. Fremstilling av L-3"(3,4-difenylmethylendioxyfenyl)-2-methyl-a lanin - hydroklorid A. Preparation of L-3"(3,4-diphenylmethylenedioxyphenyl)-2-methyl-a lanine - hydrochloride
En blanding av 19,3 g (0,0777 mol) L-3-(3,4-dihydroxyfenyl)-2 - methylalanin-hydroklorid og 37 g (0,156 mol) diklordifenylmethan neddykkes under langsom omrøring i et foropphetet oljebad ved 190°C Efter at reaksjonen er begynt, som det fremgår av kraftig gassutvikling, omrøres reaksjonsblandingen hurtig i 6 minutter ved 190°C, taes ut av det varme oljebad og får avkjøle til 25 - 30°C. Råproduktet fra 12 forsøk forenes, oppslemmes med 3 1 diethylether, filtreres, vaskes med ytterligere 2 1 diethylether og tørres ved 30°C under 50 mm trykk. Produktet omkrystalliseres ved å oppløse det i ethanol og tilsette ethylacetat for å felle produktet. Man får 255 g (66,4%) L-3-(3,4-difenylmethylendioxyfenyl)-2-methyl-alanin-hydroklorid, smp. 267 - 268°C under spaltning. A mixture of 19.3 g (0.0777 mol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine hydrochloride and 37 g (0.156 mol) dichlorodiphenylmethane is immersed with slow stirring in a preheated oil bath at 190°C After the reaction has started, as evidenced by strong gas evolution, the reaction mixture is stirred rapidly for 6 minutes at 190°C, removed from the hot oil bath and allowed to cool to 25 - 30°C. The crude product from 12 experiments is combined, slurried with 3 1 diethyl ether, filtered, washed with a further 2 1 diethyl ether and dried at 30°C under 50 mm pressure. The product is recrystallized by dissolving it in ethanol and adding ethyl acetate to precipitate the product. 255 g (66.4%) of L-3-(3,4-diphenylmethylenedioxyphenyl)-2-methyl-alanine hydrochloride are obtained, m.p. 267 - 268°C during decomposition.
B. Fremstilling av a-succinimidoethyl-L-3-(3,4-difenylmethylen-dioxyf enyl) - 2- methylalaninat B. Preparation of α-succinimidoethyl-L-3-(3,4-diphenylmethylene-dioxyphenyl)-2-methylalaninate
En oppløsning av 1,4 g (4,0 mmol) L-3-(3,4-difenylmethylen-dioxyf enyl) -2-methylalanin og 0,65 g (4,0 mmol) N- (a-klorethyl)-succinimid i 5 ml dimethylsulfoxyd omrøres ved 20 - 25°C i 23 timer. 150 ml vann tilsettes fulgt av en mettet natriumcarbonatoppløsning inntil en pH på 8 fåes. Produktet ekstraheres i 500 ml ethylether som så vaskes med 4 x 25 ml vann, tørres over vannfritt magnesium-sulf at og filtreres. Inndampning ved 15 - 20 mm og 35 - 40°C gir rått a-succinimidoethyl-L-3-(3,4-difenylmethylendioxyfenyl)-2-methylalaninat med tilstrekkelig renhet for anvendelse i det neste trinn. A solution of 1.4 g (4.0 mmol) of L-3-(3,4-diphenylmethylene-dioxyphenyl)-2-methylalanine and 0.65 g (4.0 mmol) of N-(α-chloroethyl)- succinimide in 5 ml of dimethylsulfoxide is stirred at 20 - 25°C for 23 hours. 150 ml of water is added followed by a saturated sodium carbonate solution until a pH of 8 is obtained. The product is extracted in 500 ml of ethyl ether, which is then washed with 4 x 25 ml of water, dried over anhydrous magnesium sulphate and filtered. Evaporation at 15 - 20 mm and 35 - 40°C gives crude α-succinimidoethyl-L-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate of sufficient purity for use in the next step.
C. Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat - hydroklorid C. Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate - hydrochloride
En suspensjon av 1,0 g (2,0 mmol) a-succinimidoethyl-L-3-(3 ,4-dif enylmethylendioxyf enyl)-2-methylalaninat i 25 ml 25 volum% absolutt ethanol-75 volum% ethylacetatoppløsning hydrogeneres med 1,0 g 10%-ig palladium-på-carbonkatalysator ved et begynnelsestrykk på 2,81 kg/cm og værelsetemperatur i 23 timer. Katalysatoren frafiltreres, og filtratet inndampes under nedsatt trykk ved 30 - 4o°C. Residuet oppløses i 50 .ml lO volum% ethanol-90 volum% ethylacetat-oppløsning og omrøres med 5 ml mettet natriumcarbonatoppløsning og ca. 5 g vannfritt natriumcarbonat i lo minutter. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes til tørrhet under nedsatt trykk. Residuet oppløses i 20 ml tørr kloroform, oppløsningen avkjøles på et isbad og mettes med hydrogenkloridgass i 15 minutter. Det faste stoff oppsamles, vaskes ved suspensjon i 25 ml vannfri ether tre ganger, og oppslemmes så i 25 ml ethylacetat under nitrogen i en korket kolbe ved værelsetemperatur over natten. Det uoppløselige faste stoff fjernes ved filtrering, omrøres med 30 ml hexan i 2 timer og tørres i en vakuumekssikator over calciumklorid, hvorved man får |3-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid som en blanding av a- og |3-isomerer, iakttatt Rf = 0,7 ved tynnskiktskromatografi (fluorescerende silicagelplate, 50 volum% methanol-50 volum% benzen-oppløsningsmiddel). A suspension of 1.0 g (2.0 mmol) of α-succinimidoethyl-L-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalaninate in 25 ml of 25% by volume absolute ethanol-75% by volume ethyl acetate solution is hydrogenated with 1 .0 g of 10% palladium-on-carbon catalyst at an initial pressure of 2.81 kg/cm and room temperature for 23 hours. The catalyst is filtered off, and the filtrate is evaporated under reduced pressure at 30 - 4o°C. The residue is dissolved in 50 ml of 10% by volume ethanol-90% by volume ethyl acetate solution and stirred with 5 ml of saturated sodium carbonate solution and approx. 5 g anhydrous sodium carbonate for lo minutes. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated to dryness under reduced pressure. The residue is dissolved in 20 ml of dry chloroform, the solution is cooled in an ice bath and saturated with hydrogen chloride gas for 15 minutes. The solid is collected, washed by suspension in 25 ml of anhydrous ether three times, and then suspended in 25 ml of ethyl acetate under nitrogen in a corked flask at room temperature overnight. The insoluble solid is removed by filtration, stirred with 30 ml of hexane for 2 hours and dried in a vacuum desiccator over calcium chloride, whereby |3-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride is obtained as a mixture of α- and β-isomers, observed Rf = 0.7 by thin-layer chromatography (fluorescent silica gel plate, 50 vol% methanol-50 vol% benzene solvent).
Eksempel 37 Example 37
A. Fremstilling av L-3-(3,4-diacetoxyfenyl)-2-methylalanin-hydroklorid A. Preparation of L-3-(3,4-diacetoxyphenyl)-2-methylalanine hydrochloride
Til en blanding av 320 ml iseddik og 24 ml acetylklorid tilsettes i en porsjon 69,4 g (0,291 mol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat. Temperaturen på reaksjonsblandingen stiger til ca. 50°C og en klar oppløsning fåes. Ved denne temperatur tilsettes ytterligere 85 ml acetylklorid i løpet av 10 minutter. Den erholdte klare, blekt gule oppløsning hensettes ved 20 - 25°C i 14 timer. 400 ml vannfri ethylether tilsettes i løpet av 15 minutter. Når tilsetningen er nesten fullstendig, begynner et hvitt, fast stoff å utfelles. Blandingen omrøres ved 20 - 25°C i 30 minutter, ved 5 - 10°C i 1 time og avkjøles så ved -10°C i 2 timer. Det faste stoff fjernes ved filtrering, suspenderes i 150 ml 30 volum% eddiksyre-70 volum% ethylether, filtreres og vaskes med 500 ml ethylether. Efter tørring ved 70°C i 2 timer, fåes 83,7 g (88%) L-3-(3,4-diacetoxyfenyl)-2-methylalanin-hydroklorid, smp. 196,0 - 197,0°C. To a mixture of 320 ml of glacial acetic acid and 24 ml of acetyl chloride, 69.4 g (0.291 mol) of L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate are added in one portion. The temperature of the reaction mixture rises to approx. 50°C and a clear solution is obtained. At this temperature, a further 85 ml of acetyl chloride are added over the course of 10 minutes. The clear, pale yellow solution obtained is allowed to stand at 20 - 25°C for 14 hours. 400 ml of anhydrous ethyl ether are added over 15 minutes. When the addition is almost complete, a white solid begins to precipitate. The mixture is stirred at 20 - 25°C for 30 minutes, at 5 - 10°C for 1 hour and then cooled at -10°C for 2 hours. The solid is removed by filtration, suspended in 150 ml of 30% by volume acetic acid-70% by volume ethyl ether, filtered and washed with 500 ml of ethyl ether. After drying at 70°C for 2 hours, 83.7 g (88%) of L-3-(3,4-diacetoxyphenyl)-2-methylalanine hydrochloride are obtained, m.p. 196.0 - 197.0°C.
B. Fremstilling av a-succinimidoethyl-L-3-(3,4-diacetoxyfeny1)-2-methylalaninat- hydroklorid B. Preparation of α-succinimidoethyl-L-3-(3,4-diacetoxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 1,66 g (5 mmol) L-3-(3,4-diacetoxyfenyl)-2-methylalanin-hydroklorid, 0,51 g (5 mmol) triethylamin og 0,81 9 (5 mmol) N-(a-klorethyl)-succinimid i 5 ml dimethylsulfoxyd omrøres ved 20 - 25°C i 20 - 24 timer. Dimethylsulfoxydet fjernes ved om-røring med 20 ml ethylether i flere minutter og derpå avdekanteres ethyletheren. Denne ekst raksjonsprosses utføres tre ganger. Residuet oppløses i 10 ml absolutt ethanol, og produktet felles ved tilsetning av overskudd av ethylether. Denne felningsprosess gjentaes ytterligere to ganger, hvorved man får rent a-succinimidoethyl-L-3-(3,4-diacetoxyfenyl)-2-methylalaninat-hydroklorid. A solution of 1.66 g (5 mmol) L-3-(3,4-diacetoxyphenyl)-2-methylalanine hydrochloride, 0.51 g (5 mmol) triethylamine and 0.81 g (5 mmol) N-( (α-chloroethyl)-succinimide in 5 ml of dimethylsulfoxide is stirred at 20 - 25°C for 20 - 24 hours. The dimethylsulfoxide is removed by stirring with 20 ml of ethyl ether for several minutes and then the ethyl ether is decanted off. This extraction process is performed three times. The residue is dissolved in 10 ml of absolute ethanol, and the product is precipitated by adding an excess of ethyl ether. This folding process is repeated two more times, whereby pure α-succinimidoethyl-L-3-(3,4-diacetoxyphenyl)-2-methylalaninate hydrochloride is obtained.
Eksempel 38 Example 38
Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 1,8 g (3,94 mmol) a-succinimidoethyl-L-3-(3,4-diacetoxyfenyl)-2-methylalaninat-hydroklorid (fra eksempel 37) i 10 ml 1 N saltsyre omrøres under nitrogen ved 20 - 25°C i 5 timer. Efter lyofilisering ved 0,1 - 0,3 mm i 20 timer, behandles residuet med 50 ml 10 volum% ethanol-90 volum% ethylacetatoppløsning, 5 ml A solution of 1.8 g (3.94 mmol) of α-succinimidoethyl-L-3-(3,4-diacetoxyphenyl)-2-methylalaninate hydrochloride (from Example 37) in 10 ml of 1 N hydrochloric acid is stirred under nitrogen at 20 - 25°C for 5 hours. After lyophilization at 0.1 - 0.3 mm for 20 hours, the residue is treated with 50 ml of 10% by volume ethanol-90% by volume ethyl acetate solution, 5 ml
mettet natriumcarbonatoppløsning og 5 g fast natriumcarbonat. Efter saturated sodium carbonate solution and 5 g of solid sodium carbonate. After
filtrering tørres filtratet over vannfritt magnesiumsulfat , filtreres og inndampes til tørrhet under nedsatt trykk. Residuet opp-løses i 20 ml tørr kloroform, oppløsningen avkjøles i et isbad og mettes med hydrogenkloridgass i 15 minutter. Det faste stoff oppsamles, vaskes ved suspendering i 25 ml vannfri ethylether tre ganger og oppslemmes så i 25 ml ethylacetat under nitrogen i en korket kolbe ved værelsetemperatur over natten. a-succinimidoethyl-L-3- (3,4-dihydroxyfenyl)-2-methylalaninat-hydrokloridet oppsamles og tørres i en vakuumekssikator over calciumklorid, hvorved man får hydrokloridet av en blanding av a- og |3-isomerer, iakttatt Rf =0,7 ved tynnskiktskromatografi (fluorescerende silicagelplate, 50 volum% methanol-50 volum% benzenoppløsningsmiddel). filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated to dryness under reduced pressure. The residue is dissolved in 20 ml of dry chloroform, the solution is cooled in an ice bath and saturated with hydrogen chloride gas for 15 minutes. The solid is collected, washed by suspension in 25 ml of anhydrous ethyl ether three times and then suspended in 25 ml of ethyl acetate under nitrogen in a corked flask at room temperature overnight. The α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride is collected and dried in a vacuum desiccator over calcium chloride, whereby the hydrochloride is obtained from a mixture of α- and β-isomers, observing Rf =0 .7 by thin-layer chromatography (fluorescent silica gel plate, 50% by volume methanol-50% by volume benzene solvent).
Eksempel 39 Example 39
A. Fremstilling av N-( 1- klorethyl)- maleimid A. Preparation of N-(1-chloroethyl)-maleimide
5,20 g (0,020 mol) stanniklorid tilsettes til en oppløsning 5.20 g (0.020 mol) stannous chloride is added to a solution
av 49,2 g (0,40 mol) n-vinylmaleimid ill carbontetraklorid, og blandingen omrøres mens den mettes med hydrogenklorid i 6 timer ved 20 - 30°C Efter 24 timer mettes blandingen igjen med hydrogenklorid i 1,5 timer. Ved utløpet av 48 timer dekanteres oppløsningen, og det gummiaktige residuum vaskes med 10 x lOO ml carbontetraklorid. De forenede ekstrakter oppslemmes med 10 g diatoméjord, filtreres, og filtratet inndampes under nedsatt trykk til ca. 4O0 ml. N-(l-klorethyl)-maleimidet frafiltreres og tørres ved 20 - 30°C of 49.2 g (0.40 mol) of n-vinylmaleimide in carbon tetrachloride, and the mixture is stirred while being saturated with hydrogen chloride for 6 hours at 20 - 30°C. After 24 hours, the mixture is again saturated with hydrogen chloride for 1.5 hours. At the end of 48 hours, the solution is decanted, and the gummy residue is washed with 10 x 100 ml of carbon tetrachloride. The combined extracts are slurried with 10 g of diatomaceous earth, filtered, and the filtrate is evaporated under reduced pressure to approx. 4O0 ml. The N-(1-chloroethyl)-maleimide is filtered off and dried at 20 - 30°C
B. Fremstilling av a-maleimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid B. Preparation of α-maleimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 0,95 g (4,0 mmol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat og 0,64 g (4,0 mmol) N-(a-klorethyl)-maleimid i 5 ml dimethylsulfoxyd omrøres ved 20 - 25°C i 23 timer. Oppløsningen fortynnes med 10 ml destillert vann og føres gjennom en kolonne inneholdende 5 g svakt basisk anionbytteharpiks i den basiske form. Efter eluering med vannfraksjoner, forenes fraksjonene som gir en positiv ferrikloridtest og tilsettes til en kolonne av 3 g av en svakt sur kationbytteharpiks i syreformen. Ureagert L-3-(3,4-di-hydroxyf enyl ) -2-methylalanin elueres med destillert vann inntil man får en negativ f errikloridtest, og esteren elueres så med 1 N eddiksyre. Esterfraksjonen, 55 ml (pH 3,2), behandles med 1 N saltsyre til en pH på 2,0 og lyofiliseres ved 0,1 - 0,3 mm i 20 timer, hvorved man får a-maleimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid. A solution of 0.95 g (4.0 mmol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate and 0.64 g (4.0 mmol) N-(α-chloroethyl)-maleimide in 5 ml of dimethylsulfoxide is stirred at 20 - 25°C for 23 hours. The solution is diluted with 10 ml of distilled water and passed through a column containing 5 g of weakly basic anion exchange resin in the basic form. After elution with water fractions, the fractions giving a positive ferric chloride test are combined and added to a column of 3 g of a weakly acidic cation exchange resin in the acid form. Unreacted L-3-(3,4-di-hydroxyphenyl)-2-methylalanine is eluted with distilled water until a negative ferric chloride test is obtained, and the ester is then eluted with 1 N acetic acid. The ester fraction, 55 ml (pH 3.2), is treated with 1 N hydrochloric acid to a pH of 2.0 and lyophilized at 0.1 - 0.3 mm for 20 hours, whereby α-maleimidoethyl-L-3-( 3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride.
C. Fremstilling av a-succinimidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid C. Preparation of α-succinimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 1,0 g (2,7 mmol) a-maleimidoethyl-L-3-(3,4-dihydroxyf enyl)-2-methylalaninat-hydroklorid i 25 ml absolutt ethanol hydrogeneres med 1,0 g 10%-ig palladium-på-carbonkatalysator ved atmosfæretrykk og 25°C inntil 1 ekvivalent hydrogen er opptatt. Katalysatoren frafiltreres, og filtratet inndampes under nedsatt trykk ved 30 - 40°C. Residuet oppløses i 50 ml 10 volum% ethanol-90 volum% ethylacetatoppløsning og omrøres med 5 ml mettet natrium-carbonatoppløsning og ca. 5 g vannfritt natriumcarbonat i 10 minutter. Efter filtrering tørres filtratet over vannfritt magnesium-sulf at, filtreres og inndampes til tørrhet under nedsatt trykk. Residuet oppløses i 20 ml tørr kloroform, oppløsningen avkjøles i et isbad og mettes med hydrogenklorid i 15 minutter. Det faste stoff oppsamles, vaskes ved suspendering i 25 ml vannfri ether tre ganger, og oppslemmes så i 25 ml ethylacetat under nitrogen i en korket kolbe ved 20 - 25°C over natten. Det uoppløselige faste stoff fjernes ved filtrering, omrøres med 30 ml hexan i 2 timer og tørres i en vakuumekssikator over calciumklorid, hvorved man får a-succin-imidoethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid som en blanding av a- og p-isomerer, iakttatt Rf = 0,7 ved tynnskiktskromatografi (fluorescerende silicagelplate, 50 volum% methanol- A solution of 1.0 g (2.7 mmol) of α-maleimidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride in 25 ml of absolute ethanol is hydrogenated with 1.0 g of 10% palladium-on-carbon catalyst at atmospheric pressure and 25°C until 1 equivalent of hydrogen is occupied. The catalyst is filtered off, and the filtrate is evaporated under reduced pressure at 30 - 40°C. The residue is dissolved in 50 ml of 10% by volume ethanol-90% by volume ethyl acetate solution and stirred with 5 ml of saturated sodium carbonate solution and approx. 5 g anhydrous sodium carbonate for 10 minutes. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated to dryness under reduced pressure. The residue is dissolved in 20 ml of dry chloroform, the solution is cooled in an ice bath and saturated with hydrogen chloride for 15 minutes. The solid is collected, washed by suspending in 25 ml of anhydrous ether three times, and then suspended in 25 ml of ethyl acetate under nitrogen in a corked flask at 20 - 25°C overnight. The insoluble solid is removed by filtration, stirred with 30 ml of hexane for 2 hours and dried in a vacuum desiccator over calcium chloride, whereby a-succin-imidoethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride is obtained as a mixture of α- and β-isomers, observed Rf = 0.7 by thin-layer chromatography (fluorescent silica gel plate, 50 vol% methanol
50 volum% benzenoppløsningsmiddel). 50 vol% benzene solvent).
Eksempel 40 Example 40
A. Fremstilling av g- klorethyl- 3- klor- 2, 2- dimethylpropionat A. Preparation of g-chloroethyl-3-chloro-2,2-dimethylpropionate
400 mg zinkklorid smeltes ved 0,2 - 0,5 mm trykk og avkjøles til 25 - 30°C under nitrogen. 62 g (0,40 mol) 3-klor-2,2-dimethyl-propionylklorid tilsettes til det smeltede zinkklorid fulgt av 19,2 g (0,44 mol) acetaldehyd. Under tilsetningen av acetaldehydet, som gjøres så hurtig som mulig, omrøres reaksjonsblandingen og av-kjøles for å forhindre tap av acetaldehyd på grunn av reaksjonens eksoterme natur. Efter oppvarmning under tilbakeløp i 1 time gir destillasjon a-klorethyl-3-klor-2,2-dimethylpropionat. 400 mg of zinc chloride is melted at 0.2 - 0.5 mm pressure and cooled to 25 - 30°C under nitrogen. 62 g (0.40 mol) of 3-chloro-2,2-dimethyl-propionyl chloride is added to the molten zinc chloride followed by 19.2 g (0.44 mol) of acetaldehyde. During the addition of the acetaldehyde, which is done as quickly as possible, the reaction mixture is stirred and cooled to prevent loss of acetaldehyde due to the exothermic nature of the reaction. After heating under reflux for 1 hour, distillation gives α-chloroethyl-3-chloro-2,2-dimethylpropionate.
B. Fremstilling av a-(3-klor-2,2-dimethylpropionyloxy)-ethyl-L-3-( 3, 4- dihydroxyfenyl)- 2- methylalaninat- hydroklorid B. Preparation of α-(3-chloro-2,2-dimethylpropionyloxy)-ethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 0,95 g (4,0 mmol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat og 0,81 g (4,06 mmol) a-klorethyl-3-klor-2,2-dimethylpropionat i 5 ml dimethylsulfoxyd omrøres ved 20 - 25 C i 24 timer. Oppløsningen fortynnes med 10 ml destillert vann og føres gjennom en kolonne inneholdende 5 g svakt basisk anionbytteharpiks i baseformen. Efter eluering med vannfraksjoner forenes fraksjonene som gir en positiv ferrikloridtest og tilsettes til en kolonne av 3 g svakt sur kationbytteharpiks i syreformen. A solution of 0.95 g (4.0 mmol) L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate and 0.81 g (4.06 mmol) α-chloroethyl-3-chloro-2 ,2-dimethylpropionate in 5 ml of dimethylsulfoxide is stirred at 20 - 25 C for 24 hours. The solution is diluted with 10 ml of distilled water and passed through a column containing 5 g of weakly basic anion exchange resin in the base form. After elution with water fractions, the fractions which give a positive ferric chloride test are combined and added to a column of 3 g of weakly acidic cation exchange resin in the acid form.
Uomsatt L-3-(3,4-dihydroxyfenyl)-2-methylalanin elueres med destillert vann inntil man får en'negativ ferrikloridtest, esteren elueres så med 1 N eddiksyre. Esterfraksjonen, 50 ml (pH 3,2), syres til pH 2,0 med 1 N saltsyre og lyofiliseres ved 0,1 - 0,3 mm i 20 timer, hvorved man får a-(3-klor-2,2-dimethylpropionyloxy)-ethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid som eddiksyresolvatet . Unreacted L-3-(3,4-dihydroxyphenyl)-2-methylalanine is eluted with distilled water until a negative ferric chloride test is obtained, the ester is then eluted with 1 N acetic acid. The ester fraction, 50 ml (pH 3.2), is acidified to pH 2.0 with 1 N hydrochloric acid and lyophilized at 0.1 - 0.3 mm for 20 hours, whereby α-(3-chloro-2,2- dimethylpropionyloxy)-ethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride as the acetic acid solvate.
C. Fremstilling av a-pivaloyloxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid C. Preparation of α-pivaloyloxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 1,5 g (3,66 mmol) a-(3~klor-2,2-dimethyl-propionyloxy)-ethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid i 20 ml absolutt ethanol hydrogeneres med 1,0 g 10%-ig palladium-på-carbonkatalysator ved 20 - 25°C og atmosfæretrykk inntil 1 ekvivalent hydrogen er tatt opp. Efter fjernelse av katalysatoren ved filtrering, fjernes ethanolen ved 15 - 20 mm og 30 - A solution of 1.5 g (3.66 mmol) of α-(3~chloro-2,2-dimethyl-propionyloxy)-ethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride in 20 ml of absolute ethanol is hydrogenated with 1.0 g of 10% palladium-on-carbon catalyst at 20 - 25°C and atmospheric pressure until 1 equivalent of hydrogen has been taken up. After removing the catalyst by filtration, the ethanol is removed at 15 - 20 mm and 30 -
35°C. Residuet oppløses i 4o ml ethylacetat, omrøres kort med en blanding av 2 g fast natriumcarbonat og 2 ml mettet natriumcarbonat-oppløsning og tørres over vannfritt magnesiumsulfat. Efter filtrering tilsettes 1 ml 9,6 N ethanolisk vannfritt hydrogenklorid, og oppløsningen inndampes under nedsatt trykk til tørrhet. Videre tørr-ing ved 65°C og 0,2 mm trykk gir a-pivaloyloxyethylester-hydrokloridet. 35°C. The residue is dissolved in 40 ml of ethyl acetate, stirred briefly with a mixture of 2 g of solid sodium carbonate and 2 ml of saturated sodium carbonate solution and dried over anhydrous magnesium sulfate. After filtration, 1 ml of 9.6 N ethanolic anhydrous hydrogen chloride is added, and the solution is evaporated under reduced pressure to dryness. Further drying at 65°C and 0.2 mm pressure gives the α-pivaloyloxyethyl ester hydrochloride.
Eksempel 41 Example 41
A. Fremstilling av benzylsuccinamat A. Preparation of Benzyl Succinamate
En blanding av 23,4 g (0,20 mol) ravsyre, 25,4 g (0,20 mol) benzylklorid, 20,2 g (0,20 mol) triethylamin og 250 ml dimethylformamid omrøres ved 95 C i 20 timer. Reaksjonsblandingen fortynnes med 500 ml vann, og produktet ekstraheres i 2 x 200 ml ethylether. De forenede etherekstrakter vaskes med 2 x 50 ml mettet natriumbicarbon-atoppløsning, derpå med 2 x 50 ml vann og tørres over vannfritt magnesiumsulfat . Efter filtrering inndampes oppløsningen ved 15 - 20 mm og 4o°C, hvorved man får benzylsuccinamat. A mixture of 23.4 g (0.20 mol) succinic acid, 25.4 g (0.20 mol) benzyl chloride, 20.2 g (0.20 mol) triethylamine and 250 ml dimethylformamide is stirred at 95 C for 20 hours. The reaction mixture is diluted with 500 ml of water, and the product is extracted into 2 x 200 ml of ethyl ether. The combined ether extracts are washed with 2 x 50 ml saturated sodium bicarbonate solution, then with 2 x 50 ml water and dried over anhydrous magnesium sulfate. After filtration, the solution is evaporated at 15 - 20 mm and 4o°C, whereby benzyl succinamate is obtained.
B. Fremstilling av benzyl- N- hydroxymethylsuccinamat B. Preparation of benzyl-N-hydroxymethylsuccinamate
Til en omrørt oppløsning av 20,7 g (0,lO mol) benzylsuccinamat i 150 ml ethylacetat ved 25°C tilsettes 3,0 g paraformaldehyd og 1 ml 20 vekt%-ig ethanolisk kaliumhydroxyd. Efter omrøring ved 25°C i 2o timer tilsettes hexan til blakningspunktet, og blandingen av-kjøles ved 5°C i 24 timer. Oppløsningsmidlene fradekanteres, og residuet vaskes med 25 ml hexan, hvorved man får benzyl-N-hydroxymethylsuccinamat. To a stirred solution of 20.7 g (0.10 mol) of benzyl succinamate in 150 ml of ethyl acetate at 25°C, 3.0 g of paraformaldehyde and 1 ml of 20% by weight ethanolic potassium hydroxide are added. After stirring at 25°C for 20 hours, hexane is added to the boiling point, and the mixture is cooled at 5°C for 24 hours. The solvents are decanted off, and the residue is washed with 25 ml of hexane, whereby benzyl-N-hydroxymethylsuccinamate is obtained.
C. Fremstilling av benzyl- N- klormethylsuccinamat C. Preparation of benzyl-N-chloromethylsuccinamate
En oppløsning av 24,2 g (0,10 mol) benzyl-N-hydroxymethylsuccinamat og 28,9 g (0,11 mol) trifenylfosfin i 500 ml carbontetraklorid omrøres under tilbakeløp i 12 timer. Efter filtrering og vasking av bunnfallet med benzen, fjernes de organiske oppløsnings-midler ved 5l5 - 20 mm og 30 - 4o°C, hvorved man får benzyl-N-klormethylsuccinamat av tilstrekkelig renhet for anvendelse i det neste t rinn. A solution of 24.2 g (0.10 mol) of benzyl-N-hydroxymethylsuccinamate and 28.9 g (0.11 mol) of triphenylphosphine in 500 ml of carbon tetrachloride is stirred under reflux for 12 hours. After filtering and washing the precipitate with benzene, the organic solvents are removed at 5l5 - 20 mm and 30 - 4o°C, thereby obtaining benzyl-N-chloromethylsuccinamate of sufficient purity for use in the next step.
D. Fremstilling av benzylsuccinamidomethyl-L-N-carbobenzyloxy-3-( 3, 4- difenylmethylendioxyfenyl)- 2- methylalanin D. Preparation of benzylsuccinamidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine
En oppløsning av 10,2 g (0,020 mol) L-N-carbobenzyloxy-3~(3,4-difenylmethylendioxyfenyl)-2-methylalanin, 2,02 g (0,020 mol) triethylamin og 5,12 g (0,020 mol) benzyl-N-klormethylsuccinamat i 20 ml dimethylformamid omrøres ved 70°C i 5 timer, derpå ved 20 - 30°C i 5 timer og helles til slutt i 200 ml vann. Produktet ekstraheres med 3 x lOO ml ethylacetat, vaskes med 50 ml 5%-ig natrium-hydroxydoppløsning, 50 ml vann og 50 ml mettet natriumkloridoppløs-ning, og tørres over vannfritt magnesiumsulfat. Efter filtrering fjernes oppløsningsmidlene ved 15 - 20 mm og 30 - 40°C, hvorved man får benzylsuccinamidomethyl-L-N-carbobenzyloxy-3-(3,4-difenyl-methylendioxyf enyl)-2-methylalanin. A solution of 10.2 g (0.020 mol) L-N-carbobenzyloxy-3~(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine, 2.02 g (0.020 mol) triethylamine and 5.12 g (0.020 mol) benzyl-N -chloromethylsuccinamate in 20 ml of dimethylformamide is stirred at 70°C for 5 hours, then at 20 - 30°C for 5 hours and finally poured into 200 ml of water. The product is extracted with 3 x 100 ml ethyl acetate, washed with 50 ml 5% sodium hydroxide solution, 50 ml water and 50 ml saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. After filtration, the solvents are removed at 15 - 20 mm and 30 - 40°C, whereby benzylsuccinamidomethyl-L-N-carbobenzyloxy-3-(3,4-diphenyl-methylenedioxyphenyl)-2-methylalanine is obtained.
E. Fremstilling av succinamidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid E. Preparation of succinamidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 13,8 9 (0,0189 mol) benzylsuccinamidomethyl-L-N -carbobenzyloxy-3-(3,4-difenylmethylendioxyfenyl)-2-methylalanin i 130 ml 25 volum% absolutt ethanol-75 volum% ethylacetat hydrogeneres med 5 g 10%-ig palladium-på-carbonkatalysator ved 20 - 25°C og et begynnelsestrykk på 2,81 kg/cm i 18 timer inntil hydrogenopptagelsen opphører. Efter fjernelse av katalysatoren ved filtrering og inndampning til tørrhet under nedsatt trykk, oppløses residuet i 200 ml 10 volum% absolutt ethanol-90 volum% ethylacetatoppløsning og omrøres med 5 ml mettet natriumcarbonatoppløsning og overskudd av fast natriumcarbonat i 2 minutter. 10 g vannfritt magnesiumsulfat tilsettes, og efter noen få minutter fjernes det ved filtrering. Oppløsningsmidler fjernes under nedsatt trykk, residuet vaskes med 25 ml hexan og derpå med 25 ml ethylacetat og tørres under nedsatt trykk. Residuet behandles igjen med natriumcarbonat som før for å fjerne de siste spor av a-methyl-3,4-dihydroxyfenylalanin og over-føres til hydrokloridsaltet med 3 ml 9,6 N ethanolisk vannfritt hydrogenklorid, hvorved man får succinamidomethyl-L-3-(3,4-dihydroxy-fenyl)-2-methylalaninat-hydroklorid. A solution of 13.8 9 (0.0189 mol) benzylsuccinamidomethyl-L-N -carbobenzyloxy-3-(3,4-diphenylmethylenedioxyphenyl)-2-methylalanine in 130 ml of 25 vol% absolute ethanol-75 vol% ethyl acetate is hydrogenated with 5 g 10 % palladium-on-carbon catalyst at 20 - 25°C and an initial pressure of 2.81 kg/cm for 18 hours until hydrogen uptake ceases. After removal of the catalyst by filtration and evaporation to dryness under reduced pressure, the residue is dissolved in 200 ml of 10% by volume absolute ethanol-90% by volume ethyl acetate solution and stirred with 5 ml of saturated sodium carbonate solution and excess of solid sodium carbonate for 2 minutes. 10 g of anhydrous magnesium sulphate is added, and after a few minutes it is removed by filtration. Solvents are removed under reduced pressure, the residue is washed with 25 ml of hexane and then with 25 ml of ethyl acetate and dried under reduced pressure. The residue is again treated with sodium carbonate as before to remove the last traces of α-methyl-3,4-dihydroxyphenylalanine and transferred to the hydrochloride salt with 3 ml of 9.6 N ethanolic anhydrous hydrogen chloride, whereby succinamidomethyl-L-3-( 3,4-dihydroxy-phenyl)-2-methylalaninate hydrochloride.
F. Fremstilling av succinimidomethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid- hydrat F. Preparation of succinimidomethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride hydrate
En blanding av 3,95 9 (10 mmol) succinamidomethyl-L-3-(3,4-dihydroxyf enyl-2-methylalaninat-hydroklorid og lOO ml acetylklorid omrøres ved 25°C i 6 timer. Efter inndampning ved 15 - 20 mm og 35°C oppløses residuet i 25 ml 1 N saltsyre og omrøres under nitrogen ved 20 - 25°C i 5 timer. Efter lyofilisering ved 0,1 - 0,3 mm i 20 timer, behandles residuet med 50 ml IO volum% ethanol-90 volum% ethylacetatoppløsning, 5 ml mettet natriumcarbonatoppløsning og 5 g fast natriumcarbonat. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat , filtreres og inndampes ved 15 - 20 og 30 - 4o°C. Residuet oppløses i 25 ml absolutt ethanol, behandles med 5 ml 9,6 N ethanolisk vannfri hydrogenkloridoppløsning og inndampes under nedsatt trykk, hvorved man får succinimidomethyl-L-3-(3,4-di-hydroxyf enyl)-2-methylalaninat-hydroklorid-hydrat, homogent ved tynnskiktskromatografi (fluorescerende silicagelplate, 30 volum% methanol-70 volum% benzenoppløsningsmiddel) med en iakttatt Rf = 0,5-Eksempel 42 A mixture of 3.95 g (10 mmol) of succinamidomethyl-L-3-(3,4-dihydroxyphenyl-2-methylalaninate hydrochloride and 100 ml of acetyl chloride is stirred at 25°C for 6 hours. After evaporation at 15 - 20 mm and 35 ° C, the residue is dissolved in 25 ml of 1 N hydrochloric acid and stirred under nitrogen at 20 - 25 ° C for 5 hours. After lyophilization at 0.1 - 0.3 mm for 20 hours, the residue is treated with 50 ml of 10 vol% ethanol -90% by volume ethyl acetate solution, 5 ml saturated sodium carbonate solution and 5 g solid sodium carbonate. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated at 15 - 20 and 30 - 4o°C. The residue is dissolved in 25 ml absolute ethanol, treated with 5 ml 9.6 N ethanolic anhydrous hydrogen chloride solution and evaporated under reduced pressure, thereby obtaining succinimidomethyl-L-3-(3,4-di-hydroxyphenyl)-2-methylalaninate hydrochloride hydrate, homogeneous by thin-layer chromatography (fluorescent silica gel plate, 30 volume % methanol-70 vol% benzene solvent) with an observed Rf = 0.5-Example 4 2
A. Fremstilling av 2-hydroxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat- hydroklorid A. Preparation of 2-hydroxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride
En oppløsning av 0,95 g (4,0 mmol) L-3-(3,4-dihydroxyfenyl)-2-methylalanin-seskvihydrat og 0,51 g (4,06 mmol) 2-bromethanol i 5 ml dimethylsulfoxyd omrøres ved 6o°C i 5 timer og får så avkjøle til 20 - 25°C i løpet av 23 timer. Oppløsningen fortynnes med lo ml destillert vann og føres gjennom en kolonne inneholdende 5 9 svakt basisk anionbytteharpiks i baseformen. Efter eluering med vannfraksjoner forenes fraksjonene som gir en positiv ferrikloridtest og tilsettes til en kolonne av 3 g svakt sur kationbytteharpiks i syreformen. Uomsatt L-3-(3,4-dihydroxyfenyl)-2-methylalanin elueres med destillert vann inntil en negativ ferrikloridtest fåes, og esteren elueres så med 1 N eddiksyre. Esterfraksjonen, 50 ml (pH 3,2), syres til pH 2,0 med 1 N saltsyre og lyofiliseres ved 0,1 - 0,3 mm i 20 timer, hvorved man får 2-hydroxyethyl-L-3"(3,4-dihydroxyfenyl)-2-methylalaninat-hydroklorid. A solution of 0.95 g (4.0 mmol) of L-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate and 0.51 g (4.06 mmol) of 2-bromoethanol in 5 ml of dimethyl sulfoxide is stirred at 6o°C for 5 hours and then allowed to cool to 20 - 25°C over 23 hours. The solution is diluted with 10 ml of distilled water and passed through a column containing 5 9 weakly basic anion exchange resin in the base form. After elution with water fractions, the fractions which give a positive ferric chloride test are combined and added to a column of 3 g of weakly acidic cation exchange resin in the acid form. Unreacted L-3-(3,4-dihydroxyphenyl)-2-methylalanine is eluted with distilled water until a negative ferric chloride test is obtained, and the ester is then eluted with 1 N acetic acid. The ester fraction, 50 ml (pH 3.2), is acidified to pH 2.0 with 1 N hydrochloric acid and lyophilized at 0.1 - 0.3 mm for 20 hours, whereby 2-hydroxyethyl-L-3"(3, 4-dihydroxyphenyl)-2-methylalaninate hydrochloride.
B. Fremstilling av 2-acetoxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat B. Preparation of 2-acetoxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate
En blanding av 1,0 g (3,4 mmol) 2-hydroxyethyl-L-3"(3,4~ dihydroxyfenyl)-2-methylalaninat-hydroklorid og 50 ml acetylklorid omrøres ved 25°C i 6 timer. Efter inndampning ved 15 - 20 mm og 35°C oppløses residuet i 25 ml 1 N saltsyre og omrøres under nitrogen ved 20 - 25°C i 5 timer. Efter lyofilisering ved 0,1 - 0,3 mm i 20 timer, behandles residuet med 50 ml 10 volum% ethanol-90 volum% ethylacetatoppløsning, 5 ml mettet natriumcarbonatoppløsning og 5 g fast natriumcarbonat. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes ved 15 - 20 mm og 30 - 4o°c. A mixture of 1.0 g (3.4 mmol) 2-hydroxyethyl-L-3"(3,4~ dihydroxyphenyl)-2-methylalaninate hydrochloride and 50 ml acetyl chloride is stirred at 25°C for 6 hours. After evaporation at 15 - 20 mm and 35 ° C, the residue is dissolved in 25 ml of 1 N hydrochloric acid and stirred under nitrogen at 20 - 25 ° C for 5 hours. After lyophilization at 0.1 - 0.3 mm for 20 hours, the residue is treated with 50 ml 10 vol% ethanol-90 vol% ethyl acetate solution, 5 ml saturated sodium carbonate solution and 5 g solid sodium carbonate After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated at 15 - 20 mm and 30 - 4o°c.
Residuet kromatograferes på silicagel og elueres med 20 volum% methanol-80 volum% benzen. Omkrystallisasjon skjer ved å oppløse esteren i varmt ethylacetat og tilsette tilstrekkelig cyclohexari til å felle det ønskede 2-acetoxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat, smp. 114 - H8°C (spaltn.). The residue is chromatographed on silica gel and eluted with 20 vol% methanol-80 vol% benzene. Recrystallization takes place by dissolving the ester in hot ethyl acetate and adding sufficient cyclohexari to precipitate the desired 2-acetoxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate, m.p. 114 - H8°C (dec.).
Eksempel 43 Example 43
Fremstilling av 2-acetoxyethyl-L-3-(3,4-dihydroxyfenyl)-2-methylalaninat Preparation of 2-acetoxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate
En blanding av 1,0 g (3,4 mmol) 2-hydroxyethyl-L-3-(3,4-dihydroxyf enyl ) -2 -methylalaninat -hydroklorid og 50 ml methansulfonyl-klorid omrøres ved 25°C i 6 timer. Inndampning ved 15 - 20 mm og 35°C fulgt av tørring ved 0,1 - 0,5 mm og 4o°C gir det rå methan-sulfonylderivat . Til dette tilsettes IO ml dimethylsulfoxyd og 6,6 g (10 mmol) lithiumacetat , og blandingen omrøres ved 6o°C i 6 timer. Efter tilsetning av overskudd av ethanolisk vannfri hydrogenklorid-oppløsning, fjernes dimethylsulfoxydet ved omrøring tre ganger med 50 ml ethylether og fradekantering av ethyletheren. Residuet opp-løses i 25 ml 1 N saltsyre og omrøres under nitrogen ved 20 - 25°C i 1 time. Efter lyofilisering ved 0,1 - 0,3 mm i 20 timer behandles residuet med 50 ml 10 volum% ethanol-90 volum% ethylacetatoppløsning, 5 ml mettet natriumcarbonatoppløsning og 5 g fast natriumcarbonat. Efter filtrering tørres filtratet over vannfritt magnesiumsulfat, filtreres og inndampes ved 15 - 20 mm og 30 - 40°C. A mixture of 1.0 g (3.4 mmol) of 2-hydroxyethyl-L-3-(3,4-dihydroxyphenyl)-2-methylalaninate hydrochloride and 50 ml of methanesulfonyl chloride is stirred at 25°C for 6 hours. Evaporation at 15 - 20 mm and 35°C followed by drying at 0.1 - 0.5 mm and 4o°C gives the crude methane-sulfonyl derivative. To this is added 10 ml of dimethylsulfoxide and 6.6 g (10 mmol) lithium acetate, and the mixture is stirred at 6o°C for 6 hours. After adding an excess of ethanolic anhydrous hydrogen chloride solution, the dimethylsulfoxide is removed by stirring three times with 50 ml of ethyl ether and decanting off the ethyl ether. The residue is dissolved in 25 ml of 1 N hydrochloric acid and stirred under nitrogen at 20 - 25°C for 1 hour. After lyophilization at 0.1 - 0.3 mm for 20 hours, the residue is treated with 50 ml of 10% by volume ethanol-90% by volume ethyl acetate solution, 5 ml of saturated sodium carbonate solution and 5 g of solid sodium carbonate. After filtration, the filtrate is dried over anhydrous magnesium sulfate, filtered and evaporated at 15 - 20 mm and 30 - 40°C.
Residuet kromatograferes på silicagel og elueres med 20 volum% methanol-& 0 volum% benzen. Omkrystallisasjon av esteren skjer ved oppløsning i ethylacetat og tilsetning av tilstrekkelig cyclohexan til å felle det ønskede 2-acetoxyethyl-L-3"(3,4-dihydroxyfeny1)-2-methylalaninat , smp. 114 - H8°C under spaltning. The residue is chromatographed on silica gel and eluted with 20 vol% methanol and 0 vol% benzene. Recrystallization of the ester occurs by dissolving in ethyl acetate and adding sufficient cyclohexane to precipitate the desired 2-acetoxyethyl-L-3"(3,4-dihydroxypheny1)-2-methylalaninate, m.p. 114 - H8°C during cleavage.
Eksempel 44 Example 44
Anti- hypertensiv aktivitet Anti-hypertensive activity
Metoden for å bedømme den anti-hypertensive aktivitet av de aktive forbindelser omfatter administrering av forbindelsen enten oralt eller intraperitonealt i spontant hypertensive rotter av Wistar-Okamoto-stammen. Arterietrykk opptegnes kontinuerlig i disse dyr gjennnom et istående aortisk kateter innført gjennom kaudal-arterien. Dyrene tillates fri bevegelse i metabolismeburet under målingene. The method for assessing the anti-hypertensive activity of the active compounds comprises administering the compound either orally or intraperitoneally to spontaneously hypertensive rats of the Wistar-Okamoto strain. Arterial pressure is recorded continuously in these animals through an indwelling aortic catheter inserted through the caudal artery. The animals are allowed free movement in the metabolism cage during the measurements.
Når forbindelsene som fremstilles ifølge oppfinnelsen, prøvesi oralt, merkes tydelig anti-hypertensiv aktivitet. Forbindelsene viser også anti-hypertensiv aktivitet når de prøves intraperitonealt. I noen tilfelle viser forbindelsene betraktelig mere aktivitet enn L-a-methyldopa. When the compounds produced according to the invention are tried, say orally, clear anti-hypertensive activity is noted. The compounds also show anti-hypertensive activity when tested intraperitoneally. In some cases, the compounds show considerably more activity than L-α-methyldopa.
Nedenstående tabell viser de relative antihypertensive aktiviteter i spontant hypertensive rotter av noen av fremgangsmåteforbindelsene sammenlignet med L-methyldopa. The table below shows the relative antihypertensive activities in spontaneously hypertensive rats of some of the process compounds compared to L-methyldopa.
Antihypertensiv aktivitet av forbindelser med formelen Antihypertensive activity of compounds with the formula
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40060973A | 1973-09-25 | 1973-09-25 | |
US05/482,102 US3983138A (en) | 1973-09-25 | 1974-06-25 | Amino acid esters |
Publications (3)
Publication Number | Publication Date |
---|---|
NO743274L NO743274L (en) | 1975-04-21 |
NO145690B true NO145690B (en) | 1982-02-01 |
NO145690C NO145690C (en) | 1982-05-12 |
Family
ID=27017124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO743274A NO145690C (en) | 1973-09-25 | 1974-09-12 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF ALFA-METHYL-3,4-DIHYDROXYPHENYLALANINE |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS58208256A (en) |
AR (1) | AR210248A1 (en) |
BG (1) | BG25790A3 (en) |
CS (1) | CS200172B2 (en) |
DD (1) | DD116454A5 (en) |
DK (1) | DK478574A (en) |
EG (1) | EG11695A (en) |
ES (1) | ES430320A1 (en) |
FI (1) | FI61687C (en) |
HU (1) | HU171136B (en) |
IE (1) | IE40256B1 (en) |
IL (1) | IL45669A (en) |
NO (1) | NO145690C (en) |
PH (1) | PH11794A (en) |
RO (1) | RO69156A (en) |
SE (1) | SE421789B (en) |
SU (2) | SU608471A3 (en) |
YU (2) | YU37117B (en) |
ZM (1) | ZM14074A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01107949A (en) * | 1987-10-22 | 1989-04-25 | Kawasaki Steel Corp | Method for reusing non-repaired tundish |
JP4781352B2 (en) * | 2004-06-04 | 2011-09-28 | ゼノポート,インコーポレーテッド | Levodopaprodrug and compositions thereof and uses thereof |
CA2673336A1 (en) * | 2006-12-21 | 2008-06-26 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
-
1974
- 1974-09-03 DD DD181243A patent/DD116454A5/xx unknown
- 1974-09-11 DK DK478574A patent/DK478574A/da not_active Application Discontinuation
- 1974-09-12 NO NO743274A patent/NO145690C/en unknown
- 1974-09-12 SE SE7411508A patent/SE421789B/en not_active IP Right Cessation
- 1974-09-13 FI FI2680/74A patent/FI61687C/en active
- 1974-09-16 ZM ZM140/74A patent/ZM14074A1/en unknown
- 1974-09-16 IL IL45669A patent/IL45669A/en unknown
- 1974-09-17 YU YU2514/74A patent/YU37117B/en unknown
- 1974-09-17 CS CS746376A patent/CS200172B2/en unknown
- 1974-09-17 PH PH16292A patent/PH11794A/en unknown
- 1974-09-18 IE IE1934/74A patent/IE40256B1/en unknown
- 1974-09-18 HU HU74ME00001776A patent/HU171136B/en unknown
- 1974-09-23 ES ES430320A patent/ES430320A1/en not_active Expired
- 1974-09-23 BG BG027759A patent/BG25790A3/en unknown
- 1974-09-23 AR AR255680A patent/AR210248A1/en active
- 1974-09-23 RO RO7480046A patent/RO69156A/en unknown
- 1974-09-24 SU SU742063140A patent/SU608471A3/en active
- 1974-09-24 EG EG416/74A patent/EG11695A/en active
-
1976
- 1976-01-27 SU SU762316005A patent/SU620204A3/en active
-
1981
- 1981-02-27 YU YU0503/81A patent/YU37313B/en unknown
-
1983
- 1983-04-07 JP JP58060117A patent/JPS58208256A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
FI61687B (en) | 1982-05-31 |
SE421789B (en) | 1982-02-01 |
HU171136B (en) | 1977-11-28 |
SE7411508L (en) | 1975-03-26 |
YU37117B (en) | 1984-08-31 |
YU50381A (en) | 1983-04-27 |
FI268074A (en) | 1975-03-26 |
CS200172B2 (en) | 1980-08-29 |
SU608471A3 (en) | 1978-05-25 |
BG25790A3 (en) | 1978-12-12 |
RO69156A (en) | 1981-11-24 |
ZM14074A1 (en) | 1976-11-22 |
YU251474A (en) | 1982-06-18 |
IE40256L (en) | 1975-03-25 |
PH11794A (en) | 1978-07-05 |
JPS632545B2 (en) | 1988-01-19 |
YU37313B (en) | 1984-08-31 |
FI61687C (en) | 1982-09-10 |
SU620204A3 (en) | 1978-08-15 |
IL45669A0 (en) | 1974-11-29 |
NO145690C (en) | 1982-05-12 |
AR210248A1 (en) | 1977-07-15 |
NO743274L (en) | 1975-04-21 |
DD116454A5 (en) | 1975-11-20 |
JPS58208256A (en) | 1983-12-03 |
DK478574A (en) | 1975-05-20 |
IL45669A (en) | 1977-08-31 |
ES430320A1 (en) | 1977-02-16 |
EG11695A (en) | 1977-10-31 |
IE40256B1 (en) | 1979-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3983138A (en) | Amino acid esters | |
EP0318377B1 (en) | Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications | |
DK200300345U3 (en) | Amlodipine maleate and pharmaceutical composition containing amlodipine maleate | |
CN110662743A (en) | Lactam compounds as FXR receptor agonists | |
CS275837B6 (en) | Method of production of new cycloalkan0-|1,2b¨-indole sulfonamides | |
EP0015038A1 (en) | Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation | |
EP0005689A1 (en) | Lactam-N-acetic acids, their amides, process for their preparation and therapeutic compositions containing them | |
NO148416B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDINE, MORPHOLINE AND TIAZAN DERIVATIVES | |
CA3030431A1 (en) | Pyrrolidine derivatives as ppar agonists | |
US4038411A (en) | Antihypertensive amino acid esters | |
US5747521A (en) | N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same | |
FR2560195A1 (en) | ALANYL-PROLINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL APPLICATIONS THEREOF | |
NO145690B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF ALFA-METHYL-3,4-DIHYDROXYPHENYLALANINE. | |
EP0004494A1 (en) | Derivatives of 1,3-dihydro-3-(1-(2-(2,3-dihydro-1,4-benzodioxin-2-yl)2-hydroxyethyl)piperidin-4-yl)2H-indol-2-on, process for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
US4965283A (en) | Amino acid esters, process for the preparation thereof and use thereof | |
DK165981B (en) | ISOXAZOLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS | |
FR2753970A1 (en) | N- (BENZOTHIAZOL-2-YL) PIPERIDINE-1-ETHANAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
CH639370A5 (en) | HALOGENATED MERCAPTOACYLAMINE ACIDS AND PROCESS FOR THEIR PREPARATION. | |
EP0053017A1 (en) | Amide derivatives | |
US3086972A (en) | Aza-thiaxanthene derivatives | |
NO127447B (en) | ||
US4051169A (en) | Amino acid esters | |
DK146851B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF BENZYLAMINES OR THEIR ACID ADDITION SALTS OF ONE OR MULTIMBASIC, PHYSIOLOGICALLY ACCEPTABLE ACIDS | |
EP0005091B1 (en) | Monosubstituted piperazines, processes for their preparation and pharmaceutical compositions containing them | |
US3637804A (en) | Phenylalanine derivatives and preparation thereof |